USP9X Data Analysis

HGNC Gene Name
ubiquitin specific peptidase 9 X-linked
HGNC Gene Symbol
USP9X
Identifiers
hgnc:12632 NCBIGene:8239 uniprot:Q93008
Orthologs
mgi:894681 rgd:1560056
INDRA Statements
deubiquitinations all statements
Pathway Commons
Search for USP9X
Number of Papers
340 retrieved on 2023-02-19

DepMap Analysis

The Dependency Map (DepMap) is a genome-wide pooled CRISPR-Cas9 knockout proliferation screen conducted in more than 700 cancer cell lines spanning many different tumor lineages. Each cell line in the DepMap contains a unique barcode, and each gene knockout is assigned a “dependency score” on a per cell-line basis which quantifies the rate of CRISPR-Cas9 guide drop. It has been found that proteins with similar DepMap scores across cell lines, a phenomenon known as co-dependent genes, have closely related biological functions. This can include activity in the same or parallel pathways or membership in the same protein complex or the same pathway.

We identified the strongest seven co-dependent genes (“Symbol”) for DUBs and ran GO enrichment analysis. We used Biogrid, IntAct, and Pathway Commons PPIDs, and the NURSA protein-protein interaction databases (PPIDs) to determine whether co-dependent genes interact with one another. The “Evidence” column contains the PPIDs in which the interaction appears as well as whether there is support for the association by an INDRA statement. As another approach to identify potential interactors, we looked at proteomics data from the Broad Institute's Cancer Cell Line Encyclopedia (CCLE) for proteins whose expression across ~375 cell lines strongly correlated with the abundance of each DUB; it has previously been observed that proteins in the same complex are frequently significantly co-expressed. The correlations and associated p-values in the CCLE proteomics dataset are provided. And, we determined whether co-dependent genes yield similar transcriptomic signatures in the Broad Institute's Connectivity Map (CMap). A CMap score greater than 90 is considered significantly similar.

DepMap Correlations

Symbol Name DepMap Correlation Evidence CCLE Correlation CCLE Z-score CCLE p-value (adj) CCLE Significant CMAP Score CMAP Type
UCHL5 ubiquitin C-terminal hydrolase L5 0.24 Reactome (6) -0.04 -0.31 5.72e-01
RNF25 ring finger protein 25 0.225 0.30 1.58 5.77e-08
TUBD1 tubulin delta 1 0.22
FAAP24 FA core complex associated protein 24 0.202
UBE2N ubiquitin conjugating enzyme E2 N 0.196 Reactome (3) 0.24 1.25 1.40e-05
USP7 ubiquitin specific peptidase 7 0.195 IntAct Pathway Commons INDRA (5) Reactome (10) 0.07 0.30 2.73e-01
CEP120 centrosomal protein 120 0.188 -0.00 -0.11 9.61e-01

Dependency GO Term Enrichment

Gene set enrichment analysis was done on the genes correlated with USP9Xusing the terms from Gene Ontology and gene sets derived from the Gene Ontology Annotations database via MSigDB.

Using the biological processes and other Gene Ontology terms from well characterized DUBs as a positive control, several gene set enrichment analyses were considered. Threshold-less methods like GSEA had relatively poor results. Over-representation analysis with a threshold of of the top 7 highest absolute value Dependency Map correlations yielded the best results and is reported below.

GO Identifier GO Name GO Type p-value p-value (adj.) q-value
GO:0032435 negative regulation of proteasomal ubiquitin-dependent protein catabolic process Biological Process 6.51e-05 1.15e-02 3.68e-03
GO:2000059 negative regulation of ubiquitin-dependent protein catabolic process Biological Process 1.25e-04 2.21e-02 3.68e-03
GO:1901799 negative regulation of proteasomal protein catabolic process Biological Process 1.78e-04 3.15e-02 3.68e-03

Transcriptomics

The following table shows the significantly differentially expressed genes after knocking out USP9X using CRISPR-Cas9.

Knockout Differential Expression

Symbol Name log2-fold-change p-value p-value (adj.)
MMP1 matrix metallopeptidase 1 3.41e-01 2.46e-06 4.59e-02
PSMB4 proteasome 20S subunit beta 4 -4.17e-01 4.16e-06 4.59e-02

Gene Set Enrichment Analysis

There were too few differentially expressed genes to run a meaningful GSEA.

Literature Mining

INDRA was used to automatically assemble known mechanisms related to USP9X from literature and knowledge bases. The first section shows only DUB activity and the second shows all other results.

Deubiquitinase Activity

psp cbn pc bel_lc signor biogrid tas hprd trrust ctd vhn pe drugbank omnipath conib crog dgi minerva creeds ubibrowser acsn | geneways tees gnbr semrep isi trips rlimsp medscan eidos sparser reach
USP9X deubiquitinates MCL1. 10 / 19
1 | 18

reach
USP9X deubiquitylation of MCL1 inhibits its proteasomal degradation, thus promoting its anti-apoptotic functions.

reach
USP9X deubiquitinates and stabilizes MCL1 in distinct human cancers including human follicular lymphomas, diffuse large B cell lymphomas, glioblastoma, colon and lung cancers 19.

reach
Deubiquitination of Mcl-1 by USP9X.

reach
USP9X deubiquitylates poly-ubiquitylated MCL1, protecting it from proteasomal degradation, thus increasing its stability and thereby promoting cell survival.

reach
USP9X interacts with and deubiquitinates MCL-1, thereby stabilising it.

reach
Conversely, the deubiquitinase USP9X reverses polyubiquitination of Mcl-1 and promotes its stability [XREF_BIBR].

reach
Thus in multiple cancer cell types, the level at which USP9X is able to deubiquitylate and stabilise MCL1 dictates its anti-apoptotic function.

reach
Two DUBs USP9X and USP13 deubiquitinate and stabilise MCL1, and hypomorphic mutations in both have been linked to neurodevelopmental disorders and neurodegenerative disease [XREF_BIBR, XREF_BIBR].

reach
It has been reported that Usp9x deubiquitinates Mcl-1 by removing the conjugated ubiquition.

reach
The overexpression of USP9X stabilizes the MCL1 protein in human lymphomas, and the depletion of USP9X increases MCL1 ubiquitination, which leads to MM cell apoptosis [31].
| PMC
USP9X deubiquitinates SMAD4. 10 / 12
1 | 11

reach
For example USP9X may upregulate ID2 gene expression by deubiquitinating and stabilizing the transcription factor SMAD4 (Dupont et al., 2009).

reach
USP9X reverses Smad4 ubiquitination to reactivate the pathway and reinstate TGFbeta signaling.

reach
The deubiquitination of Smad4 by FAM is direct.

reach
FAM and USP9X is required for TGFbeta induced migration of MDA-MB-231 breast cancer cells; mechanistically, FAM and USP9X inhibits the monoubiquitination of SMAD4, a modification that blocks the association of SMAD4 with phospho-SMAD2 [XREF_BIBR] (XREF_FIG).

reach
Subsequently it was shown that USP9X deubiquitylates SMAD4 that is monoubiquitylated at K519 (XREF_FIG).

reach
Usp9x promotes TGFbeta pathway signalling by deubiquitylating Smad4, allowing it to complex with phosphorylated receptor Smads and then shuttle into the nucleus to execute transcriptional responses to TGFbeta family ligands [XREF_BIBR].

reach
Taken together, these results demonstrate that USP9x selectively binds to SMAD4 in competition with TIF1gamma and deubiquitinates SMAD4, promoting nuclear SMAD4 retention, SMAD3 and SMAD4 complex formation and target gene expression.

reach
USP9X (also known as FAM) deubiquitylates SMAD4 and thereby sustains TGF-beta signaling (Dupont etal.

ubibrowser
Multiple mono-ubiquitination of SMAD3 can be removed by USP15 and mono-ubiquitination of SMAD4 seems to be removed by FAM/USP9X.

reach
This inhibitory event is readily reversed by FAM and USP9x, which deubiquitinates Smad4 and restores its responsiveness to TGF-beta [XREF_BIBR].
USP9X deubiquitinates ERG. 7 / 7
1 | 6

reach
Previously, we found that ERG undergoes ubiquitination and then is deubiquitinated by USP9X in prostate cancer cells to prevent its proteasomal degradation.

reach
A role for ERG ubiquitination in prostate cancer cells was also demonstrated by Wang et al. who showed that the enzyme USP9X, which is highly expressed in ERG positive prostate tumours, mediates ERG deubiquitination and thus its stabilization XREF_BIBR.

reach
Indeed, previous reports have shown Usp9x deubiquitinates and stabilizes ERG, and our previously described DUB inhibitor (WP1130) demonstrated anti-tumour efficacy in ERG driven prostate cancer XREF_BIBR.

reach
Here, we show that ubiquitin specific peptidase 9, X linked (USP9X), a deubiquitinase enzyme, binds ERG in VCaP prostate cancer cells expressing TMPRSS2-ERG and deubiquitinates ERG in vitro.

reach
USP9X binds to the ETS domain in ERG protein; therefore, USP9X deubiquitinates and stabilizes full-length ERG and TMPRSS2 - ERG fusion gene products.

ubibrowser
we show that ubiquitin-specific peptidase 9, X-linked (USP9X), a deubiquitinase enzyme, binds ERG in VCaP prostate cancer cells expressing TMPRSS2-ERG and deubiquitinates ERG in vitro.

reach
Wang et al. demonstrated that ubiquitin specific peptidase 9, X linked (USP9X), a deubiquitinase enzyme, binds ERG in VCaP prostate cancer cells expressing TMPRSS2-ERG and deubiquitinates ERG in vitro XREF_BIBR.
USP9X deubiquitinates SNCA. 7 / 7
2 | 5

ubibrowser
Deubiquitination of α-synuclein by USP9X impairs SIAH-dependent α-synuclein proteasomal degradation and promotes degradation by autophagy

ubibrowser
We recently found that USP9X deubiquitinates α-synuclein, and that this process determines the partition of α-synuclein between the proteasomal and autophagy pathways.

reach
We recently found that USP9X deubiquitinates alpha-synuclein, and that this process determines the partition of alpha-synuclein between the proteasomal and autophagy pathways.

reach
Usp9x also deubiquitylates mono-ubiquitylated alpha-synuclein raising the possibility it may play a role in the progression of neurodegenerative diseases such as Parkinson 's disease XREF_BIBR.

reach
Moreover, USP9X can increase MAPT phosphorylation via a second mechanism, by deubiquitinating the protein alpha-synuclein (SNCA) [XREF_BIBR], which functions as a connecting mediator between the glycogen synthase kinase 3beta (GSK3B) and MAPT and has been shown to stimulate MAPT phosphorylation via GSK3B in vitro [XREF_BIBR].

reach
We now report that the deubiquitinase USP9X interacts in vivo with and deubiquitinates alpha-synuclein.

reach
In the brain tissues of PD patients, USP9X colocalises with alpha-synuclein inclusions, and in vitro studies show a functional interaction; whilst monoubiquitylated alpha-synuclein is degraded by the proteasome, USP9X deubiquitylation of alpha-synuclein directs its degradation by the less efficient autophagy pathway [XREF_BIBR].
USP9X deubiquitinates IRS2. 6 / 6
| 6

reach
In addition, USP9X in LNCaP cells was not co-immunoprecipitated with IRS-2 (XREF_SUPPLEMENTARY), suggesting that USP9X does not deubiquitinate IRS-2 in LNCaP cells.

reach
Thus, it is possible that USP9X preferentially deubiquitinates IRS-2 much more than IRS-1 because of the difference of such ubiquitination patterns.

reach
IRS-2 deubiquitination by USP9X maintains anchorage independent cell growth via Erk1/2 activation in prostate carcinoma cell line.

reach
In addition, the interaction between USP9X and IRS-2 was not observed in LNCaP cells (XREF_SUPPLEMENTARY), suggesting that USP9X in LNCaP does not deubiquitinate and stabilize IRS-2 because of the absence of interaction between them.

reach
Knockdown of USP9X dramatically reduced IRS-2 protein level, increased IRS-2 ubiquitination, and promoted the proteasomal degradation of IRS-2 in PC3 cells, suggesting that USP9X also deubiquitinates IRS-2 to prevent its proteasomal degradation.

reach
These data suggest that USP9X deubiquitinates IRS-2 and prevents its proteasomal degradation.
USP9X deubiquitinates CTNNB1. 5 / 5
1 | 1 3

reach
As shown in Figure XREF_FIG, knockdown of USP9X increased the ubiquitination of beta-catenin and subsequent degradation.

reach
In the Wnt pathway, FAM deubiquitinates betacatenin, preventing its degradation in mammalian cells, but the effect of FAM activity on Wnt signaling was not noted.

ubibrowser
Additionally, DUBs USP14, USP15, USP47, and Fam/USP9X have been reported to prevent β-catenin turnover by inhibiting its Ub-proteasomal degradation

reach
Deubiquitinase USP9X deubiquitinates beta-catenin and promotes high grade glioma cell growth.

trips
Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
USP9X deubiquitinates YAP1. 5 / 5
1 | 4

reach
Here we demonstrate that the deubiquitination enzyme USP9X deubiquitinates and stabilizes YAP1, thereby promoting cancer cell survival.

reach
Mechanistically, USP9X deubiquitinates and stabilizes YAP1.

ubibrowser
Here we demonstrate that the deubiquitination enzyme USP9X deubiquitinates and stabilizes YAP1, thereby promoting cancer cell survival.

reach
Since YAP1 plays a key role in human cancer development, it is possible that USP9X promotes deubiquitination and stabilization of YAP1 in human cancers.

reach
Mechanistically, it was found that hsa_circ_0024093 could regulate the expression of USP9X, which further induced YAP1 deubiquitination to stabilize YAP1 protein.
USP9X deubiquitinates ZBTB38. 5 / 5
1 | 4

reach
Together these data show that USP9X deubiquitinates ZBTB38, both in basal conditions, and in conditions where ZBTB38 ubiquitination is augmented by RBBP6.

reach
USP9X deubiquitinates ZBTB38.

reach
We thus conclude that USP9X activity triggers the deubiquitination of ZBTB38 in cells.

reach
By poly-ubiquitination assays, we observed that USP9X causes deubiquitination of ZBTB38, even in cells over-expressing RBBP6 and conversely that inactivation of USP9X amplifies the polyubiquitination induced by RBBP6 over-expression (XREF_SUPPLEMENTARY).

ubibrowser
Molecularly, these functions depend on a deubiquitinase, USP9X, which interacts with ZBTB38, deubiquitinates it, and stabilizes it.
USP9X deubiquitinates SMURF1. 4 / 4
1 | 3

ubibrowser
Review

reach
Moreover, USP9X deubiquitinates and stabilizes SMURF1, a member of the NEDD4 family of ubiquitin ligases; silencing USP9X expression in MDA-MB-231 breast cancer cells destabilized SMURF1 and inhibited SMURF1 dependent cell migration [XREF_BIBR].

reach
In another study, in breast cancer cells ubiquitination of Smurf1 could be reversed by the deubiquitinating enzyme USP9X through Smurf1 WW domain binding, which improved Smurf1 's stability.

reach
USP9X (FAM) deubiquitylates the autoubiquitylated E3 ligases Itch and SMURF1 and, thereby, increases their stability XREF_BIBR - XREF_BIBR.
USP9X deubiquitinates TDRD3. 4 / 4
| 4

reach
To test whether USP9X de-ubiquitinates TDRD3 in cells, we transfected HeLa cells with either control or USP9X specific siRNA, and measured TDRD3 ubiquitination.

reach
USP9X prevents TDRD3 ubiquitination.

reach
USP9X prevents polyubiquitination of TDRD3 in cells.

reach
We observed that when the cellular levels of USP9X were reduced by siRNA, the TDRD3 ubiquitination levels markedly increased (XREF_FIG, upper panel -- compare lane 2 to lane 5) and inhibition of the proteasome greatly augmented this difference (XREF_FIG, upper panel -- compare lane 3 to lane 6), suggesting that USP9X is necessary to suppress TDRD3 ubiquitination.
USP9X deubiquitinates PRC2_complex. 3 / 3
| 3

reach
We report here that Usp9x deubiquitinates and stabilizes PRC2, acting as a gatekeeper to the switch in H3K27me3 deposition patterns during mouse development.

reach
Usp9x deubiquitinates and stabilizes PRC2.

reach
This finding led us to hypothesize that Usp9x deubiquitinates and stabilizes PRC2 components to drive H3K27me3 deposition.
USP9X deubiquitinates EPS15. 3 / 3
1 1 | 1

signor
We identify the endocytic protein Eps15 as one of the critical substrates of USP9X

ubibrowser
USP9X Controls EGFR Fate by Deubiquitinating the Endocytic Adaptor Eps15

reach
Interestingly, recent findings further demonstrate that EPS15 de-ubiquitination by USP9X affects EGFR internalization and its trafficking to lysosomes.
USP9X deubiquitinates STIL. 3 / 3
| 3

reach
As USP9X interacts with and deubiquitylates the MD3 domain (aa 715-988) of STIL and removal of the MD3 domain destabilized STIL, USP9X controls STIL levels via the MD3 antidegron of STIL.

reach
To test whether USP9X deubiquitylates the STIL MD3 domain, we incubated immunoprecipitated full-length STIL or the MD3 domain of STIL with recombinant GST, GST-USP7, or GST fused to the catalytic domain of USP9X (USP9X CD).

reach
USP9X directly deubiquitylates STIL.
USP9X deubiquitinates SOX2. 3 / 3
1 | 2

reach
Usp9x knockdown in melanoma increased SOX2 ubiquitination, leading to its depletion, and enhanced apoptotic effects of BRAF inhibitor and MEK inhibitors.

reach
We identified that Usp9x deubiquitinates SOX2 and can increaseSOX2 levels, but additional studies are needed to confirm the specific ubiquitin sites among the 16 lysine residues in SOX2 that could be putative ubiquitin acceptors.

ubibrowser
Review
USP9X deubiquitinates IGF1R. 3 / 3
| 3

reach
Furthermore, knockdown of USP9X significantly increased IGF-IR ubiquitination in HEK293T cells.

reach
These results raise the possibility that USP9X deubiquitinates IGF-IR to prevent its degradation.

reach
We found that USP9X interacted with IGF-IR, and that knockdown of USP9X decreases IGF-IR protein level and increased ubiquitination of IGF-IR.
USP9X deubiquitinates IQCB1. 3 / 3
1 | 2

reach
Because USP9X deubiquitinates NPHP5 (XREF_FIG), we hypothesize that NPHP5 is prone to ubiquitination when its association with USP9X is compromised in G2/M.

ubibrowser
NPHP5 directly binds to a deubiquitinating enzyme USP9X/FAM and two E3 ubiquitin ligases BBS11/TRIM32 and MARCH7/axotrophin. NPHP5 undergoes K63 ubiquitination in a cell cycle dependent manner and K48/K63 ubiquitination upon USP9X depletion or inhibition.

reach
Only wild type USP9X could robustly deubiquitinate NPHP5 (XREF_FIG).
USP9X deubiquitinates CEP131. 3 / 3
1 | 2

reach
USP9X deubiquitinates CEP131.

ubibrowser
USP9X can also regulate and stabilize CEP131, a centriolar satellite protein, ultimately promoting breast carcinogenesis, indicating that USP9X is a significant regulator of centrosome biogenesis and revealing a critical role for the USP9X/CEP131 axis in breast carcinogenesis

reach
USP9X gain-of-function leads to CEP131 deubiquitylation, stabilisation and centrosome amplification [XREF_BIBR].
USP9X deubiquitinates MIB1. 3 / 3
1 | 2

ubibrowser
USP9x in turn stimulates JAG1 activity through two mechanisms: (1) through TRB3 deubiquitination and stabilization, and (2) through deubiquitination and activation of Mind Bomb 1, an E3 ligase required for JAG1 ubiquitination-mediated endocytosis and Notch activation.

reach
Further, in human breast cancer cell lines, USP9X deubiquitinates and stabilizes MIB1, an activator of ligand dependent canonical NOTCH1 signaling that is important for cardiac development.

reach
Therefore, we postulated that nitrosylated USP9X deubiquitinates and stabilizes MIB1 in valvular interstitial cells, which potentiates the ability of a ligand producing cell to activate NOTCH on a neighboring cell.
Modified USP9X leads to the deubiquitination of SMAD4. 3 / 3
| 3

reach
Loss of USP9X therefore prevents deubiquitination of SMAD4, enhancing tumour progression.

reach
Strikingly, overexpression of wild-type FAM, but not of the catalytically inactive FAM mutant, inhibited Smad4 monoubiquitination in vivo.

reach
Overexpression of FAM also inhibits monoubiquitination of endogenous Smad4.
USP9X deubiquitinates XIAP. 3 / 3
| 3

reach
We reasoned that USP9X deubiquitylates XIAP to regulate mitotic survival.

reach
Engel et al. [XREF_BIBR] demonstrate that USP9X is the mitotic deubiquitinase of the X linked inhibitor of apoptosis protein (XIAP) and that deubiquitylation and stabilization of XIAP by USP9X lead to increased resistance toward mitotic spindle poisons.

reach
These studies revealed a mitosis specific function for the ubiquitin specific protease 9X (USP9X), which we show to deubiquitylate and stabilize XIAP in order to promote mitotic survival.
USP9X deubiquitinates ITCH. 3 / 3
1 | 2

reach
USP9X (FAM) deubiquitylates the autoubiquitylated E3 ligases Itch and SMURF1 and, thereby, increases their stability XREF_BIBR - XREF_BIBR.

reach
USP8 and USP9X deubiquitinate ITCH to induce ubiquitination and degradation of the anti-apoptotic protein c-FLIP, leading to apoptosis in glioblastoma [XREF_BIBR], or to anoikis in pancreatic ductal adenocarcinoma [XREF_BIBR].

ubibrowser
Review
USP9X deubiquitinates SMAD4 on K519. 3 / 3
3 |

signor
Smad4 is monoubiquitinated in lysine 519 in vivo, a modification that inhibits smad4 by impeding association with phospho-smad2. Fam reverts this negative modification, re-empowering smad4 function;control of smad4 is a good way to regulate bone formation. Fam and ectodermin/tif1gamma (ecto) were reported to respectively regulate the de-ubiquitination and ubiquitination of smad4.

signor
Smad4 is monoubiquitinated in lysine 519 in vivo, a modification that inhibits smad4 by impeding association with phospho-smad2. Fam reverts this negative modification, re-empowering smad4 function;control of smad4 is a good way to regulate bone formation. Fam and ectodermin/tif1gamma (ecto) were reported to respectively regulate the de-ubiquitination and ubiquitination of smad4.

signor
Smad4 is monoubiquitinated in lysine 519 in vivo, a modification that inhibits smad4 by impeding association with phospho-smad2. Fam reverts this negative modification, re-empowering smad4 function;control of smad4 is a good way to regulate bone formation. Fam and ectodermin/tif1gamma (ecto) were reported to respectively regulate the de-ubiquitination and ubiquitination of smad4.
USP9X deubiquitinates CDC20. 2 / 2
| 2

reach
We hypothesize that USP9X deubiquitinates Cdc20 directly; however, we can not rule out the possibility that USP9X loss enhances Cdc20 ubiquitination and degradation indirectly.

reach
In summary, the data presented here show that USP9X antagonizes Cdc20 auto-ubiquitination and degradation to limit the turnover of MCC complexes by APC/C.
USP9X leads to the deubiquitination of ETS1. 2 / 2
1 | 1

reach
A recent report demonstrated that USP9X prevents ETS1 ubiquitination and thereby stabilizes the protein [XREF_BIBR].

ubibrowser
Ets-1 deubiquitination blocks its proteasomal destruction and enhances tumorigenicity, which could be reversed by Usp9x knockdown or inhibition.
USP9X leads to the deubiquitination of MARK4. 2 / 2
1 | 1

reach
An investigation of the polyubiquitination of AMPK-RKs showed that the deubiquitinating enzyme USP9X (ubiquitin specific protease-9) modulates the deubiquitination of NUAK1 (AMPK related kinase 5) and MARK4 (microtubule-affinity-regulating kinase 4) in cells XREF_BIBR.

ubibrowser
Review
USP9X deubiquitinates F2R. 2 / 2
| 2

reach
To test whether FAF directly de-ubiquitinates PAR-1, we used affinity purified FAF and HA-Ub-labelled PAR-1 in an in vitro reaction.

reach
FAF clearly reduced poly-ubiquitinated PAR-1 level in vitro (XREF_FIG), supporting that FAF directly de-ubiquitinates PAR-1.
USP9X deubiquitinates BCL9. 2 / 2
| 2

reach
The USP9X mediated BCL9 deubiquitination promotes formation of the beta, catenin, BCL9, and PYGO complex, increasing the transcriptional activity of the Wnt and beta-catenin target genes.

reach
Additionally, the deubiquitination of BCL9 by USP9X increases proliferation and invasion of breast cancer cells.
USP9X deubiquitinates CD274. 2 / 2
| 2

reach
Indeed, USP9X induces PD-L1 deubiquitination and regulates its stabilization by ubiquitin specific protease activity.

reach
Our data indicate that USP9X deubiquitinates and stabilizes PD-L1.
USP9X deubiquitinates LATS2. 2 / 2
1 | 1

reach
We further demonstrated that USP9X deubiquitinates LATS2 and thus prevents LATS2 degradation by the proteasome.

ubibrowser
Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway
USP9X leads to the deubiquitination of BCL10. 2 / 2
1 | 1

reach
Finally, the ubiquitin specific protease 9X (USP9X) interacts with BCL10 in activated T cells and silencing of USP9X augments BCL10 ubiquitination and impairs NF-kappaB signaling in T cells.

ubibrowser
Mechanistically, USP9X interacts with Bcl10 of the Carma1-Bcl10-Malt1 (CBM) complex and removes the TCR-induced ubiquitin chain from Bcl10, which facilitates the association of Carma1 with Bcl0-Malt1.
USP9X deubiquitinates epnA. 2 / 2
| 2

reach
It was recently shown that silencing Fam by siRNA abrogated ionomycin induced decrease in Epsin ubiquitylation, indicating that Fam plays a role in regulating levels of Epsin ubiquitylation [15].

reach
However, in vitro data on direct deubiquitylation of Epsin by Fam are lacking, and the ~ 50% identity between Faf and Fam suggests different specificities for substrates [49]; indeed, the only reporte[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
USP9X leads to the deubiquitination of ARNTL. 2 / 2
1 | 1

reach
Through biochemical experiments, we discover that USP9X reduces BMAL1 ubiquitination, enhances its stability, and increases its protein level, leading to the elevated transcriptional activity.

ubibrowser
Here, we use affinity purification and mass spectrometry analysis to identify probable ubiquitin carboxyl-terminal hydrolase FAF-X (USP9X) as an interacting protein of the core clock protein aryl hydrocarbon receptor nuclear translocator-like protein 1 (ARNTL or BMAL1).
USP9X leads to the deubiquitination of NUAK1. 2 / 2
1 | 1

reach
An investigation of the polyubiquitination of AMPK-RKs showed that the deubiquitinating enzyme USP9X (ubiquitin specific protease-9) modulates the deubiquitination of NUAK1 (AMPK related kinase 5) and MARK4 (microtubule-affinity-regulating kinase 4) in cells XREF_BIBR.

ubibrowser
Review
USP9X leads to the deubiquitination of FBXW7. 2 / 2
| 2

reach
USP9X antagonized FBW7 ubiquitylation and protected mice from CRC.

reach
USP9X antagonized FBW7 ubiquitylation, and Usp9x deletion caused Fbw7 destabilization.
USP9X leads to the deubiquitination of TP53. 2 / 2
1 | 1

ubibrowser
Review

reach
USP9X inhibited p53 ubiquitination mediated degradation.
USP9X deubiquitinates GJA1. 2 / 2
| 1 1

trips
USP9X deubiquitinates connexin43 to prevent high glucose-induced epithelial-to-mesenchymal transition in NRK-52E cells.

reach
The following findings were observed : (1) Expression of USP9X was down-regulated in the kidney tissue of db/db diabetic mice; (2) overexpression of USP9X suppressed high glucose (HG)-induced expressions of EMT markers and extra cellular matrix (ECM) in NRK-52E cells; (3) depletion of USP9X further aggravated EMT process and ECM production in NRK-52E cells; (4) USP9X deubiquitinated Cx43 and suppressed its degradation to regulate EMT process; (5) USP9X deubiquitinated Cx43 by directly binding to the C-terminal Tyr 286 of Cx43.
USP9X deubiquitinates MARCHF7. 2 / 2
1 | 1

ubibrowser
Review

reach
Exogenous expression and short interfering RNA depletion experiments demonstrate that MARCH7 can be stabilized by both USP9X and USP7, which deubiquitylate MARCH7 in the cytosol and nucleus, respectively.
USP9X deubiquitinates AMOTL2. 2 / 2
1 | 1

ubibrowser
we report for the first time that USP9X is a deubiquitinase of Angiomotin-like 2 (AMOTL2) and that AMOTL2 mono-ubiquitination is required for YAP inhibition.

reach
These results indicate that deubiquitination of AMOTL2 by USP9X depresses LATS1/2 activity and subsequently activates YAP.
USP9X deubiquitinates AMOT on K496. 2 / 2
| 2

reach
USP9x acts to deubiquitylate Angiomotin at lysine 496, resulting in stabilization of Angiomotin and lower YAP and TAZ activity.

reach
USP9X leads to deubiquitinate AMOT at Lys 496, resulting in stabilization of AMOT and reduced YAP and TAZ activity.
USP9X deubiquitinates AMOT. 2 / 2
| 2

reach
USP9X in the DUBs (ubiquitin-specific protease family) could bind to and deubiquitinate AMOT.
| PMC

reach
Thus, it appears that the direct effect of limiting deubiquitylation of AMOT by USP9x offsets the reduced potential for ubiquitylation due to lower E3 ligase levels.
USP9X deubiquitinates SNRPN. 1 / 1
| 1

reach
Usp9x deubiquitinates SMN that is mostly mono- and di ubiquitinated.
USP9X leads to the deubiquitination of pygo. 1 / 1
| 1

reach
The USP9X mediated BCL9 deubiquitination promotes formation of the beta, catenin, BCL9, and PYGO complex, increasing the transcriptional activity of the Wnt and beta-catenin target genes.
USP9X deubiquitinates MTOR. 1 / 1
1 |

ubibrowser
Review
USP9X deubiquitinates KCNH2. 1 / 1
1 |

ubibrowser
Review
USP9X deubiquitinates CDH1. 1 / 1
1 |

ubibrowser
Review
Modified USP9X leads to the deubiquitination of XIAP. 1 / 1
| 1

reach
Indeed, ubiquitylation of XIAP was substantially increased upon silencing or chemical inhibition of USP9X (Figs XREF_FIG E and XREF_FIG A) in mitotic cells, while forced expression of USP9X attenuated XIAP ubiquitylation (Fig XREF_FIG A).
USP9X deubiquitinates ALDH1A3. 1 / 1
| 1

reach
USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells.
USP9X deubiquitinates EIF4A2. 1 / 1
1 |

ubibrowser
Our results provide evidence that USP9X is a novel regulator of the translation initiation process via deubiquitination of eIF4A1
USP9X deubiquitinates FOXO3. 1 / 1
1 |

ubibrowser
Hydroxylation of these sites prevents the binding of USP9x deubiquitinase, thereby promoting the proteasomal degradation of FOXO3a.
USP9X deubiquitinates STMN1. 1 / 1
1 |

ubibrowser
In this report, we find that Usp9x, a deubiquitinating enzyme, stably associates with the SMN complex via directly interacting with SMN.| Usp9x deubiquitinates SMN that is mostly mono- and di-ubiquitinated.
USP9X deubiquitinates EIF4A1. 1 / 1
| 1

reach
These data suggested that the deubiquitination of eIF4A1 by USP9X is required for eIF4A1 protein stability.
Modified USP9X leads to the deubiquitination of AMOT. 1 / 1
| 1

reach
We demonstrate that loss of USP9x leads to increased ubiquitylation of AMOT, resulting in reduced AMOT levels.
USP9X deubiquitinates BECN1. 1 / 1
1 |

ubibrowser
Interestingly, Beclin1 and the Bcl-2 family member, MCL-1, compete for their interaction with USP9X, which contributes to their stabilization by protecting them from proteasomal degradation in HEK293T cells
USP9X deubiquitinates TTK. 1 / 1
1 |

ubibrowser
Conclusions: In summary, our data demonstrated that the USP9X-TTK axis may play a critical role in NSCLC, and could be considered as a potential therapeutic target.
USP9X deubiquitinates F3. 1 / 1
| 1

reach
Usp9x deubiquitinates and stabilizes the TF, ERG, in prostate, and we previously published that DUB inhibitor (WP1130) has anti-tumor activity in ERG fusion driven prostate cancer [XREF_BIBR, XREF_BIBR, XREF_BIBR].
USP9X deubiquitinates ERBB2. 1 / 1
1 |

ubibrowser
?In contrast, ErbB2 immunoprecipitates were found to contain significant USP9x relative to control immunoprecipitates prepared using anti-ERalpha IgG
USP9X deubiquitinates DDI1. 1 / 1
1 |

ubibrowser
Identification of USP9X as the DUB Responsible for Deubiquitination of Human DDI1
USP9X deubiquitinates PEX5. 1 / 1
1 |

ubibrowser
In addition, Pex5p can be deubiquitinated by the deubiquitinase USP9X
USP9X deubiquitinates TRIB3. 1 / 1
1 |

ubibrowser
USP9x in turn stimulates JAG1 activity through two mechanisms: (1) through TRB3 deubiquitination and stabilization, and (2) through deubiquitination and activation of Mind Bomb 1, an E3 ligase required for JAG1 ubiquitination-mediated endocytosis and Notch activation.
USP9X deubiquitinates ubiquitinated SMAD4. 1 / 1
| 1

reach
FAM and Usp9x deubiquitinates the monoubiquitinated SMAD4 (which is exported from the nucleus (XREF_FIG)) and thereby enables SMAD2 and SMAD4 complex formation.
USP9X deubiquitinates DVL2. 1 / 1
1 |

ubibrowser
Our findings indicate that USP9X-mediated deubiquitylation of DVL2 is required for canonical WNT activation, while increased DVL2 ubiquitylation is associated with localization to actin-rich projections and activation of the planar cell polarity (PCP) pathway.
USP9X deubiquitinates PCM1. 1 / 1
1 |

ubibrowser
?Collectively, our experiments identified USP9X as an integral component of the centrosome where it functions to stabilize PCM1 and CEP55 and promote centrosome biogenesis.
USP9X deubiquitinates EPN. 1 / 1
| 1

reach
Agonist stimulation of Notch leads to the recruitment of USP9X, a deubiquitinating enzyme, which deubiquitinates epsin and enables it to promote Notch internalization.
USP9X leads to the deubiquitination of NFE2L2. 1 / 1
| 1

reach
Taken together, USP9X reduced Nrf2 ubiquitination level and promoted Nrf2-ARE pathway activation to prevent the accumulation of extracellular matrix, eventually alleviated the pathological process of diabetic renal fibrosis.
USP9X deubiquitinates GPSM1. 1 / 1
1 |

ubibrowser
Review
USP9X deubiquitinates SMAD1. 1 / 1
1 |

ubibrowser
Review
USP9X deubiquitinates ALKBH3. 1 / 1
| 1

reach
Instead, it seemed to act as a scaffold protein, recruiting two further DUBs, USP7 and USP9x, which then de-ubiquitylated ALKBH3.
USP9X deubiquitinates PRICKLE1. 1 / 1
| 1

reach
[XREF_BIBR, XREF_BIBR, XREF_BIBR - XREF_BIBR] We postulated the physical interaction between the PRICKLEs and USP9X might indicate that PRICKLE was a USP9X substrate, and that USP9X deubiquitinates and stabilizes both PRICKLE1 and PRICKLE2.
USP9X deubiquitinates NFX1. 1 / 1
| 1

reach
In addition, we identified STAM and NFX1, which are known to be deubiquitylated by USP8 and USP9 respectively.
USP9X deubiquitinates TMPRSS2. 1 / 1
| 1

reach
USP9X binds to the ETS domain in ERG protein; therefore, USP9X deubiquitinates and stabilizes full-length ERG and TMPRSS2 - ERG fusion gene products.
USP9X deubiquitinates IQCB1 on K48. 1 / 1
| 1

reach
On the basis of our findings that NPHP5 is deubiquitinated by USP9X, K48 ubiquitinated by MARCH7 and K63 ubiquitinated by BBS11, we asked whether simultaneous ablation of MARCH7 and/or BBS11 might override the effects of USP9X loss on NPHP5.
USP9X deubiquitinates IRS1. 1 / 1
| 1

reach
On the other hand, the reduction of IRS-1 protein level was relatively small, suggesting that deubiquitination of IRS-1 by USP9X is not so active as for IRS-2.
USP9X deubiquitinates EIF4B. 1 / 1
1 |

ubibrowser
USP9X controls translation efficiency via deubiquitination of eukaryotic translation initiation factor 4A1
USP9X leads to the deubiquitination of FN1. 1 / 1
| 1

reach
Importantly, USP9x depletion augmented and maintained the FN induced integrin alpha5beta1 complex ubiquitination and led to a slower migration rate, suggesting that USP9x contributes to deubiquitinati[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
USP9X leads to the deubiquitination of APC_C. 1 / 1
| 1

reach
Because USP9X is a DUB and the SAC signal relies on inhibition of the APC/C ubiquitin ligase, USP9X might antagonize APC/C dependent ubiquitination to help maintain the SAC.
USP9X deubiquitinates CEP55. 1 / 1
1 |

ubibrowser
?Collectively, our experiments identified USP9X as an integral component of the centrosome where it functions to stabilize PCM1 and CEP55 and promote centrosome biogenesis.
USP9X deubiquitinates TAS2R13. 1 / 1
1 |

ubibrowser
USP9x in turn stimulates JAG1 activity through two mechanisms: (1) through TRB3 deubiquitination and stabilization, and (2) through deubiquitination and activation of Mind Bomb 1, an E3 ligase required for JAG1 ubiquitination-mediated endocytosis and Notch activation.
USP9X deubiquitinates MAP3K5. 1 / 1
1 |

ubibrowser
Review
USP9X deubiquitinates STAM. 1 / 1
| 1

reach
In addition, we identified STAM and NFX1, which are known to be deubiquitylated by USP8 and USP9 respectively.
USP9X leads to the deubiquitination of EGFR. 1 / 1
| 1

reach
However, silencing of USP9X did not increase EGFR ubiquitination, arguing that the receptor itself is not the direct target.
Modified USP9X leads to the deubiquitination of CD274. 1 / 1
| 1

reach
In Oral Squamous Cell Carcinoma (OSCC) cells, the high expression of USP9X increases the deubiquitination of PD-L1 and reduces its degradation, resulting in protein accumulation in these cells.
USP9X deubiquitinates PSD. 1 / 1
1 |

ubibrowser
USP9x-mediated deubiquitination of EFA6 regulates de novo tight junction assembly
USP9X deubiquitinates BIRC5 on lysine. 1 / 1
| 1

reach
Lysine 63 de-ubiquitination of survivin by hFAM is required for the dissociation of survivin from centromeres.
USP9X deubiquitinates SMN1. 1 / 1
1 |

signor
Ubiquitin-specific Protease 9x Deubiquitinates and Stabilizes the Spinal Muscular Atrophy Protein-Survival Motor Neuron
USP9X deubiquitinates PRICKLE2. 1 / 1
| 1

reach
[XREF_BIBR, XREF_BIBR, XREF_BIBR - XREF_BIBR] We postulated the physical interaction between the PRICKLEs and USP9X might indicate that PRICKLE was a USP9X substrate, and that USP9X deubiquitinates and stabilizes both PRICKLE1 and PRICKLE2.
USP9X deubiquitinates ZAP70. 1 / 1
1 |

ubibrowser
Usp9X becomes competent to deubiquitinate ZAP70 through TCR-dependent phosphorylation and enhancement of its catalytic activity and association with the LAT signalosome.
USP9X deubiquitinates LATS1. 1 / 1
1 |

ubibrowser
In addition, USP9X can also function as a tumor suppressor. USP9X strongly interacts with LATS, a core kinase in the Hippo pathway. Increased USP9X expression significantly up-regulates and stabilizes LATS and leads to a decrease in the transport of YAP/TAZ into the nucleus as well as inhibiting of their target genes.

Other Statements

psp cbn pc bel_lc signor biogrid tas hprd trrust ctd vhn pe drugbank omnipath conib crog dgi minerva creeds ubibrowser acsn | geneways tees gnbr semrep isi trips rlimsp medscan eidos sparser reach
USP9X affects MCL1
| 1 38
USP9X activates MCL1.
| 1 16
USP9X activates MCL1. 10 / 27
| 1 16

reach
Recent reports have suggested also that USP9X enhances Mcl-1 stability by preventing its proteasomal destruction through de-ubiquitination [XREF_BIBR].

reach
We therefore investigated the effect of Usp9X knockdown in Mcl1 -/- MEFs to rule out the possibility that USP9X mediates its mitosis specific effects by stabilizing MCL1.

reach
In contrast, the deubiquitinase USP9x prevented Mcl-1 degradation and stabilized Mcl-1 levels by removing the poly-ubiquitin chain [XREF_BIBR].

reach
In addition, ionising radiation-induced activation of USP9x inhibits Mcl-1 degradation, resulting in increased radio-resistance and apoptosis [106].

reach
For example, by removing K48 linked polyubiquitin chains from MCL1, USP9X inhibits the proteasomal degradation of MCL1, a pro survival BCL2 family member that is overexpressed in multiple cancer types and contributes to chemoresistance and tumor recurrence [XREF_BIBR].

reach
Together, our results indicate that radiation induced activation of USP9x inhibits Mcl-1 degradation and apoptosis resulting in increased radioresistance.

reach
USP9x expression correlated moderately but significantly with Mcl-1 expression in glioblastoma, supporting our hypothesis that USP9x stabilizes Mcl-1 in glioblastoma cells.

reach
Importantly, examination of USP9X targets MCL1 and beta-catenin by western blot analysis did not reveal a change in their protein levels when USP9X was knocked down in DAOY cells.

reach
Furthermore, the chemical inhibition of USP9X increased the sensitivity of the human lung carcinoma lines A549 and H1299 to an anti-apoptotic inhibitor (ABT-737, targets BCL-xl, but not MCL1).

reach
In Jurkat T lymphoma and K562 chronic myelogenous cells, USP9X is enzymatically activated in response to ionising radiation and causes MCL1 stabilisation, in turn inhibiting apoptosis and resulting in radioresistance [XREF_BIBR].
USP9X increases the amount of MCL1.
| 14
USP9X increases the amount of MCL1. 10 / 12
| 12

reach
We have shown previously that USP9X inhibition by WP1130 reduces MCL-1 levels, promotes apoptosis and increases tumor cell sensitivity to chemotherapy [XREF_BIBR].

reach
While Usp9X is known to modulate Mcl-1 expression, our observed effects of Usp9X manipulation on Bag3 and Bcl-2 have not been previously described and may suggest that Usp9X also interacts with Bag3 as well as Bcl-2.

reach
XREF_BIBR More recently, in non small cell lung carcinoma, inhibition of USP9X by either siRNA knockdown or via a small molecule inhibitor WP1130 decreased MCL1 expression and sensitized cells to radiation therapy.

reach
Furthermore, knockdown of Usp9X or Bag3 depleted endogenous Mcl-1 protein levels and in turn enhanced apoptosis induced through Bcl-2 and Bcl-xL inhibition [XREF_BIBR].

reach
Usp9X modulates Mcl-1 levels and counteracts apoptosis in cancer cells [XREF_BIBR].

reach
Similar distinction was also observed for Mcl-1, one observed substrate of Usp9x, where Usp9x KD increased Mcl-1 levels in 8041 cells but decreased Mcl-1 in MIAPACA2 cells.

reach
These isothiocyanates increased Mcl-1 ubiquitination and either isothiocyanate treatment, or RNAi mediated silencing of USP9x decreased Mcl-1 levels, consistent with the notion that USP9x is a primary target of isothiocyanate activity.

reach
These ITCs increased Mcl-1 ubiquitination and either ITC treatment or RNAi mediated silencing of USP9x decreased Mcl-1 levels, consistent with the notion that USP9x is a primary target of ITC activity.

reach
We also observed that Usp9x KD decreased Mcl-1 levels in MIAPACA2 cells but increased Mcl-1 levels in 8041 cells.

reach
Mechanistically, Usp9X knockdown caused concomitant suppression of Bag3, Mcl-1 and Bcl-2 expression, which remarkably recapitulates the effects of CP-d and n-ATF 5-S1 on these molecules.
Modified USP9X increases the amount of MCL1. 1 / 1
| 1

reach
Overexpression of Usp9x increased 3D growth and invasion in PANC1 cells and up-regulated the expression of known Usp9x substrates Mcl-1 and ITCH.
USP9X bound to MCL1 increases the amount of MCL1. 1 / 1
| 1

reach
Additionally, Schwickart et al. demonstrated that in hematologic malignancies 51, the expression of deubiquitinase USP9X expression correlates with that of Mcl-1, and USP9X binds to Mcl-1, stabilizes it and thereby promotes Mcl-1 overexpression and cell survival.
USP9X inhibits MCL1.
| 5
USP9X inhibits MCL1. 5 / 8
| 5

reach
Although USP9X depletion did not cause an obvious change in Mcl-1 degradation during mitosis, it did increase the loss of other mitotic APC/C substrates, in particular cyclin A, but also cyclin B and NEK2A (XREF_FIG A).

reach
Therefore, the indirectly supported, USP9X mediated degradation of MCL-1 can be regarded as a novel autophagy independent, oncosuppressive function of BECLIN 1 [XREF_BIBR].

reach
Indeed, knock-down of USP9X reduced the half-life of Mcl-1 and increased its conjugation to Lys48 linked poly-ubiquitin chains [XREF_BIBR] that generally target proteins for proteasomal degradation.

reach
Indeed, knockdown of Usp9X increased mitotic cell death in Mcl1 -/- cells to a similar extent as in WT MEFs, thus indicating independence of MCL1 (Fig XREF_FIG A and B).

reach
The USP9X inhibitor WP1130 or depletion of USP9X by its specific shRNAs induces MCL-1 degradation in cells and increases tumor cell sensitivity to chemo and radiotherapies 39.
USP9X decreases the amount of MCL1.
| 3
USP9X decreases the amount of MCL1. 3 / 7
| 3

reach
Moreover, knock-down of Usp9X or Bag3 depleted endogenous Mcl-1 protein levels and in turn enhanced apoptosis induced through Bcl-2 and Bcl-xL inhibition.

reach
Usp9x siRNA transfection downregulated Mcl-1 levels and increased the activated levels of apoptosis related proteins (caspase-9, caspase-3 and PARP) (XREF_FIG).

reach
We also observed that Usp9x KD decreased Mcl-1 levels in MIAPACA2 cells but increased Mcl-1 levels in 8041 cells.

reach
So, knockdown of USP9X not only inhibited the proliferation of glioma cells in vitro, but also suppressed the tumorigenicity of primary glioma cells in vivo.

reach
It is worth noting that the proliferation defect caused by Usp9X deficiency was observed in CD8 + T cells as well as CD4 + T cells (XREF_FIG).

reach
In breast cancer, USP9X deubiquitinates and stabilizes YAP to promote breast cancer cell proliferation and chemoresistance to therapeutic drugs XREF_BIBR.

reach
FAF enhanced the proliferation of human gingival fibroblasts, human skin fibroblasts, and human umbilical vein endothelial cells in subconfluent and confluent cells, suggesting that FAF might be functioning as a competence factor.

reach
USP9X possibly promotes head and neck cancer cell proliferation through the mTOR pathway.

reach
In contrast, in immortalized but non tumorigenic HaCaT keratinocytes, USP9X depletion led to increase in cell proliferation, maintaining direct regulation of Notch activity.

reach
These data demonstrate that loss of USP9X decreases the proliferation of ReNcell VM cells but does not alter their morphology, cell death or differentiation.

reach
In addition, USP9X activates glycolysis and promotes cell proliferation through pVHL.

reach
By these results, we concluded that USP9X contributes to proliferation of PC3 cells through maintenance of IRS-2-Erk1/2 axis.

reach
When FRT tagged USP9X was introduced into USP9X -/- cells, the cell proliferation rate nearly recovered to that of WT cells, whereas overexpression of USP9X in WT cells slightly promoted cell proliferation as well.
| 1 1 3 9

reach
Knockdown of USP9X inhibited cell proliferation and cell cycle progression and increased apoptosis.

reach
In addition, depletion of USP9X decreases breast cancer proliferation, tumorigenesis, and chemoresistance in a YAP1 dependent manner.

reach
Down-regulation of Usp9X inhibits proliferation in glioblastoma cell lines.

sparser
Knockdown of FAM196B Inhibited Cell Proliferation of A549and H1299 cell lines.

reach
Depletion of USP9X led to decreased cell proliferation (XREF_FIG), while depletion of both USP9X and YAP1 did not cause a further decrease in cell proliferation compared with cells depleted of YAP1 alone.

eidos
The expression of USP9X in cholangiocarcinoma inhibited cell proliferation and colony formation in vitro as well as xenograft tumorigenicity in vivo .

sparser
Recent studies have demonstrated that FAM134B inhibits colon cancer cells proliferation, migration, wound healing, colony formation and tumour formation in vivo [21,39] .

reach
USP9X null neurospheres have reduced neural progenitor proliferation but not stem cell self-renewal.

reach
Knockdown of USP9X suppresses cell proliferation, inhibits G1/S phase conversion, and induces apoptosis in U251 and A172 cells.

reach
Importantly, knockdown of EGLN3 impaired USP9X mediated suppression of proliferation.
| 1 1 41
| 1 31

reach
As inhibition of USP9X resulted in caspase 3 and caspase 8 activation and increased the rates of apoptosis, USP9X might promote cell survival by inhibiting apoptosis in glioma cells.

reach
Furthermore, we demonstrated that knockdown of USP24 but not USP9X could significantly induce growth inhibition and apoptosis of T-ALL cells.

reach
In contrast, USP9x knockdown slightly increased apoptosis in IR resistant A172 cells and significantly in Ln229 cells and reduced clonogenic survival after irradiation only on these two cell lines.

reach
Usp9X knockdown induces apoptosis, caspase activation and recapitulates effects of CP-d and n-ATF 5-S1.

reach
Inhibition of USP9X induces apoptosis in FLT3-ITD-positive AML cells cooperatively by inhibiting the mutant kinase through aggresomal translocation and inducing oxidative stress.

sparser
FAM129A inhibited apoptosis and promoted migration and proliferation in human cancers.

reach
Furthermore, ectopic expression of USP9X prevented c-FLIP downregulation and apoptosis upon combined treatment.

reach
Although both Usp9X and Mcl-1 knockdown elicited some features of apoptosis, broad spectrum caspase inhibition was ineffective in preventing knockdown induced MPNST cell death suggesting that caspase independent death pathways were also activated.

reach
Although USP9x knockdown reduced Mcl-1 levels and increased apoptosis in A172 cells, USP9x regulated radiosensitivity independently of Mcl-1 in Ln229 cells.

reach
Considering our observations with respect to Bcl-2 family members and IAPs, Usp9X appears to block death-receptor-mediated apoptosis most likely at the level of initiator- as well as effector caspases, involving a combination of factors.
| 1 10

reach
Down-regulation of USP24 but not USP9X induces growth inhibition and apoptosis of T-ALL cells.

reach
Knockdown of endogenous USP9X expression evidently inhibited the migration and invasion of PANC-1 cells, and promoted cell apoptosis.

reach
Whole-genome transcriptome analysis revealed that FAM induced up-regulation of apoptosis related genes and genes that encode for mediators of oxidative stress resistance and heat shock proteins.

reach
Previous studies have suggested that deubiquitinase USP9X stabilizes myeloid cell leukemia sequence 1 (MCL1) and promotes tumor cell survival and apoptosis resistance [XREF_BIBR, XREF_BIBR].

reach
Specific knock-down of Usp9X induces apoptosis in glioblastoma cells.

eidos
USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bbeta via deubiquitinating EGLN3 .

reach
Knockdown of USP9X suppresses cell proliferation, inhibits G1/S phase conversion, and induces apoptosis in U251 and A172 cells.

reach
These results show that expression of USP9X is upregulated in hepatoma cells SMMC7721 and HepG2, and that downregulating USP9X by siRNA may induce cell apoptosis, inhibit cell growth and cell migration in the HCC SMMC7721 and HepG2 cell lines.

reach
Expression levels of ARF-BP1 and Mule and Usp9x appears to be critical for the maintenance of proper cellular balance of anti- and pro apoptotic proteins, and contributes to cell sensitivity to apoptosis and is linked to tumor formation [XREF_BIBR, XREF_BIBR].

reach
USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bbeta via deubiquitinating EGLN3.
USP9X affects CTNNB1
| 1 14
USP9X activates CTNNB1.
| 1 8
USP9X activates CTNNB1. 8 / 13
| 1 7

eidos
At molecular level , USP9X induces beta-catenin signaling to mediate HCC progression.124 Therefore , mediating GSK-3beta degradation and triggering beta-catenin nuclear translocation can significantly enhance proliferation rate of HCC cells.125 Besides , activation of beta-catenin signaling induces resistance of HCC cells toward apoptosis.126 Histone deacetylase 6 ( HDAC6 ) acts as tumor-suppressor and diminishes beta-catenin expression to induce apoptosis in HCC cells .
| PMC

reach
By evaluating signaling in U251 cells treated with a Wnt ligand, we found that USP9X knockdown partly blocked the activation of Wnt and beta- catenin pathway by regulating the stability of beta-catenin.

reach
In summary, these results indicate that USP9X stabilizes beta-catenin and activates Wnt and beta-catenin signal pathway to promote glioma cell proliferation and survival.

reach
The results of the western blot suggested that knockdown of USP9X decreased beta-catenin protein, but the results of RT-PCR suggested that beta-catenin mRNA expression levels did not change (XREF_SUPPLEMENTARY).

reach
Previous studies have suggested that USP9X is co-immunoprecipitated with beta-catenin and inhibits the degradation of beta-catenin through the deubiquitination of beta-catenin in mouse lymphocyte cells [XREF_BIBR].

reach
USP9X promotes the progression of hepatocellular carcinoma by regulating beta-catenin.

reach
Down-regulation of USP9X also consistently inhibits the tumorigenicity of primary glioma cells in vivo.In summary, these results indicate that USP9X stabilizes beta-catenin and activates Wnt and beta-catenin signal pathway to promote glioma cell proliferation and survival.

reach
At molecular level, USP9X induces β-catenin signaling to mediate HCC progression.124 Therefore, mediating GSK-3β degradation and triggering β-catenin nuclear translocation can significantly enhance proliferation rate of HCC cells.125 Besides, activation of β-catenin signaling induces resistance of HCC cells toward apoptosis.126 Histone deacetylase 6 (HDAC6) acts as tumor-suppressor and diminishes β-catenin expression to induce apoptosis in HCC cells.
| PMC
USP9X bound to CTNNB1 activates CTNNB1. 1 / 1
| 1

reach
It was found that USP9x interacted with beta-catenin and inhibited the degradation of beta-catenin through the deubiquitination of beta-catenin.
USP9X increases the amount of CTNNB1.
| 5
USP9X increases the amount of CTNNB1. 3 / 3
| 3

reach
Mechanically, USP9X promotes HCC cell proliferation by regulating the expression of beta-catenin.

reach
USP9X has also been reported to increase the levels of beta-catenin, a transcription factor linked to the growth of brain tumors XREF_BIBR, XREF_BIBR, and overexpression of USP9X has been reported to enhance the half-life and expression of beta-catenin in mouse L cells and MCF7 cells, respectively XREF_BIBR, XREF_BIBR.

reach
However, in contrast to previous studies, which indicated Usp9x positively regulates beta-catenin protein levels, significantly increased pbeta-catenin33/37/41 and Tyr654 pbeta-catenin levels observed in Usp9x -/Y neocortices implied a novel regulatory mechanism in NPs.
Modified USP9X increases the amount of CTNNB1. 2 / 2
| 2

reach
Overexpression of Dvl, ATDC, and deubiquitinating enzyme Fam, which also affects the degradation of beta-catenin, has been reported to elevate beta-catenin level.

reach
In MDCK cells, overexpression of the USP9X catalytic domain increased the steady-state levels of beta-catenin, presumably by its ability to deubiquitylate and hence rescue from proteasomal degradation.
USP9X inhibits CTNNB1.
| 1
USP9X inhibits CTNNB1. 1 / 3
| 1

reach
Deletion of Usp9x increases the levels of beta-catenin protein in Neural Progenitors.
| 18
USP9X activates Cell Survival.
| 16
| 15

reach
Usp9x expression increases cell survival and 3D growth, and induces invasion in human PDAC cell line PANC1.

reach
However, in established human pancreatic tumor cells, Usp9x supports tumor cell survival and the malignant phenotype, illustrating wide distinctions in function in murine tumor cell models and bona fide human pancreatic cancer while also highlighting the potential for Usp9x inhibitors to be used in the treatment of human PDAC.

reach
Here we show that the deubiquitinase USP9X stabilizes MCL1 and thereby promotes cell survival.

reach
The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization.

reach
The hypothesis that UBP43 is an anti-neoplastic target is consistent with recent work reported with the deubiquitinase USP9X, which promoted cancer cell survival by regulating stability of a pro survival BCL2 family member.

reach
From these results we conclude that USP9X and ZBTB38 both contribute to cell survival upon oxidative stress, and that they act in the same pathway.

reach
Furthermore, USP9X knockdown increased the inhibition of cell viability after cisplatin administration.

reach
On the contrary, USP9X acts as an oncogene and stabilizes MCL1, a critical antiapoptotic member of the BCL-2 family, and thereby promotes cell survival of multiple myeloma XREF_BIBR.

reach
USP9X has, however, also been proposed to promote tumor cell survival by limiting the degradation of the anti-apoptotic protein Mcl-1.

reach
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.
USP9X bound to MCL1 activates Cell Survival. 1 / 1
| 1

reach
Additionally, Schwickart et al. demonstrated that in hematologic malignancies 51, the expression of deubiquitinase USP9X expression correlates with that of Mcl-1, and USP9X binds to Mcl-1, stabilizes it and thereby promotes Mcl-1 overexpression and cell survival.
USP9X inhibits Cell Survival.
| 2

reach
FAm significantly decreased cell viability and increased intracellular lipid accumulation, whereas LF significantly recovered cell viability without affecting lipid accumulation.

reach
As inhibition of USP9X resulted in caspase 3 and caspase 8 activation and increased the rates of apoptosis, USP9X might promote cell survival by inhibiting apoptosis in glioma cells.
USP9X affects SMAD4
3 | 11
USP9X activates SMAD4.
3 | 9
USP9X activates SMAD4. 10 / 12
3 | 9

reach
A recent study reported that USP9X activates SMAD4 by deubiquitination at K519, resulting in the activation of SMAD2/3, and promotion of TGFbeta pathway, which will induce cell apoptosis.

reach
USP9x has been reported to increase SMAD4 activity by removing an inhibitory ubiquitin moiety [XREF_BIBR].

reach
USP9X was previously reported to regulate Smad4 transcriptional activity positively, thus we hypothesized that decreased USP9X expression would attenuate Smad4 function and TGF-beta responsiveness in HCC cell lines [XREF_BIBR].

reach
Removal of the mono-ubiquitin by the de-ubiquitinase FAM and USP9x restores Smad4 function [XREF_BIBR].

reach
Since USP9X was previously reported to positively regulate SMAD4 transcriptional activity 17 and SMAD4 is commonly mutated in PDA 4, we hypothesized that Usp9x loss would attenuate Smad4 function or TGFbeta responsiveness in PDA cell lines.

signor
Smad4 is monoubiquitinated in lysine 519 in vivo, a modification that inhibits smad4 by impeding association with phospho-smad2. Fam reverts this negative modification, re-empowering smad4 function;control of smad4 is a good way to regulate bone formation. Fam and ectodermin/tif1gamma (ecto) were reported to respectively regulate the de-ubiquitination and ubiquitination of smad4.

reach
Sall4 shows an interaction with Usp9x (XREF_FIG B), an essential component of the TGF-beta and BMP signaling pathway, which activates Smad4 by removing a monoubiquitin group.

reach
Thus, the de-ubiquitylase FAM and USP9 can remove K519 mono-ubiquitylation of Smad4 imposed by TIF1gamma, and thus restore Smad4 function.

reach
Loss of the USP9x homologue Fat facets in Drosophila inhibits the activity of the Smad4 homologue Medea through ubiquitination of Medea on K738 (equivalent to K519 in human Smad4) (Stinchfield et al.,[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

signor
Smad4 is monoubiquitinated in lysine 519 in vivo, a modification that inhibits smad4 by impeding association with phospho-smad2. Fam reverts this negative modification, re-empowering smad4 function;control of smad4 is a good way to regulate bone formation. Fam and ectodermin/tif1gamma (ecto) were reported to respectively regulate the de-ubiquitination and ubiquitination of smad4.
USP9X inhibits SMAD4.
| 1
USP9X inhibits SMAD4. 1 / 3
| 1

reach
USP9x shRNA delivery significantly inhibits TGF-beta-induced SMAD4 nuclear retention and eliminates PA promotion of TGF-beta-induced SMAD4 nuclear retention.
USP9X increases the amount of SMAD4.
| 1
USP9X increases the amount of SMAD4. 1 / 1
| 1

reach
A recent report shows that USP9X modulates Smad4 levels in cells through reduction of its mono-ubiquitination.
USP9X affects VHL
| 13
USP9X inhibits VHL.
| 9
USP9X inhibits VHL. 8 / 8
| 8

reach
USP9X degrades pVHL through protection of its substrate, the newly identified pVHL E3 ligase Smurf1.

reach
Our findings show pVHL is induced by USP9X knockdown, raising the possibility a suitable USP9X inhibitor may exert a similar effect.

reach
Smurf1 thus mediates downregulation of pVHL by USP9X.

reach
USP9X down-regulates pVHL through Smurf1.

reach
USP9X negatively regulates pVHL.

reach
In order to demonstrate USP9X negatively regulates pVHL in clear cell renal cell carcinoma (ccRCC) which is a VHL disease associated neoplasm, USP9X was knocked down in 786-0 cells stably expressing HA tagged pVHL.

reach
USP9X knockdown up-regulated pVHL, while HUWE1 showed no evidence of pVHL regulation at the protein level (XREF_SUPPLEMENTARY).

reach
Previous results demonstrated USP9X decreases the protein stability of pVHL, raising a question as to how USP9X destabilizes pVHL.
USP9X inhibits mutated VHL. 1 / 1
| 1

reach
Newly identified unstable pVHL mutants maintain partial pVHL function and are negatively regulated by USP9X.
USP9X decreases the amount of VHL.
| 3
USP9X decreases the amount of VHL. 3 / 3
| 3

reach
As knockdown of USP9X in HEK293T cells significantly increased pVHL levels, both mRNA levels and protein half-life of pVHL were evaluated in HEK293T cells to further investigate the mechanism by which USP9X regulates pVHL.

reach
This study shows that inhibition of USP9X function by either shRNA or a chemical inhibitor significantly enhances pVHL levels and suppresses tumor cell proliferation.

reach
USP9X negatively regulates pVHL levels and consequently protects HIF and NF-kappaB activity.
USP9X activates VHL.
| 1
USP9X activates VHL. 1 / 1
| 1

reach
Knockdown of USP9X caused induction of pVHL, and protein levels of HIF-2alpha were consequently decreased in HepG2 cells and PC3 cells.
USP9X affects CEP131
| 13
USP9X activates CEP131.
| 11
| 10

reach
To investigate whether and how other substrates of USP9X might affect the cellular function of USP9X promoted CEP131 stabilization, we analysed by WB analysis the expression of IPO5, PRMT5 and PPM1B, which were also identified as interactors of USP9X (XREF_SUPPLEMENTARY), and the results indicate that the protein abundance of these proteins was essentially unchanged upon USP9X knockdown (XREF_SUPPLEMENTARY).

reach
Collectively, these observations suggest a potential role for USP9X promoted CEP131 stabilization in breast carcinogenesis.

reach
Since centrosome dysregulation associated mitotic defects could result in genome instability and cell apoptosis XREF_BIBR XREF_BIBR XREF_BIBR, we examined whether USP9X promoted CEP131 stabilization plays a role in genome stability and cell death.

reach
We next asked the question how USP9X promoted CEP131 stabilization has an impact on centrosome biogenesis.

reach
In vitro deubiquitination assays revealed that, while USP9X was able to remove ubiquitins of CEP131 and K504R, but not that of CEP131 and K254R (XREF_FIG), favouring the argument that USP9X targets K254 of CEP131 for deubiquitination, although polyubiquitin chains conjugated onto CEP131 and K254R and CEP131 and K504R were both dramatically reduced (XREF_FIG).

reach
These results indicate that USP9X promoted CEP131 stabilization is required for breast cancer cell survival.

reach
Combining the findings that mildly disrupted centrosomal localization of PCM1 has minimal effect on CEP131 recruitment and the observations that USP9X directly interacts with CEP131 and opposes its polyubiquitin linkages in vitro, we get the conclusion that the effect of USP9X on CEP131 stabilization is attributed to the interplay between these two molecules but not through USP9X targeting other substrates like PCM1, and USP9X regulated PCM1 stabilization on centrosome activity, if it does so, seems to be independent of USP9X promoted CEP131 stabilization.

reach
On the other hand, Li and colleagues demonstrated that USP9X, a well studied protein with oncogenic potential (Schwickart et al., 2010), promotes CEP131 stabilization through deubiquitination (Li et a[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Together, these results indicate that overexpression of USP9X promotes centrosome amplification and mitotic defects in a CEP131 dependent manner.

reach
To gain molecular insights into the functional connection between USP9X and CEP131, we examined whether USP9X promoted CEP131 stabilization is dependent on the enzymatic activity of USP9X.
Modified USP9X activates CEP131. 1 / 1
| 1

reach
Moreover, USP9X overexpression was able to restore the expression of CEP131 and prolong the half-life of CEP131 in USP9X deficient cells (XREF_FIG).
USP9X inhibits CEP131.
| 1
USP9X inhibits CEP131. 1 / 1
| 1

reach
Vice versa, depletion of USP9X also decreased cellular pools of CEP131 and PCM1.
USP9X increases the amount of CEP131.
| 1
Modified USP9X increases the amount of CEP131. 1 / 1
| 1

reach
Moreover, USP9X overexpression was able to restore the expression of CEP131 and prolong the half-life of CEP131 in USP9X deficient cells (XREF_FIG).
USP9X affects TGFB
| 11
USP9X activates TGFB.
| 8
USP9X activates TGFB. 8 / 9
| 8

reach
USP9X might also act as a regulator of the TGF-beta pathway, another signaling circuitry of great relevance to cancer, as witnessed by the fact that loss of USP9X abolishes multiple TGF-beta gene responses XREF_BIBR.

reach
FAM and USP9x activity is required for Smad4 mediated TGFbeta signaling, because it re-enables Smad4 to form complexes with R-Smads and signal in the nucleus.

reach
The results, exemplified in Figures 1 C, 1D, and S1, show that loss of FAM abolishes multiple TGFbeta gene responses.

reach
FAM knockdown also blocks TGFbeta mediated induction of a synthetic Smad promoter fused to luciferase (CAGA12-lux, Figure 1 E), in line with the notion that FAM is a critical factor for Smad signaling[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Since USP9X was previously reported to positively regulate SMAD4 transcriptional activity 17 and SMAD4 is commonly mutated in PDA 4, we hypothesized that Usp9x loss would attenuate Smad4 function or TGFbeta responsiveness in PDA cell lines.

reach
The deubiquitylating enzyme USP9X (also known as FAM) reverts the effects of TRIM33 on Smad4 and restores TGF-beta signaling.

reach
USP9X positively regulates TGF-beta signaling by deubiquitylating SMAD4 and promoting its association with SMAD2 [XREF_BIBR].

reach
Loss of Usp9x Disrupts Cortical Architecture, Hippocampal Development and TGFbeta Mediated Axonogenesis.
USP9X inhibits TGFB.
| 3
USP9X inhibits TGFB. 3 / 3
| 3

reach
Where indicated, control cells were supplemented with 5 muM SB431542 (Tocris) in the medium to quench autocrine TGFbeta signaling.For FAM knockdown, the sequences of the siRNA were as follows : # 1 : [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Thus loss of USP9x can increase TGFbeta signaling, potentially contributing to tumorigenesis.

reach
Depletion of FAM or Smad4 abolished TGFbeta induced migration.
USP9X affects GPSM1
| 11
USP9X activates GPSM1.
| 6
USP9X activates GPSM1. 6 / 7
| 6

reach
The observations that knockdown of USP9x decreases the cellular level of AGS3 (XREF_FIG) and overexpression of USP9x increases the staining intensity of AGS3 (XREF_FIG) imply that USP9x can regulate the level of AGS3.

reach
These data show that ectopic expression of USP9x at a high level increases the staining signal of AGS3, and that this effect of USP9x requires its deubiquitinating activity.

reach
Presumably this indicates that low amounts of USP9x are sufficient to prevent AGS3 degradation.

reach
To test whether the ability of USP9x to enhance AGS3 staining depends on its deubiquitinating activity, we repeated the experiment using the UCH domain of USP9x alone, which is the catalytic domain responsible for the deubiquitinase activity of USP9x XREF_BIBR, XREF_BIBR.

reach
Relative to the full-length USP9x, which increased the AGS3 staining primarily in cells expressing a high level of transfected USP9x-HA (~ 30% of these cells), the UCH domain led to enhanced AGS3 staining in almost all transfected cells displaying a moderate-to-high level of overexpression (XREF_FIG).

reach
Taken together, our study suggests that USP9x can modulate the level of a subpopulation of AGS3, and this modulation plays a role in regulating the structure of the late Golgi compartments.
USP9X increases the amount of GPSM1.
| 4
USP9X increases the amount of GPSM1. 3 / 3
| 3

reach
The observations that knockdown of USP9x decreases the cellular level of AGS3 (XREF_FIG) and overexpression of USP9x increases the staining intensity of AGS3 (XREF_FIG) imply that USP9x can regulate the level of AGS3.

reach
Collectively, our study supports a model in which USP9x can modulate the level of AGS3 (or a pool of it), and that this modulation plays a role in regulating the structure and/or function of the late Golgi compartments.

reach
Under this scenario, it would be worthwhile to investigate whether USP9x modulates the level of AGS3 associated with the Golgi membrane considering our findings that knockdown of AGS3 or USP9x both affect the late Golgi compartments (XREF_FIG).
Modified USP9X increases the amount of GPSM1. 1 / 1
| 1

reach
In contrast, overexpression of either USP9x or its deubiquitinating domain UCH increases the amount of AGS3, whereas expression of the mutant UCH domain that lacks deubiquitinating activity does not have the same effect.
USP9X decreases the amount of GPSM1.
| 1
USP9X decreases the amount of GPSM1. 1 / 1
| 1

reach
Knockdown of USP9x causes a moderate reduction in the level of AGS3.
USP9X affects cell death
| 8
USP9X activates cell death.
| 4
| 4

reach
It is thus possible that USP9X promotes or prevents H 2 O 2 -triggered cell death by acting on different targets at varying levels of oxidative damage.

reach
Thus, USP9X positively regulates ASK1 activity and ASK1 dependent cell death through the deubiquitination and stabilization of ASK1 [XREF_BIBR].

reach
Finally, the Usp9X pharmacological inhibitor WP1130 significantly reduced human MPNST growth and induced tumor cell death in an in vivo xenograft model.

reach
Since centrosome dysregulation associated mitotic defects could result in genome instability and cell apoptosis XREF_BIBR XREF_BIBR XREF_BIBR, we examined whether USP9X promoted CEP131 stabilization plays a role in genome stability and cell death.
USP9X inhibits cell death.
| 4
| 4

reach
Interestingly, different from Peterson 's finding that USP9X is an oncogene in B-cell malignancies [XREF_BIBR], we found that knockdown of USP9X did not induce cell death of T-ALL cells, indicating that the role of USP9X is cell type dependent.

reach
Pharmacological inhibition of USP9X potently induced cell death in OSCC cells in vitro and in vivo.

reach
Moreover, USP9x silencing resulted in significantly increased cell death in BaF3 and p210 cells (XREF_SUPPLEMENTARY), suggesting that the ITC induced inhibition of USP9x can, at least partially, account for the reduced viability and increased cell death observed upon ITC treatment.

reach
Indeed, knockdown of Usp9X increased mitotic cell death in Mcl1 -/- cells to a similar extent as in WT MEFs, thus indicating independence of MCL1 (Fig XREF_FIG A and B).
| 7

reach
Usp9x expression increases cell survival and 3D growth, and induces invasion in human PDAC cell line PANC1.

reach
In brief, USP9X promoted the migration and invasion of PANC-1 cells probably by provoking epithelial-mesenchymal transition, and also inhibited apoptosis.

reach
Furthermore, USP9X inhibition also reversed the increased migration and invasion mediated by miR-132 inhibition.

reach
G9 mediated inhibition of Usp9x in pancreatic cancer cells not only reduced the in vitro 3D growth and invasion but also inhibited tumor growth of human pancreatic cancer MIAPACA2 cells in vivo.

reach
Depletion of USP9X in prostate cancer LNCaP and PC-3 cells by small interfering RNA promoted cell invasion and migration.

reach
Inhibition of USP9X by its inhibitor WP1130 reduced the migration and invasion of NSCLC cells.

reach
Importantly, reintroduction of RNF115 in USP9X depleted cells partially rescued the reduced proliferation, migration, and invasion of breast cancer cells by USP9X knockdown.
| 2 1

sparser
Enforced expression of FAM198B inhibited cell invasion, migration, mobility, proliferation and anchorage-independent growth and FAM198B silencing exhibited opposite activities in vitro.

reach
Knockdown of endogenous USP9X expression evidently inhibited the migration and invasion of PANC-1 cells, and promoted cell apoptosis.

sparser
The invasided cell numbers were reduced after the overexpression of FAM3D-AS1, suggesting that FAM3D-AS1 can inhibit the cell invasion ( xref E), Thus, these results revealed that FAM3D-AS1 possessed the function of inhibition of cell proliferation and invasion.
USP9X affects Notch
| 6
USP9X activates Notch.
| 3
USP9X activates Notch. 3 / 5
| 3

reach
Loss of Usp9x disrupts cell adhesion, and components of the Wnt and Notch signaling pathways in neural progenitors.

reach
Usp9x promotes Notch signalling by antagonising the degradation of Mind bomb1, as well as activating Epsin in the signal sending cell XREF_BIBR, XREF_BIBR.

reach
Using a murine TNBC model, we show that USP9x knockdown abrogates Notch activation, reducing the production of the proinflammatory cytokines, C-C motif chemokine ligand 2 (CCL2) and interleukin-1 beta (IL-1β).
USP9X inhibits Notch.
| 3
USP9X inhibits Notch. 3 / 3
| 3

reach
Of note, the meta-analysis of the published transcriptomics datasets highlighted potential dysregulation of upstream regulators able to activate (MECOM and USP9X) [50,51] or inhibit Notch (e.g., ARRB1) [52].
| PMC

reach
The pharmacological inhibition of USP9x using G9, a partially selective, small-molecule USP9x inhibitor, reduced Notch activity, remodeled the tumor immune landscape, and reduced tumor growth without associated toxicity.

reach
Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer.
USP9X affects 3D
| 8
USP9X inhibits 3D.
| 4
USP9X inhibits 3D. 4 / 4
| 4

reach
Although G9 treatment reduced human MIAPACA2 tumor burden in vivo, in mouse pancreatic cancer cell lines established from constitutive (8041) and doxycycline inducible (4668) KrasG12D and Tp53R172H mouse pancreatic tumors, Usp9x inhibition increased and sustained the 3D colony growth and showed no significant effect on tumor growth in 8041-xenografts.

reach
Adding clinical relevance to our findings, Usp9x KD completely diminished 3D growth in patient derived PDX cells.

reach
Usp9x KD in all four PDX cell lines completely inhibited 3D colony growth (XREF_FIG, B and C) as compared to their respective scrambled controls.

reach
Usp9x Inhibition Promotes 3D Colony Growth Independent of Mutant Kras Activity in Mouse Pancreatic Tumor Derived Cell Lines.
USP9X activates 3D.
| 4
USP9X activates 3D. 4 / 4
| 4

reach
Usp9X Inhibition Inhibits 3D Colony Growth in Established and Patient Derived Human Pancreatic Cancer Cells.

reach
ShRNA mediated Usp9x knockdown suppresses 3D growth in PANC1 cells and induces apoptosis in MIAPACA2 cells.

reach
Usp9x Inhibition Reduces 3D Colony Growth in Mutant Kras Cell Line MIAPACA2 But Not in w/t BXPC3 Cells.

reach
Usp9x expression increases cell survival and 3D growth, and induces invasion in human PDAC cell line PANC1.
USP9X affects YAP1
| 8
USP9X activates YAP1.
| 4
USP9X activates YAP1. 4 / 4
| 4

reach
In this study, we demonstrate that USP9X may target YAP1 for deubiquitination and stabilization, thereby promoting breast cancer growth and tumor progression.

reach
Mechanistically, it was found that hsa_circ_0024093 could regulate the expression of USP9X, which further induced YAP1 deubiquitination to stabilize YAP1 protein.

reach
Taken together, these results suggest that USP9X directly regulates YAP1 stability.

reach
Moreover, overexpression of USP9X, dramatically increased YAP1 stabilization (XREF_SUPPLEMENTARY), while overexpression of the CS mutant decreased YAP1 stability.
USP9X decreases the amount of YAP1.
| 3
USP9X decreases the amount of YAP1. 3 / 3
| 3

reach
Similarly, depletion of USP9X in cells using two specific shRNAs significantly decreased YAP1 protein levels (XREF_FIG) and increased cellular sensitivity to MMC, cisplatin and etoposide (XREF_FIG), while reconstituting USP9X depleted cells with FLAG-YAP1 reversed chemotherapy drugs hypersensitivity (XREF_FIG).

reach
Concersely, depletion of USP9X in MDA-MB-231 cells significantly decreased YAP1 protein level but did not affect YAP1 mRNA level (XREF_FIG).

reach
Depletion of USP9X in ovarian cancer cell line OVCAR8 also downregulated YAP1 protein levels (XREF_SUPPLEMENTARY).
USP9X inhibits YAP1.
| 1
USP9X inhibits YAP1. 1 / 1
| 1

reach
In addition, depletion of USP9X decreases breast cancer proliferation, tumorigenesis, and chemoresistance in a YAP1 dependent manner.
USP9X affects XIAP
| 6
USP9X activates XIAP.
| 4
USP9X activates XIAP. 4 / 6
| 4

reach
In this analysis, USP9X and XIAP double high cases were compared to the remaining cases (including cases with low USP9X and high XIAP) because these cases reflect the constellation where elevated XIAP is predicted to result from mitotic USP9X mediated stabilization of XIAP.

reach
In aggressive B cell lymphoma, USP9X decreased the degradation of X linked inhibitor of apoptosis protein (XIAP) to confer resistance against spindle poison containing chemotherapy [XREF_BIBR].

reach
In addition, loss of USP9X caused a substantial reduction in the protein expression of c-Myc and XIAP, whereas the protein levels of GAPDH and beta-actin (DeltaG 5 ' UTR = -16 kcal and mol), whose 5 ' UTR are relatively unstructured, remained unchanged.

reach
First, we investigated the role of USP9X mediated stabilization of XIAP in the context of B-cell lymphoma maintenance invivo.
USP9X increases the amount of XIAP.
| 2
USP9X increases the amount of XIAP. 1 / 1
| 1

reach
Other USP9X independent causes of elevated XIAP levels likely exist, which would however not reflect the situation in which DLBCL cells depend on the mitotic activity of the USP9X-XIAP axis.
Modified USP9X increases the amount of XIAP. 1 / 1
| 1

reach
Moreover, rescuing USP9X expression in USP9X -/- cells significantly increased the protein levels of c-Myc and XIAP with a minimal effect on their corresponding mRNA levels.
USP9X affects TP53
| 1 7
USP9X inhibits TP53.
| 5
USP9X inhibits TP53. 5 / 5
| 5

reach
USP9X deficient cells promoted p53 degradation suggesting it to be considered as a potential therapeutic modulator in p53 related tumors.

reach
miR-26b enhances the sensitivity of hepatocellular carcinoma to Doxorubicin via USP9X dependent degradation of p53 and regulation of autophagy.

reach
In conclusion, this study revealed that miR-26b regulation was a mechanism involved in the sensitivity of HCC cell lines to doxorubicin directly through USP9X dependent degradation of p53 and regulation of autophagy.

reach
WP1130 also increases sensitivity to doxorubicin via degrading p53 by a USP9X dependent mechanism in HCC cells XREF_BIBR.

reach
It also confers doxorubicin sensitivity of hepatocellular carcinoma through USP9X dependent degradation of p53 [XREF_BIBR].
USP9X decreases the amount of TP53.
| 2
USP9X decreases the amount of TP53. 2 / 2
| 2

reach
Among the compounds targeting USP9X, a non specific inhibitor of USP9X, named (EOAI3402143) G9, belonging to the USP9X-second generation inhibitors, has been shown to destabilize the pro survival protein MCL1 and increased p53 levels, promoting apoptosis in a dose dependent manner and reducing tumor growth of human myeloma xenograft [XREF_BIBR].

reach
USP9X knockdown eliminated the decreased p53 expression caused by WP1130 in the presence of cisplatin.
USP9X activates TP53.
| 1
USP9X activates TP53. 1 / 1
| 1

sparser
FAM188B silencing activates p53 and its downstream pathway.
USP9X affects Wnt
| 6
USP9X activates Wnt.
| 4
USP9X activates Wnt. 4 / 5
| 4

reach
Down-regulation of USP9X also consistently inhibits the tumorigenicity of primary glioma cells in vivo.In summary, these results indicate that USP9X stabilizes beta-catenin and activates Wnt and beta-catenin signal pathway to promote glioma cell proliferation and survival.

reach
In summary, these results indicate that USP9X stabilizes beta-catenin and activates Wnt and beta-catenin signal pathway to promote glioma cell proliferation and survival.

reach
By evaluating signaling in U251 cells treated with a Wnt ligand, we found that USP9X knockdown partly blocked the activation of Wnt and beta- catenin pathway by regulating the stability of beta-catenin.

reach
Loss of Usp9x disrupts cell adhesion, and components of the Wnt and Notch signaling pathways in neural progenitors.
USP9X inhibits Wnt.
| 2
USP9X inhibits Wnt. 2 / 2
| 2

reach
Therefore, to test if loss of Usp9x can directly activate Wnt signalling, TCF-TOPflash reporter assays were performed on HEK293 cells from which USP9X was depleted with siRNA.

reach
Loss of Usp9x also activated the Wnt signalling pathway and, at least in cultured cells, this can occur directly.
| 4

reach
In vivo studies further substantiate that inhibition of ERK and USP9x suppressed obesity induced metastasis.

reach
A patient with cancer of unknown primary site suffering from diffuse bone marrow metastasis and DIC, was treated with FAM (5-fluorouracil, adriamycin and mitomycin C) combination chemotherapy.

reach
We next ascertained if the ERK and USP9x pathway observed in cell culture could modulate breast cancer metastasis in obese animal models.

reach
Inhibition of ERK and USP9x suppressed obesity induced metastasis.
| 2

reach
The results indicated that FA-M (PTX) prevented pulmonary metastasis of H22, and the efficacy was stronger than pure PTX and simple PTX conjugated micelles.

reach
Furthermore, inhibition of USP9x in vivo suppressed obesity induced breast cancer metastasis.
USP9X affects ITCH
| 7
USP9X activates ITCH.
| 5
USP9X activates ITCH. 5 / 5
| 5

reach
We demonstrate that the expression of the deubiquitinase USP9X, which activates ITCH stability, is increased in 9F7-F11-treated pancreatic cancer cells.

reach
It was previously reported that USP9X knock-down induces ITCH down-regulation in BxPC3 cells cultured in agar suspension, but not in monolayer [XREF_BIBR].

reach
The USP9x deubiquitylating enzyme has been shown to promote ITCH stability by counteracting auto-ubiquitylation [XREF_BIBR].

reach
Loss of Usp9x led to decreased Itch and Numb levels, and a concomitant increase in levels of the Notch intracellular domain as well as, increased expression of the Notch target gene Hes5.

reach
ITCH and AIP4 activity was activated by the deubiquitinases USP8 and USP9X, as demonstrated by RNA interference.
USP9X increases the amount of ITCH.
| 2
Modified USP9X increases the amount of ITCH. 2 / 2
| 2

reach
Overexpression of Usp9x increased 3D growth and invasion in PANC1 cells and up-regulated the expression of known Usp9x substrates Mcl-1 and ITCH.

reach
We also show for the first time that Usp9x interacts with the Notch inhibitor Numb in NPs and loss of Usp9x significantly decreased Numb and Itch protein levels.
USP9X affects SOX2
| 1 6
USP9X activates SOX2.
| 1 2
USP9X activates SOX2. 3 / 3
| 1 2

eidos
Usp9x knockdown , as well as inhibition with DUB inhibitor , G9 , blocked SOX2 expression , suppressed in vitro colony growth , and induced apoptosis of BRAF-mutant melanoma cells .

reach
Exogenous overexpression of Usp9x in SK-Mel29 cells lead to upregulation of SOX2 (XREF_FIG) and as expected, increased 3D tumor growth (XREF_FIG).

reach
MG132 treatment reversed the reduction of SOX2 by Usp9x KD, indicating that ubiquitin proteasome pathway plays a role in controlling SOX2 levels (XREF_FIG).
USP9X inhibits SOX2.
| 2
USP9X inhibits SOX2. 2 / 2
| 2

reach
Usp9x KD blocked the induction of SOX2 by vemurafenib or MEKi treatment in melanoma cell lines with mutant BRAF, A375 (XREF_FIG), SK-Mel28 (XREF_FIG) and wild type BRAF, SK-Mel147 (XREF_FIG).

reach
Furthermore, we found that Usp9x KD reduced the half-life of SOX2 in the presence of cycloheximide from 6 to 4 h (XREF_FIG), suggesting that in the absence of new protein translation, Usp9x can control pre-existing SOX2 levels.
USP9X increases the amount of SOX2.
| 1
USP9X increases the amount of ubiquitinated SOX2. 1 / 1
| 1

reach
Immunoprecipitation of FLAG-SOX2 from HEK293T cells also expressing HA-ubiquitin, we show that Usp9x KD increased the levels of ubiquitinated SOX2 in the cells (XREF_FIG).
USP9X decreases the amount of SOX2.
| 1
USP9X decreases the amount of SOX2. 1 / 1
| 1

reach
Usp9x KD but not Usp34 KD (XREF_FIG) reduced SOX2 levels in both BRAF mutant A375, SK-Mel28 (XREF_FIG), and NRAS-mutant SK-Mel147 (XREF_FIG) melanoma cell lines.
USP9X affects NRAS
| 7
USP9X increases the amount of NRAS.
| 3
USP9X increases the amount of NRAS. 3 / 3
| 3

reach
In melanoma, both MEK and BRAF inhibition led to an induction of Ets-1 and NRAS expression that could be blocked by Usp9x inhibition.

reach
Thus, Usp9x mediated stabilization of Ets-1 (and ERG) regulates NRAS expression.

reach
These results suggest that Usp9x enhances NRAS expression and in vivo tumour growth, which could be blocked by Usp9x depletion or inhibition.
USP9X activates NRAS.
| 2
USP9X activates NRAS. 2 / 2
| 2

reach
In two melanoma cell lines (SK-Mel29, WM1366; XREF_FIG), Usp9x activated NRAS promoter activity by ~ 2-fold, while Ets-1 expression increased promoter activity by> 2.5-fold.

reach
Thus, Usp9x modulates the Ets-1 and NRAS regulatory network and may have biologic and therapeutic implications.
USP9X inhibits NRAS.
| 1
USP9X inhibits NRAS. 1 / 1
| 1

reach
Usp9x KD reduced NRAS protein levels in both NRAS and BRAF mutant cells with little to no effect on HRAS or KRAS expression (XREF_FIG).
USP9X decreases the amount of NRAS.
| 1
USP9X decreases the amount of NRAS. 1 / 1
| 1

reach
Usp9x KD blocked kinase inhibitor induced Ets-1 and NRAS expression (XREF_FIG) and correlated with greater cell growth inhibition (XREF_FIG) and apoptosis (XREF_FIG) than that activated by kinase inhibition alone.
USP9X affects MYC
| 7
USP9X inhibits MYC.
| 5
USP9X inhibits MYC. 4 / 4
| 4

reach
In agreement with these findings, USP9X silencing using 2 different siRNAs increased c-MYC transcriptional activity in HCT116-FBW7 +/+ but not in HCT116-FBW7 Delta and Delta cells, as indicated by a dual luciferase c-MYC reporter assay (XREF_FIG).

reach
Besides, USP9X negatively regulated c-Myc by directly stabilizing FBW7 to restore damaged intestinal epithelium and inhibit the development of colitis-associated colon cancer in animal models (140).
| PMC

reach
Hence, Usp9x controls tissue homeostasis in the murine gut by negatively regulating c-Myc and Notch1, most likely via stabilization of Fbw7.

reach
Thus, USP9X negatively regulates c-MYC activity via direct stabilization of FBW7.
USP9X inhibits MYC. 1 / 1
| 1

reach
Consistent with the notion that USP9X negatively regulates c-MYC protein stability, c-MYC ubiquitylation was reduced in USP9X-knockdown cells, with no effect on its mRNA (XREF_FIG).
USP9X increases the amount of MYC.
| 1
Modified USP9X increases the amount of MYC. 1 / 1
| 1

reach
Moreover, rescuing USP9X expression in USP9X -/- cells significantly increased the protein levels of c-Myc and XIAP with a minimal effect on their corresponding mRNA levels.
USP9X activates MYC.
| 1
USP9X activates MYC. 1 / 1
| 1

reach
In addition, loss of USP9X caused a substantial reduction in the protein expression of c-Myc and XIAP, whereas the protein levels of GAPDH and beta-actin (DeltaG 5 ' UTR = -16 kcal and mol), whose 5 ' UTR are relatively unstructured, remained unchanged.
| 6
| 6

reach
In the upper layers of the epidermis FAF mediates adhesion through binding to galectin-7 - a keratinocyte cell marker.

reach
To investigate whether FAF mediates adhesion of F. magna to skin tissue via the interaction with BM-40, colocalization studies were performed.

reach
The majority of F. magna isolates express the surface protein FAF, that mediates bacterial adhesion to epidermis and basement membranes.

reach
FAF was found to mediate this adhesion via interactions with BM-40, a basement membrane protein.

reach
Loss of Usp9x disrupts cell adhesion, and components of the Wnt and Notch signaling pathways in neural progenitors.

reach
The surface protein FAF mediates adhesion of F. magna through an interaction with BM-40, a protein present in basement membranes and in the epidermis.
NR1I3 affects USP9X
| 6
NR1I3 activates USP9X. 6 / 6
| 6

sparser
Activation of the mouse FAM84A promoter by CAR.

sparser
HepG2 cell-based reporter assays indicated that CAR activated the FAM84A promoter.

sparser
However, statistically significant up-regulation of transcriptional activity of the -9.0-kb FAM84A promoter was observed with CAR activation, so these results indicate that CAR activates the FAM84A gene.

sparser
HepG2 cell-based reporter assays indicated that CAR activated the FAM84A promoter.

sparser
Activation of the mouse FAM84A promoter by CAR.

sparser
However, statistically significant up-regulation of transcriptional activity of the -9.0-kb FAM84A promoter was observed with CAR activation, so these results indicate that CAR activates the FAM84A gene.
USP9X affects MTOR
| 1 5
USP9X inhibits MTOR.
| 1 4
USP9X inhibits MTOR. 5 / 5
| 1 4

reach
USP9X, as a novel mTORC1 and -2 binding partner, negatively regulates mTOR activity and further affects the differentiation of skeletal muscle [XREF_BIBR].

reach
As such it would be expected that both CUL4B-DDB1 and TRAF2 enhance mTORC1 dependent S6K and 4E-BP1 phosphorylation while UCH-L1 and OTUD7B enhance mTORC2 dependent AKT phosphorylation at S473.mTOR si[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

sparser
MTOR signalling can further be downregulated through a number of ubiquitin dependent mechanisms with mTOR itself being negatively regulated by both Cul1-Skp-Fbw7 E3 ligase and the DUB USP9X . The targ[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
The targeting of the Cul1, Skp, and Fbw7 complex to mTOR results in the latter 's ubiquitination and degradation while the mechanism through which USP9X inhibits mTOR signalling remains ill defined.

reach
Ubiquitin specific peptidase 9, X linked (USP9X) modulates activity of mammalian target of rapamycin (mTOR).
USP9X activates MTOR.
| 1
USP9X activates MTOR. 1 / 1
| 1

reach
Therefore in C2C12 myoblasts, the regulation of mTOR signalling by Usp9x may be indirect.
MCL1 affects USP9X
| 4
MCL1 activates USP9X.
| 3
MCL1 activates USP9X. 3 / 5
| 3

reach
Hence, and as shown from our current data, increasing Mcl-1 ubiquitination via PS341 promotes the association of USP9X with Mcl-1.

reach
The activation of Noxa makes Mcl-1 degrade by decreasing deubiquitinase Usp9x after pemetrexed exposure.

reach
Importantly, examination of USP9X targets MCL1 and beta-catenin by western blot analysis did not reveal a change in their protein levels when USP9X was knocked down in DAOY cells.
MCL1 inhibits USP9X.
| 1
MCL1 bound to PMAIP1 inhibits USP9X. 1 / 1
| 1

reach
Based on these data, we hypothesized that the binding of Noxa to Mcl-1 actually decreases the availability of Usp9x to Mcl-1; as a result, this leads to augmentation of its ubiquitination level.

reach
USP9X thereby opposes activation of anaphase promoting complex and cyclosome (APC/C) and specifically inhibits the mitotic degradation of SAC controlled APC/C substrates.

reach
This function is critical for mitotic fidelity because loss of USP9X causes a reduction in the efficiency of the SAC, an increased frequency of chromosome mis-segregations and the generation of chromosomal instability (CIN).

reach
USP9X Enhances SAC Efficiency to Protect against CIN.

reach
We demonstrate that depletion or loss of USP9X reduces the effectiveness of the SAC, elevates chromosome segregation defects, and enhances chromosomal instability (CIN).

reach
In the presence of many unattached kinetochores, the SAC signal is strong and therefore, although USP9X depletion reduces SAC efficiency in cells arrested in mitosis with nocodazole, the arrest still persists for several hours (XREF_FIG B).
USP9X affects cell growth
| 4
USP9X activates cell growth.
| 2
| 2

reach
We investigated the role of USP9X in B-ALL and found that USP9X knockdown significantly reduced leukemic cell growth and increased spontaneous apoptosis, thereby improving survival in immunodeficient mice.

reach
Although USP9X may function as a tumor-suppressor during the establishment of PDAC, data presented here argue that USP9X promotes cell growth in advanced PDAC cells when PDAC is typically diagnosed.
USP9X inhibits cell growth.
| 2
| 2

reach
Knockdown of USP9X significantly reduced anchorage independent cell growth of prostate carcinoma cell line.

reach
These data show that in contrast to human pancreatic tumor cell line models, Usp9x suppresses cell growth, and its inhibition leads to increased colony formation in mouse pancreatic cancer cell lines.
USP9X affects ZBTB38
| 5
USP9X inhibits ZBTB38.
| 4
USP9X inhibits ZBTB38. 4 / 4
| 4

reach
Conversely, the depletion of USP9X further down-regulated the abundance of ZBTB38 protein in cells over-expressing RBBP6 (XREF_SUPPLEMENTARY).

reach
We noticed that ZBTB38 protein levels are regulated during the cell cycle : ZBTB38 expression was higher in S-phase cells (synchronized by hydroxyurea) than in M-phase cells (synchronized by nocodazole), and USP9X depletion significantly reduced ZBTB38 protein abundance in both cases.

reach
These data indicate that the depletion of USP9X or the inhibition of its deubiquitinase activity prevents the accumulation of ZBTB38 induced by H 2 O 2 exposure.

reach
The level of ZBTB38 protein was found to be very low in cells treated with siRNAs targeting USP9X, and the exposure to H 2 O 2 did not induce ZBTB38 accumulation in these cells.
USP9X activates ZBTB38.
| 1
USP9X activates ZBTB38. 1 / 1
| 1

reach
USP9X overexpression was found to rescue the destabilization of ZBTB38 caused by RBBP6 overexpression (XREF_SUPPLEMENTARY).
USP9X affects Ubiquitin
| 5
USP9X activates Ubiquitin.
| 3
| 3

reach
USP9X can also modulate ubiquitin ligase SMURF1, a negative regulator of TGFbeta and BMP signaling that controls tumor cell migration and invasion by targeting Rho family proteins [XREF_BIBR]-[XREF_BIBR].

reach
Both Usp9x KD and G9 treatment increased Ets-1 ubiquitin content (XREF_FIG).

reach
Depletion of USP9x increased the incorporation of ubiquitin into AMOT (XREF_FIG).
USP9X inhibits Ubiquitin.
| 2
| 2

reach
Results from the in vitro experiments suggested that USP9X mediates the ubiquitin dependent degradation of AMPK-alpha2.

reach
USP9x has been reported to increase SMAD4 activity by removing an inhibitory ubiquitin moiety [XREF_BIBR].
USP9X affects Neoplasms
| 2 1
USP9X inhibits Neoplasms.
| 1 1
| 1 1

eidos
USP9X elicited tumor suppressor role by preventing degradation of EGLN3 .

reach
The pharmacological inhibition of USP9x using G9, a partially selective, small-molecule USP9x inhibitor, reduced Notch activity, remodeled the tumor immune landscape, and reduced tumor growth without associated toxicity.
USP9X activates Neoplasms.
| 1
| 1

eidos
In the same study , it was observed that MCL-1 levels were increased in malignant tissues from melanoma patients while Beclin1 was destabilized , suggesting that USP9X promotes tumor progression .
USP9X affects MARCHF7
| 3
USP9X inhibits MARCHF7.
| 2
| 2

reach
BBS11 is a resident centrosomal protein, whereas cytoplasmic USP9X sequesters the majority of MARCH7 away from the centrosome during interphase.

reach
Decreasing axotrophin auto-ubiquitination by overexpression of ubiquitin hydrolases USP7 and USP9x increased the axotrophin level XREF_BIBR.
USP9X activates MARCHF7.
| 1
USP9X activates MARCHF7. 1 / 1
| 1

reach
Furthermore, DUBs are known to regulate stability of only 4 of these proteins, including the ubiquitin ligases MARCH7 and BIRC3, which are targeted by USP7 or USP9 and USP19, respectively.
USP9X affects FBXW7
| 5
USP9X inhibits FBXW7.
| 4
USP9X inhibits FBXW7. 4 / 4
| 4

reach
FBW7, the substrate binding component of a ubiquitin ligase complex, targets MCL-1 for degradation by the 26S proteasome, whereas the deubiquitinase USP9X reverses the polyubiquitinating activity of the FBW7 complex [XREF_BIBR].

reach
USP9X antagonized FBW7 ubiquitylation, and Usp9x deletion caused Fbw7 destabilization.

reach
Although the E3 ligase Itch was shown to mediate the antitumor effects of USP9X in the pancreas, our data demonstrate that USP9X can prevent intestinal cancer by directly regulating the stability of FBW7 protein.

reach
Besides, USP9X negatively regulated c-Myc by directly stabilizing FBW7 to restore damaged intestinal epithelium and inhibit the development of colitis-associated colon cancer in animal models (140).
| PMC
USP9X activates FBXW7.
| 1
USP9X activates FBXW7. 1 / 1
| 1

reach
To explore Usp9x mediated Fbw7 regulation in vivo, we crossed Usp9x fl/fl mice with the gut specific Villin-Cre mouse and analyzed transverse sections of gut from the resulting Usp9x fl/fl Villin-Cre and Usp9x fl/y Villin-Cre mice (Usp9x DeltaG mice).

reach
Here we report that both BITC and PEITC inhibit USP9X and UCH37 and other DUBs at physiologically relevant concentrations and time scales.

reach
BITC and PEITC inhibit USP9x and UCH37 in vitro.

reach
BITC and PEITC inhibit USP9x and UCH37.

reach
PEITC inhibited labeling of recombinant USP9x with Cy5-UbVME with an IC 50 value of 20 +/- 2 muM, in good agreement with the lysate assays (XREF_SUPPLEMENTARY).
USP9X affects TRIM33
| 3 1
USP9X inhibits TRIM33. 4 / 4
| 3 1

reach
USP9x competitively inhibits TIF1gamma from binding and monoubiquitinating SMAD4, thus maintains SMAD4 nuclear retention and stabilizes the SMAD3 and SMAD4 complex in the nucleus.

sparser
USP9x inhibited the E3 ubiquitin-protein ligase TIF1γ from binding and monoubiquitinating SMAD4, hence maintaining SMAD4 nuclear retention.

sparser
USP9x competitively inhibits TIF1γ from binding and monoubiquitinating SMAD4, thus maintains SMAD4 nuclear retention and stabilizes the SMAD3/SMAD4 complex in the nucleus.

sparser
USP9x inhibited the E3 ubiquitin-protein ligase TIF1γ from binding and monoubiquitinating SMAD4, hence maintaining the SMAD4 nuclear retention.
USP9X affects Integrins
| 3 1
| 3 1

sparser
Fam38A-induced integrin activation is blocked by inhibition of either R-Ras or calpain activity, or by siRNA knockdown of talin, a well-described calpain substrate.

sparser
Integrin activation by Fam38A uses a novel mechanism of R-Ras targeting to the endoplasmic reticulum.

sparser
This highlights a novel mechanism for integrin activation by Fam38A, utilising calpain and R-Ras signalling from the ER.

reach
Thus, the deubiquitination induced recycling of integrin alpha5beta1 mediated by USP9x promotes cell migration, while the degradative HD-PTP and UBAP1 pathway is required for ESCRT dependent lysosomal[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
USP9X affects EBPL
| 4
USP9X activates EBPL. 4 / 4
| 4

reach
The third ERP component commonly elicited by FAF, the P2, has been shown to increase linearly as the size of the feedback perturbations increases XREF_BIBR, leading to the suggestion that the amplitude of the P2 component reflects the size of the speech production error XREF_BIBR, XREF_BIBR.

reach
Although researchers are just beginning to understand how FAF modulates the P1, N1, and P2 ERP components, their sensitivity to FAF makes them ideal for assessing the influence of attention on the processing of auditory feedback during ongoing speech.

reach
However, the results of this study also suggest that the P1-N1-P2 ERP components elicited by FAF are less sensitive to divided attention.

reach
Divided attention resulted in the modulation of compensatory vocal responses to FAF; however, divided attention did not modulate the amplitude or latency of the P1-N1-P2 ERP components elicited by the FAF in this study.
USP9X affects AMOT
| 4
USP9X activates AMOT. 4 / 4
| 4

reach
Moreover, USP9X was reported to target Angiomotin (AMOT) and Angiomotin like 2 (AMOTL2), which in turn regulates YAP1 activation XREF_BIBR, XREF_BIBR.

reach
USP9x targets AMOT and AMOT like proteins.

reach
These findings are consistent with a model in which USP9x mediated deubiquitylation increases AMOT stability.

reach
Moreover, previous studies showed that USP9X targets Angiomotin (AMOT) and Angiomotin like 2 (AMOTL2), which in turn regulates YAP1 activation XREF_BIBR, XREF_BIBR.
CEBPA affects USP9X
4 |
CEBPA decreases the amount of USP9X. 4 / 4
4 |

biopax:msigdb
No evidence text available

biopax:msigdb
No evidence text available

biopax:msigdb
No evidence text available

biopax:msigdb
No evidence text available
USP9X affects mitosis
| 4
USP9X inhibits mitosis.
| 2
| 2

reach
Control or USP9X depleted human osteosarcoma U2OS cells were arrested in mitosis with the microtubule destabilizing drug nocodazole for 2, 4, or 6hr to examine the rate of degradation of Mcl-1 and key mitotic regulators.

reach
We found that USP9X depletion reduced the duration of the arrest and cells exited mitosis despite the presence of the drug (XREF_FIG B).
USP9X activates mitosis.
| 2
USP9X activates mitosis. 2 / 2
| 2

reach
APC15 knockdown also caused a delay in mitosis that was abolished by co-depletion of USP9X (XREF_FIG B and XREF_SUPPLEMENTARY E).

reach
We therefore investigated the effect of Usp9X knockdown in Mcl1 -/- MEFs to rule out the possibility that USP9X mediates its mitosis specific effects by stabilizing MCL1.
| 3
USP9X inhibits cell migration.
| 1

reach
Cell migration was notably inhibited in HepG2 and PC3 cells after knockdown of USP9X with shRNA, suggesting USP9X promotes cell migration (XREF_SUPPLEMENTARY).
USP9X activates cell migration.
| 2

reach
Thus, the deubiquitination induced recycling of integrin alpha5beta1 mediated by USP9x promotes cell migration, while the degradative HD-PTP and UBAP1 pathway is required for ESCRT dependent lysosomal[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]

reach
Deubiquitinase USP9X promotes cell migration, invasion and inhibits apoptosis of human pancreatic cancer.
| 3

reach
Immunoblot analysis failed to detect any change in the level of the astrocytic marker GFAP or neuronal marker betaIII-tubulin, indicating that loss of USP9X did not induce the differentiation of ReNcell VM cells to post-mitotic cell fates.

reach
As expected, Usp9x DeltaG colonic ulcers after acute colitis were marked by increased proliferation and decreased secretory differentiation, most likely because the normalization of c-Myc and NICD1 protein is delayed in the absence of Usp9x, and the damaged intestine was locked in a proliferative state (XREF_FIG).

reach
Recently, we have shown that Msi2 is required for the self-renewal and pluripotency of mouse ESC XREF_BIBR and, more recently, we have determined that knockdown of Usp9x in mouse ESC substantially increases the differentiation of ESC (unpublished results).
| 1

reach
Nor did USP9X depletion promote the differentiation of ReNcells VM to post-mitotic neuronal or glial lineages.
USP9X affects USP9X
| 4
USP9X increases the amount of USP9X. 3 / 3
| 3

reach
USP9X has been shown to regulate multiple cellular functions, and increased expression of USP9X in tumors is significantly associated with poor prognosis for patients with multiple myeloma [XREF_BIBR].

reach
Usp9x knock-in mice expressing the fusion protein tdTomato-T2A-Usp9X allowed a more detailed analysis of Usp9x mRNA expression in the hematopoietic compartment (XREF_FIG).

reach
Second, inducible USP9X specific shRNA mediated knock-down, and transient over-expression of full length USP9X resulted in a concomitant decrease and increase in RAPTOR protein, respectively.
Modified USP9X increases the amount of USP9X. 1 / 1
| 1

reach
USP9X overexpression promoted NF-kB activation, while NF-kB inactivation inhibited USP9X transcription and HPAEpiC injury induced by USP9X overexpression.
USP9X affects SMURF1
| 2
USP9X inhibits SMURF1.
| 1
USP9X inhibits SMURF1. 1 / 2
| 1

reach
Importantly, depletion of USP9X in MDAMB231 metastatic breast cancer cells, which have elevated SMURF1 expression, inhibits SMURF1 dependent breast cancer cell motility [XREF_BIBR].
USP9X activates SMURF1.
| 1
USP9X activates SMURF1. 1 / 2
| 1

reach
USP9X can also modulate ubiquitin ligase SMURF1, a negative regulator of TGFbeta and BMP signaling that controls tumor cell migration and invasion by targeting Rho family proteins [XREF_BIBR]-[XREF_BIBR].
USP9X affects KRAS
| 4
USP9X decreases the amount of KRAS.
| 2
USP9X decreases the amount of KRAS. 2 / 2
| 2

reach
Usp9x KD suppressed NRAS, but not KRAS gene expression (XREF_FIG).

reach
Usp9x KD did not affect the Kras levels in mouse 8041 cells but reduced Kras levels in human MIAPACA2 cells.
USP9X activates KRAS.
| 2
USP9X activates KRAS-G12D. 2 / 2
| 2

reach
The FAM labelled probe targeted the KRAS G12D allele, while the CAL Fluor Orange560 labeled probe (VIC alternative probe) targeted the WT allele.

reach
In these models, genetic inactivation of Usp9x (either by insertional mutagenesis or Pdx1-Cre mediated deletion) was found to enhance oncogenic Kras G12D in accelerating tumourogenesis and cancer progression [XREF_BIBR].
USP9X affects ICP0
| 4
USP9X decreases the amount of ICP0.
| 3
USP9X decreases the amount of ICP0. 3 / 3
| 3

reach
However, the mechanism by which USP9X downregulates ICP0 expression is unknown at present, although it is possible that USP9X deubiquitylates and stabilizes an unknown ICP0 interacting factor that downregulates ICP0.

reach
Notably, ICP0 expression was downregulated by USP9X, in contrast to other USP9X interacting proteins.

reach
These observations suggested that USP9X negatively regulates ICP0 expression to inhibit viral replication, although we can not exclude the possibility that USP9X may suppress HSV-1 replication through other pathways.
USP9X activates ICP0.
| 1
USP9X activates ICP0. 1 / 1
| 1

reach
Notably, USP9X depletion increased the ICP0 abundance and promoted viral replication.
USP9X affects Death
| 4
USP9X activates Death.
| 3
USP9X activates Death. 3 / 3
| 3

reach
It can display both pro- and anti-cell death functions, mediated by the ability of USP9X to deubiquitylate the critical components of the apoptotic signalling networks.

reach
FAF increases the risk of stroke and sudden death.

reach
A novel mechanism of action was found in which the peptide reduces expression of the deubiquitinating enzyme Usp9X, which in turn leads to depletion of Mcl-1 and Bcl-2 and to consequent apoptotic death.
USP9X inhibits Death.
| 1
USP9X inhibits Death. 1 / 1
| 1

reach
In the latter two cell lines, USP9x knockdown also increased radiation induced clonogenic death.
RPE affects USP9X
| 4
RPE activates USP9X.
| 3
RPE activates USP9X. 3 / 3
| 3

reach
However, when outer retinal changes develop and, particularly, when RPE damage causes FAF changes, permanent scars may be more likely to develop [XREF_FIG].

reach
Systematic comparison of FAF signaled RPE molecular status with retinal cross-sections revealed by spectral-domain OCT may allow RPE morphologic features to be explored in areas of high FAF using large populations of patients.

reach
The principal finding is that a variability in RPE cellular morphologic features underlies the increased FAF at the transition between normal RPE and GA..
RPE inhibits USP9X.
| 1
RPE inhibits USP9X. 1 / 1
| 1

reach
These effects can then lead to incipient RPE degeneration, which is reflected in a decrease of bisretinoid content and consequently locally decreased FAF signal.
CTX3 affects USP9X
| 4
CTX3 inhibits USP9X.
| 2
CTX3 inhibits USP9X. 2 / 2
| 2

reach
As shown in XREF_FIG, CTX3 induced a decrease in the FAM fluorescence of FAM and DABCYL labeled A 40 in a concentration dependent manner, and maximal reduction in FAM fluorescence was noted when CTX3 was> = 120 nM.

reach
As per the above findings, CTX3 disrupted the coralyne induced stem-loop MB structure and quenched the FAM fluorescence of A 12 -MB-A 12 irrespective of coralyne, hence two possibilities could be considered : (1) CTX3 bound to coralyne; and (2) CTX3 induced formation of the stem-loop MB structure.
CTX3 activates USP9X.
| 2
CTX3 activates USP9X. 2 / 2
| 2

reach
Thus, CTX3 concentration-dependently restores FAM fluorescence of MB.

reach
Noticeably, CTX3 caused a recovery of FAM fluorescence to approximately 50% of that noted with coralyne-free MB.

reach
Taken together, BIX-01294 decreases the expression of USP9X and promotes the degradation of MCL1, which eventually leads to apoptosis in bladder cancer cells.

reach
We found that BIX-01294 up-regulated the expression of PMAIP1 and down-regulated the level of MCL1 and USP9X.

reach
We found that BIX-01294 reduced the level of USP9X in the dose- and time dependent manner, and MCL1 was degraded more in USP9X siRNA knockdown cells compared with the Control siRNA knockdown cells.

reach
Moreover, BIX-01294 also reduces USP9X and then affects the stability of MCL1.
| 2 2
USP9X activates PRC2_complex.
| 2
| 2

eidos
Loss of Usp9x leads to PRC2 destabilization , restricted H3K27me3 deposition and global hypertranscription with priming of postimplantation lineages in ES cells .

eidos
Our data suggest that the decline in Usp9x expression at implantation contributes to destabilizing PRC2 to allow exit from pluripotency and lineage induction .
USP9X inhibits PRC2_complex.
| 1
| 1

reach
We asked whether Usp9x depletion relieves PRC2 mediated transcriptional repression.
USP9X increases the amount of PRC2_complex.
| 1
USP9X increases the amount of PRC2_complex. 1 / 1
| 1

reach
We next explored the possibility that Usp9x may directly regulate PRC2 levels or activity.
USP9X affects IRS2
| 4
USP9X increases the amount of IRS2.
| 2
USP9X increases the amount of IRS2. 2 / 2
| 2

reach
USP9X knockdown decreased IRS-2 protein level through ubiquitin proteasomal degradation in PC3 cells.

reach
USP9X contributes to DNA synthesis of PC3 cells by maintaining the quantity of IRS-2.
USP9X decreases the amount of IRS2.
| 1
USP9X decreases the amount of IRS2. 1 / 1
| 1

reach
Knockdown of USP9X dramatically reduced IRS-2 protein level, increased IRS-2 ubiquitination, and promoted the proteasomal degradation of IRS-2 in PC3 cells, suggesting that USP9X also deubiquitinates IRS-2 to prevent its proteasomal degradation.
USP9X activates IRS2.
| 1
USP9X activates IRS2. 1 / 1
| 1

reach
Since USP9X knockdown reduced two important mediators of IGF-I signaling, IRS-2 and IGF-IR in PC3 cells, we assessed the effect of knockdown of USP9X on IGF-I signaling.
USP9X affects FGF9
| 4
USP9X increases the amount of FGF9.
| 3
Modified USP9X increases the amount of FGF9. 2 / 2
| 2

reach
Moreover, overexpression of lncRNA FAF could also increase the expression of FGF9.

reach
Additional analysis revealed that Fibroblast growth factor 9 (FGF9) is a direct target of lncRNA FAF, as the overexpression of lncRNA FAF could increase the expression of FGF9 and knockdown of the FGF9 expression could attenuate the down-regulation of lncRNA FAF on TGFbeta1-P-Smad2/3 pathway.
USP9X increases the amount of FGF9. 1 / 1
| 1

reach
LncRNA FAF positively regulates FGF9 expression.
USP9X activates FGF9.
| 1
USP9X activates FGF9. 1 / 1
| 1

reach
A study [XREF_BIBR] pointed out that LncRNA FAF can inhibit cardiac fibrosis by targeting FGF9.
USP9X affects ETS1
| 4
USP9X increases the amount of ETS1.
| 2
USP9X increases the amount of ETS1. 2 / 2
| 2

reach
In melanoma, both MEK and BRAF inhibition led to an induction of Ets-1 and NRAS expression that could be blocked by Usp9x inhibition.

reach
Usp9x KD blocked kinase inhibitor induced Ets-1 and NRAS expression (XREF_FIG) and correlated with greater cell growth inhibition (XREF_FIG) and apoptosis (XREF_FIG) than that activated by kinase inhibition alone.
USP9X inhibits ETS1.
| 1
USP9X inhibits ETS1. 1 / 1
| 1

reach
We determined that Ets-1 is primarily ubiquitinated with K63 linked polymers (XREF_SUPPLEMENTARY), and Ets-1 reduction by Usp9x KD was blocked by 20S proteasome inhibition, indicating Ets-1 degradation is proteasome dependent XREF_BIBR (XREF_FIG).
USP9X activates ETS1.
| 1
USP9X activates ETS1. 1 / 1
| 1

reach
Ub-remnant analysis indicated that both Usp9x KD and inhibition of activity with G9 increased Ets-1 (and its isoform), Ets-2, ETV2 and/or GABPalpha ubiquitination specifically within their ETS domain (K388 in Ets-1), a domain previously shown to be recognized by Usp9x (XREF_FIG) XREF_BIBR.
USP9X affects STIL
| 4
USP9X increases the amount of STIL.
| 2
Modified USP9X increases the amount of STIL. 1 / 1
| 1

reach
Elevated expression of HA-USP9X increased STIL levels while HA-USP9X C1566A did not (XREF_FIG; and Fig.
USP9X increases the amount of STIL. 1 / 1
| 1

reach
Together, these findings demonstrate that USP9X promotes STIL levels.
USP9X inhibits STIL.
| 1
USP9X inhibits STIL. 1 / 1
| 1

reach
Depletion of USP9X, but not USP14 or the other DUBs, decreased the centrosomal localization and protein levels of STIL (XREF_FIG; and Fig.
USP9X activates STIL.
| 1
USP9X activates STIL. 1 / 1
| 1

reach
As USP9X is a DUB that controls STIL levels, we investigated whether pharmacological inhibition of USP9X decreases STIL stability.
| 1 2
| 1 2

reach
Together, these data indicate that NO activates USP9X by S nitrosylation, which deubiquitinates and stabilizes MIB1, and this is followed by the activation of NOTCH1 signaling to prevent calcification.

eidos
Together , these data indicate that NO activates USP9X by S-nitrosylation , which deubiquitinates and stabilizes MIB1 , and this is followed by the activation of NOTCH1 signaling to prevent calcification .

reach
NO activates USP9X to deubiquitinate MIB1.
3 |
Hsa-miR-6895-3p decreases the amount of USP9X. 3 / 3
3 |

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available
3 |
Hsa-miR-6849-3p decreases the amount of USP9X. 3 / 3
3 |

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available
3 |
Hsa-miR-6818-3p decreases the amount of USP9X. 3 / 3
3 |

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available
3 |
Hsa-miR-6732-3p decreases the amount of USP9X. 3 / 3
3 |

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available
3 |
Hsa-miR-593-3p decreases the amount of USP9X. 3 / 3
3 |

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available
3 |
Hsa-miR-5699-3p decreases the amount of USP9X. 3 / 3
3 |

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available
3 |
Hsa-miR-548s decreases the amount of USP9X. 3 / 3
3 |

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available
3 |
Hsa-miR-4684-5p decreases the amount of USP9X. 3 / 3
3 |

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available
3 |
Hsa-miR-4421 decreases the amount of USP9X. 3 / 3
3 |

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available
3 |
Hsa-miR-3926 decreases the amount of USP9X. 3 / 3
3 |

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available
3 |
Hsa-miR-339-5p decreases the amount of USP9X. 3 / 3
3 |

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available
3 |
Hsa-miR-3190-5p decreases the amount of USP9X. 3 / 3
3 |

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available
3 |
Hsa-miR-10b-5p decreases the amount of USP9X. 3 / 3
3 |

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available
3 |
Hsa-miR-10a-5p decreases the amount of USP9X. 3 / 3
3 |

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available

biopax:mirtarbase
No evidence text available

reach
BITC and PEITC inhibit USP9x and UCH37.

reach
Here we report that both BITC and PEITC inhibit USP9X and UCH37 and other DUBs at physiologically relevant concentrations and time scales.

reach
BITC and PEITC inhibit USP9x and UCH37 in vitro.
Amiodarone affects USP9X
| 3
| 3

reach
Thus, unlike oral administration, aerosolised amiodarone failed to produce the expected FAM responses.

reach
Currently, there are two established distinct mechanisms which observe development of a FAM phenotype, namely phospholipidosis or apoptosis, which can be induced either by amiodarone or staurosporine respectively (9, 10).
| PMC

reach
The cells were further exposed to FAM inducing-compounds amiodarone and staurosporine.
| PMC
| 1 1

reach
In addition, USP9X activates glycolysis and promotes cell proliferation through pVHL.

sparser
In addition, USP9X activates glycolysis and promotes cell proliferation through pVHL.
USP9X affects TDRD3
| 1
USP9X activates TDRD3. 1 / 3
| 1

reach
Interestingly, the C terminus of USP9X has been reported to mediate the interactions with its de-ubiquitination substrates, including FOXO3, MIB1 and VMP1 [XREF_BIBR], suggesting that USP9X may target TDRD3 for de-ubiquitination; we have tested this hypothesis extensively in the next sections.
USP9X affects PRF1
| 3
USP9X activates PRF1. 3 / 3
| 3

reach
The ssDNA P1 was synthesized and labeled by carboxyfluorescein based dye (FAM, Ex : 480nm) at the 3 ' terminal 35.

reach
The P1, N1, and P2 event related potentials (ERPs) are reliably elicited by FAF XREF_BIBR, XREF_BIBR, XREF_BIBR.

reach
Although researchers are just beginning to understand how FAF modulates the P1, N1, and P2 ERP components, their sensitivity to FAF makes them ideal for assessing the influence of attention on the processing of auditory feedback during ongoing speech.

reach
Since centrosome dysregulation associated mitotic defects could result in genome instability and cell apoptosis XREF_BIBR XREF_BIBR XREF_BIBR, we examined whether USP9X promoted CEP131 stabilization plays a role in genome stability and cell death.

reach
The Ubiquitin Specific Protease 9X (USP9X) contributes to genome stability during DNA replication and chromosome segregation.

reach
The Ubiquitin Specific Protease 9X (USP9X) contributes to genome stability during DNA replication and chromosome segregation.
USP9X affects CFLAR
| 3
USP9X inhibits CFLAR. 3 / 3
| 3

reach
Furthermore, ectopic expression of USP9X prevented c-FLIP downregulation and apoptosis upon combined treatment.

reach
Interestingly, knockdown of USP9X markedly induced c-FLIP downregulation, upregulation of miR-708 expression and sensitivity to TRAIL.

reach
WP1130 Enhances TRAIL Induced Apoptosis through USP9X Dependent miR-708-Mediated Downregulation of c-FLIP.
USP9X affects CEP55
| 1
USP9X activates CEP55. 1 / 3
| 1

reach
Interestingly, we showed that USP9X promotes stabilization of centrosome proteins PCM1 and CEP55 through its catalytic activity.
TDRD3 affects USP9X
| 3
TDRD3 activates USP9X. 3 / 3
| 3

reach
Knockdown TDRD3 inhibits the presence of USP9X in the structure of SGs and increases cellular apoptosis (Narayanan et al., 2017).
| PMC

reach
Furthermore, we found that one of the USP9X de-ubiquitination targets, myeloid cell leukemia protein 1, is regulated by TDRD3, indicating that TDRD3 potentially regulates USP9X de-ubiquitinase activity.

reach
This dynamic change was diminished in Tdrd3-null MEFs, suggesting that TDRD3 mediates USP9X SG localization (XREF_FIG).
PMAIP1 affects USP9X
| 2
PMAIP1 inhibits USP9X. 2 / 3
| 2

reach
These results suggest that BIX-01294 degrades the MCL1 through up-regulation of PMAIP1 and reduction of USP9X, which is consistent to our previous study that PMAIP1 upregulation reduces the availability of USP9X to MCL1, thereby promoting its ubiquitination and degradation, leading to the apoptosis of neoplastic cells [XREF_BIBR].

reach
In conclusion, after pemetrexed treatment in NSCLC cells, Noxa downregulated Usp9x, resulting in a decrease in Mcl-1 and eventually leading to apoptosis.
AMOT affects USP9X
| 3
AMOT activates USP9X. 3 / 3
| 3

reach
USP9x targets AMOT and AMOT like proteins.

reach
On the other hand, overexpression of AMOT could not rescue cancer cell growth in USP9X depleted cells (XREF_SUPPLEMENTARY).

reach
Moreover, previous studies showed that USP9X targets Angiomotin (AMOT) and Angiomotin like 2 (AMOTL2), which in turn regulates YAP1 activation XREF_BIBR, XREF_BIBR.
All-trans-retinoic acid decreases the amount of USP9X.
1 | 1
All-trans-retinoic acid decreases the amount of USP9X. 2 / 2
1 | 1

ctd
No evidence text available

reach
Because the level of USP9X was decreased by ATRA treatment (XREF_FIG), we concluded that the ATRA induced increase in Mcl-1 stability proceeds through activation of p90RSK, ERK and inactivation of GSK3beta.
All-trans-retinoic acid increases the amount of USP9X.
1 |
All-trans-retinoic acid increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
USP9X affects translation
| 3
USP9X activates translation.
| 2
| 2

reach
This result suggested that USP9X modulated protein translation mostly if not exclusively through the regulation of eIF4A1 turnover.

reach
Importantly, modulation of USP9X expression altered overall protein biosynthesis along with specific regulation of IRES driven translation.
USP9X inhibits translation.
| 1
| 1

reach
Meanwhile, Re-expression of exogenous USP9X can partially rescue the translation impairment.
USP9X affects mTORC1
| 3
USP9X activates mTORC1.
| 2
USP9X activates mTORC1. 2 / 2
| 2

reach
Knockdown of Usp9x in these cells increased mTORC1 activity 15.

reach
In addition, we demonstrated that USP9X inhibition negatively regulates mTORC1 activity toward its substrate S6K1.
USP9X inhibits mTORC1.
| 1
USP9X inhibits mTORC1. 1 / 1
| 1

reach
USP9X depletion in ReNcell VM cells reduces mTORC1 signalling.
USP9X affects cisplatin
| 3
USP9X inhibits cisplatin.
| 2
| 2

reach
Knockdown of USP9X reverses cisplatin resistance by decreasing beta-catenin expression in nasopharyngeal carcinoma cells.

reach
However, USP9X knockdown increased NSCLC cell sensitivity to cisplatin, as it did with WP1130.
USP9X activates cisplatin.
| 1
| 1

reach
Our results show that USP9X knockdown eliminated the synergistic effect of WP1130 plus cisplatin in NSCLC cells.
USP9X affects SMAD
| 3
USP9X activates SMAD.
| 2
USP9X activates SMAD. 2 / 2
| 2

reach
If FAM targets Smad activity, then it should be required for both types of responses.

reach
FAM knockdown also blocks TGFbeta mediated induction of a synthetic Smad promoter fused to luciferase (CAGA12-lux, Figure 1 E), in line with the notion that FAM is a critical factor for Smad signaling[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
USP9X inhibits SMAD.
| 1
USP9X inhibits SMAD. 1 / 1
| 1

reach
More importantly, depletion of USP9X impairs TGF-beta2 and Smad signaling and radioresistance by destabilizing KDM4C in lung cancer cells.
USP9X affects PRICKLE2
| 2
USP9X activates PRICKLE2.
| 1
| 1

reach
USP9X, a deubiquitinase, reduces proteasomal degradation of synaptic Prickle2, an evolutionarily conserved seizure-suppressive protein [XREF_BIBR].
USP9X inhibits PRICKLE2.
| 1
| 1

reach
In forebrain neurons of mice, USP9X deficiency reduced levels of Prickle2 protein.
USP9X affects NFkappaB
| 2
USP9X inhibits NFkappaB.
| 1
| 1

reach
USP9X silencing in both a human T-cell line and mouse primary T cells reduced T-cell receptor (TCR) signaling induced NF-kappaB activation.
USP9X activates NFkappaB.
| 1
| 1

reach
USP9X overexpression promoted NF-kB activation, while NF-kB inactivation inhibited USP9X transcription and HPAEpiC injury induced by USP9X overexpression.
USP9X affects EGFR
| 3
USP9X activates EGFR.
| 2
USP9X activates EGFR. 2 / 2
| 2

reach
The exact molecular mechanism through which USP9X modulates EGFR internalization remains to be established.

reach
USP9X knockdown reduced the internalization rate of the EGFR, as described above, whereas it did not further decrease the internalization rate in the triple-KD cells.
USP9X inhibits EGFR.
| 1
USP9X inhibits EGFR. 1 / 1
| 1

reach
Indeed, depletion of USP9X caused a significant delay in EGFR degradation, leaving 80% of the initial EGFR intact even 2 hr post-stimulation, as shown by both IB and DELFIA analyses.
| 3
USP9X inhibits E3_Ub_ligase.
| 2
| 2

reach
USP9x inhibited the E3 ubiquitin protein ligase TIF1gamma from binding and monoubiquitinating SMAD4, hence maintaining the SMAD4 nuclear retention.

reach
USP9x inhibited the E3 ubiquitin protein ligase TIF1gamma from binding and monoubiquitinating SMAD4, hence maintaining SMAD4 nuclear retention.
USP9X activates E3_Ub_ligase.
| 1
| 1

reach
In addition to acting on integrin alpha5beta1 complex, USP9x may modulate other E3 ligases (e.g., Cbl and SMURF1) (Magnifico et al., 2003; Xie et al., 2013) and influence endosomal sorting of other ub[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
USP9X affects CCND1
| 3
USP9X increases the amount of CCND1.
| 2
USP9X increases the amount of CCND1. 2 / 2
| 2

reach
Finally, as in HEK293 cells, depletion of USP9X increased CCND1 gene expression to levels approaching that of exogenous Wnt3a in ReNcell VM NPs.

reach
Therefore USP9X depletion increased CCND1 expression in ReNcell VM NPs and TOPFlash induction in HEK293 cells but the effect on CCND1 was greater.
USP9X decreases the amount of CCND1.
| 1
USP9X decreases the amount of CCND1. 1 / 1
| 1

reach
Induction of CCND1 expression following USP9X depletion in ReNcell VM NPs was of a similar level as exposure to exogenous Wnt3a.
Doxorubicin affects USP9X
| 3
Doxorubicin inhibits USP9X.
| 1
| 1

reach
To investigate a direct functional involvement of USP9X, we silenced USP9X in these cells and treated with either taxol or doxorubicin, which typically induces G2/M arrest in tumor cells via activation of the DNA damage response.
Doxorubicin decreases the amount of USP9X.
| 1
Doxorubicin decreases the amount of USP9X. 1 / 1
| 1

reach
The Western blot analysis showed that the combination of doxorubicin and miR-26b mimics could down-regulate the increased expression of USP9X, p53, and LC3II and LC3I following doxorubicin treatment, and up-regulated the decrease in p62 expression induced by doxorubicin.
Doxorubicin activates USP9X.
| 1
| 1

reach
The level of USP9X and p53 protein expression following treated with doxorubicin was increased and p62 expression was decreased compared with the Control; however, the sp94dr and miR-26b mimic nanoparticles could reduce the up-regulation of USP9X and p53 induced by doxorubicin, increase doxorubicin induced the decrease level of p62.
USP9X affects PCM1
| 3
USP9X inhibits PCM1.
| 1
USP9X inhibits PCM1. 1 / 1
| 1

reach
Vice versa, depletion of USP9X also decreased cellular pools of CEP131 and PCM1.
USP9X decreases the amount of PCM1.
| 1
USP9X decreases the amount of PCM1. 1 / 1
| 1

reach
Knockdown of USP9X in human cell lines reduces PCM1 protein levels, disrupts centriolar satellite particles, and causes localization of satellite proteins, such as CEP290, to centrosomes.
USP9X activates PCM1.
| 1
USP9X activates PCM1. 1 / 1
| 1

reach
Interestingly, we showed that USP9X promotes stabilization of centrosome proteins PCM1 and CEP55 through its catalytic activity.
USP9X affects NFE2L2
| 3
USP9X decreases the amount of NFE2L2.
| 2
USP9X decreases the amount of NFE2L2. 1 / 1
| 1

reach
Taken together, USP9X reduced Nrf2 ubiquitination level and promoted Nrf2-ARE pathway activation to prevent the accumulation of extracellular matrix, eventually alleviated the pathological process of diabetic renal fibrosis.
Modified USP9X decreases the amount of NFE2L2. 1 / 1
| 1

reach
AGEs also increased Nrf2 ubiquitination level, and overexpression of USP9X, instead of USP9X-C1556S, significantly reduced the ubiquitination level of Nrf2.
USP9X increases the amount of NFE2L2.
| 1
Modified USP9X increases the amount of NFE2L2. 1 / 1
| 1

reach
Under AGEs treatment conditions, USP9X overexpression markedly increased the total and nuclear levels, ARE binding ability, and transcriptional activity of Nrf2, upregulated the protein expressions of Nrf2 downstream genes HO-1 and NQO1, and eventually reduced the excessive production of ROS.
USP9X affects IQCB1
| 3
USP9X inhibits IQCB1.
| 1
USP9X inhibits IQCB1. 1 / 1
| 1

reach
Depletion of USP9X significantly reduces the intensity of NPHP5 immunofluorescence at the centrosome (XREF_FIG and XREF_SUPPLEMENTARY) and protein levels, endogenous (XREF_FIG and XREF_SUPPLEMENTARY) or recombinant (XREF_SUPPLEMENTARY), without affecting mRNA levels (XREF_SUPPLEMENTARY).
USP9X increases the amount of IQCB1.
| 1
Modified mutated USP9X increases the amount of IQCB1. 1 / 1
| 1

reach
Conversely, over-expression of wild type but not mutant USP9X elevated the protein levels of NPHP5 (XREF_FIG).
USP9X activates IQCB1.
| 1
USP9X activates IQCB1. 1 / 1
| 1

reach
Depletion of USP9X induced down-regulation and mis localization of NPHP5 (XREF_FIG and XREF_SUPPLEMENTARY, XREF_SUPPLEMENTARY, XREF_SUPPLEMENTARY Figs).
USP9X affects F2R
| 3
USP9X inhibits F2R.
| 1
USP9X inhibits F2R. 1 / 1
| 1

reach
Conversely, introduction of a FAF RNA interference (RNAi) transgene, which was effective in knocking down FAF mRNA and protein expression (XREF_SUPPLEMENTARY), partially suppressed GMR-Gal4> PAR-1 effect (XREF_SUPPLEMENTARY).
USP9X decreases the amount of F2R.
| 1
USP9X decreases the amount of ubiquitinated F2R. 1 / 1
| 1

reach
FAF clearly reduced poly-ubiquitinated PAR-1 level in vitro (XREF_FIG), supporting that FAF directly de-ubiquitinates PAR-1.
USP9X activates F2R.
| 1
USP9X activates F2R. 1 / 1
| 1

reach
Thus, LKB1 and FAF both positively regulate PAR-1, and the overexpression of FAF may enhance LKB1 overexpression effects through the stabilization of p-PAR-1 generated by LKB1.
USP9X affects BCL2
| 3
USP9X inhibits BCL2.
| 1
USP9X inhibits BCL2. 1 / 1
| 1

reach
CP-d and n-ATF 5-S1 promoted tumor cell apoptotic susceptibility in part by reducing expression of the deubiquitinase Usp9X and lead to diminished levels of anti-apoptotic Bcl-2 family members Mcl-1 and Bcl-2.
USP9X increases the amount of BCL2.
| 1
USP9X increases the amount of BCL2. 1 / 1
| 1

reach
Mechanistically, Usp9X knockdown caused concomitant suppression of Bag3, Mcl-1 and Bcl-2 expression, which remarkably recapitulates the effects of CP-d and n-ATF 5-S1 on these molecules.
USP9X activates BCL2.
| 1
USP9X activates BCL2. 1 / 1
| 1

reach
CP-d and n-ATF 5-S1 promoted tumor cell apoptotic susceptibility in part by reducing expression of the deubiquitinase Usp9X and led to diminished levels of antiapoptotic Bcl-2 family members Mcl-1 and Bcl-2.
2 |
Valproic acid decreases the amount of USP9X. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
| 2

reach
Silica stimulated FAM released less IL-1 than BII or BIII, and induced less fibroblast growth than BII, but induced as much as BIII, possibly because of the increased capacity of BIII cells to produce PGE2, which is known to inhibit fibroblast growth.

reach
We estimated the capacity of FAM (2.5 X 10 (5] to synthesize DNA (3H-thymidine uptake) and RNA (3H-uridine uptake), and the activities of silica stimulated FAM to cause proliferation of mouse thymocytes (IL-1 activity) and rat lung fibroblasts (FP activity), and to produce PGE2.
Potassium chromate decreases the amount of USP9X. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
Guanine affects USP9X
| 2
| 2

reach
XREF_BIBR Results revealed that both guanine and adenine diminish FAM fluorescence.

reach
34 Results revealed that both guanine and adenine diminish FAM fluorescence.
Entinostat affects USP9X
2 |
Entinostat increases the amount of USP9X. 2 / 2
2 |

ctd
No evidence text available

ctd
No evidence text available
Cocaine affects USP9X
1 |
Cocaine increases the amount of USP9X. 1 / 2
1 |

ctd
No evidence text available
Cisplatin affects USP9X
| 2
| 2

reach
USP9X mRNA expression predicts clinical outcome for esophageal squamous cell carcinoma treated with cisplatin based therapy.

reach
The purpose of this study was to explore the predictive effects of USP9X on advanced ESCC patients treated with cisplatin based regimens.
| 2

reach
Patients treated with FAM ' enjoyed longer MTP and greater pain alleviation than those treated with CTX.

reach
Given that the tested CTX isotoxins caused a recovery of FAM fluorescence of hairpin shaped MB, it was likely that snake venom containing CTXs might restore FAM fluorescence.
Adenine affects USP9X
| 2
| 2

reach
XREF_BIBR Results revealed that both guanine and adenine diminish FAM fluorescence.

reach
34 Results revealed that both guanine and adenine diminish FAM fluorescence.

reach
Loss of Usp9x also activated the Wnt signalling pathway and, at least in cultured cells, this can occur directly.

reach
Knockdown of Circular Ubiquitin-specific Peptidase 9 X-Linked Alleviates Oxidized Low-density Lipoprotein-induced Injuries of Human Umbilical Vein Endothelial Cells by Mediating the miR-148b-3p/KLF5 Signaling Pathway.
USP9X affects mTORC2
| 1
USP9X inhibits mTORC2. 1 / 2
| 1

reach
Interestingly, upon initiation of differentiation of C2C12 mouse skeletal myoblasts, knockdown of USP9X increases mTORC2 activity.
USP9X affects glucose
| 2
USP9X decreases the amount of glucose. 2 / 2
| 2

reach
The following findings were observed : (1) Expression of USP9X was down-regulated in the kidney tissue of db/db diabetic mice; (2) overexpression of USP9X suppressed high glucose (HG)-induced expressions of EMT markers and extra cellular matrix (ECM) in NRK-52E cells; (3) depletion of USP9X further aggravated EMT process and ECM production in NRK-52E cells; (4) USP9X deubiquitinated Cx43 and suppressed its degradation to regulate EMT process; (5) USP9X deubiquitinated Cx43 by directly binding to the C-terminal Tyr 286 of Cx43.

reach
The following findings were observed : (1) Expression of USP9X was down-regulated in the kidney tissue of db/db diabetic mice; (2) overexpression of USP9X suppressed high glucose (HG)-induced expressions of EMT markers and extra cellular matrix (ECM) in NRK-52E cells; (3) depletion of USP9X further aggravated EMT process and ECM production in NRK-52E cells; (4) USP9X deubiquitinated Cx43 and suppressed its degradation to regulate EMT process; (5) USP9X deubiquitinated Cx43 by directly binding to the C-terminal Tyr 286 of Cx43.
USP9X affects gel
| 2
USP9X activates gel. 2 / 2
| 2

reach
The FAM fluorescent tag enables downstream detection of the amplicons via LFS and fluorescent gel imaging (Fig. 1c).

reach
In combination with pvuII digestion, the FAM-tagged loop primers allow us to identify the gel bands that are directly associated with the LAMP products that are captured by the anti-FAM test line on the LFS.
USP9X affects fluorescein
| 2
| 2

reach
Fluorescein labelled peptides were synthesized for VIP-82, ATSP-7041 and sMTIDE-02, by addition of FAM to their N-terminus via a beta-alanine linker, and then tested in the T22 p53 reporter assay to ensure that they retained comparable biological activity to their unlabeled analogs, respectively.

reach
FAM labeled oligonucleotides were synthesized using fluorescein labeled phosphoramidite.

reach
These results likely explain why CEP131 overexpression could not fully compensate centrosomal biogenesis defects induced by USP9X depletion.

reach
These results point to a role of CEP131 regulated CDK2 localization in USP9X promoted centrosome biogenesis.
| 2

reach
Could USP9X also contribute to cellular quiescence in vivo?

reach
Future work aimed at deciphering how USP9X may mediate both polarity and quiescence in neural stem cells within the adult dentate gyrus will enable greater mechanistic insights into the in vivo role of this DUB.
USP9X affects ZAP70
| 2
USP9X activates ZAP70. 2 / 2
| 2

reach
Whether Usp9X targets ZAP70 directly or indirectly remains to be determined.

reach
The DUB probable ubiquitin carboxyl-terminal hydrolase FAF-X (USP9X) also targets ZAP70; however, ZAP70 phosphorylation is intact in USP9X deficient T cells.
USP9X affects USP24
| 2
USP9X inhibits USP24. 2 / 2
| 2

reach
In order to determine whether USP9X promote the degradation of USP24, we over-expressed USP9X in 293T cells and examined the protein level of USP24.

reach
Moreover, the decreasing of USP24 could be rescued by MG132, indicating that USP9X can promote the degradation of USP24.
USP9X affects UBE2K
| 2
USP9X inhibits UBE2K. 2 / 2
| 2

reach
USP9x inhibited the E3 ubiquitin protein ligase TIF1gamma from binding and monoubiquitinating SMAD4, hence maintaining the SMAD4 nuclear retention.

reach
USP9x inhibited the E3 ubiquitin protein ligase TIF1gamma from binding and monoubiquitinating SMAD4, hence maintaining SMAD4 nuclear retention.
USP9X affects TGFB1
| 2
USP9X inhibits TGFB1. 2 / 2
| 2

reach
USP9X prevents AGEs induced upregulation of FN and TGF-beta1 through activating Nrf2-ARE pathway in rat glomerular mesangial cells.

reach
USP9X overexpression attenuated AGEs induced upregulation of FN, TGF-beta1, and Collagen IV, three fibrosis related marker proteins, in a deubiquitinase activity dependent manner.
USP9X affects RPE
| 2
USP9X activates RPE. 2 / 2
| 2

reach
FAF and OCTA images allowed us to detect damage of the RPE before the choriocapillaris atrophy in a case of presumed choroideremia with preserved central vision.

reach
Systematic comparison of FAF signaled RPE molecular status with retinal cross-sections revealed by spectral-domain OCT may allow RPE morphologic features to be explored in areas of high FAF using large populations of patients.
USP9X affects P2
| 2
USP9X activates P2. 2 / 2
| 2

reach
The P1, N1, and P2 event related potentials (ERPs) are reliably elicited by FAF XREF_BIBR, XREF_BIBR, XREF_BIBR.

reach
Although researchers are just beginning to understand how FAF modulates the P1, N1, and P2 ERP components, their sensitivity to FAF makes them ideal for assessing the influence of attention on the processing of auditory feedback during ongoing speech.
USP9X affects Melanin
| 2
USP9X activates Melanin. 2 / 2
| 2

reach
Later continued accumulation of lipofuscin with loss of melanin granules may be reflected in the increase in lipofuscin associated FAF signal and concurrent decrease in the melanin associated NIA signal.

reach
FAF imaging allows the topographic representation of lipofuscin and melanin distribution in the RPE, which corresponds to the intensity of the signal emitted.
USP9X affects MYOM2
| 2
USP9X activates MYOM2. 2 / 2
| 2

reach
OC43 was detected using a previously published protocol with 0.3 uM of primers and 0.2 uM of the FAM probe targeting the M protein, the membrane glycoprotein.

reach
OC43 was detected using a previously published protocol with 0.3 uM of primers and 0.2 uM of the FAM probe targeting the M protein, the membrane glycoprotein (Vijgen et al., 2005).
USP9X affects LNPEP
| 2
USP9X activates LNPEP. 2 / 2
| 2

reach
In stage III and IV cases with detectable lesions, a response was observed in 61.3% (19/31) treated with CAP and in 10.5% (2/19) treated with FAM.

reach
The 5-year survival rate was 61.6% for cases treated with CAP and 56.3% for cases treated with FAM.
USP9X affects JAK2
| 2
USP9X activates JAK2. 2 / 2
| 2

reach
USP9X positively regulated the JAK2 and STAT3 pathway to promote the malignant progression of liver cancer cells.

reach
We further found that activated JAK2 may be naturally suppressed in 25% of CRLF2 pos DS-ALLs by loss-of-function aberrations in USP9X, a deubiquitinase previously shown to stabilize the activated phosphorylated JAK2.
USP9X affects JAG1
| 1
USP9X activates JAG1. 1 / 2
| 1

reach
USP9x in turn stimulates JAG1 activity through two mechanisms : (1) through TRB3 deubiquitination and stabilization, and (2) through deubiquitination and activation of Mind Bomb 1, an E3 ligase required for JAG1 ubiquitination mediated endocytosis and Notch activation.
USP9X affects IL1B
| 2
USP9X activates IL1B. 2 / 2
| 2

reach
Using a murine TNBC model, we show that USP9x knockdown abrogates Notch activation, reducing the production of the proinflammatory cytokines, C-C motif chemokine ligand 2 (CCL2) and interleukin-1 beta (IL-1β).

reach
Using a murine TNBC model, we show that USP9x knockdown abrogates Notch activation, reducing the production of the proinflammatory cytokines, C-C motif chemokine ligand 2 (CCL2) and interleukin-1 beta (IL-1β).
USP9X affects HHEX
| 2
USP9X activates HHEX. 2 / 2
| 2

reach
The ratio of the positive signal in FAM (SO 2)/positive signal in HEX (RPP30, non polymorphic gene) illustrates the ratio man and woman.

reach
Regular RT-PCR and RT-ddPCR were performed on different cDNA samples using FAM labeled probes targeting luciferase gene or endogenous KLC2 gene and Hex labeled probe targeting an internal control housekeeping gene AAEL002401.
USP9X affects FN1
| 2
USP9X inhibits FN1. 2 / 2
| 2

reach
USP9X overexpression attenuated AGEs induced upregulation of FN, TGF-beta1, and Collagen IV, three fibrosis related marker proteins, in a deubiquitinase activity dependent manner.

reach
USP9X prevents AGEs induced upregulation of FN and TGF-beta1 through activating Nrf2-ARE pathway in rat glomerular mesangial cells.
USP9X affects COVID-19
| 2
| 2

reach
Monitoring the fluorescence intensity, shape of FAM and VIC fluorophores, and cycle threshold values (Ct values) during the automated RT-PCR allowed the qualitative detection of COVID-19 as positive or negative [25–27].

reach
Monitoring the fluorescence intensity, shape of FAM and VIC fluorophores, and cycle threshold values (Ct values) during the automated RT-PCR allowed the qualitative detection of COVID-19 as positive or negative [25] [26] [27] .
USP9X affects CAMP
| 1 1
USP9X inhibits CAMP. 2 / 2
| 1 1

reach
Moreover, FAF blocks the activity of the antibacterial peptide LL-37.

sparser
A key observation of this study is that FAF-expressing F. magna is more resistant to LL-37 and that soluble FAF also binds and inactivates LL-37.
USP9X affects APC_C
| 2
USP9X activates APC_C. 2 / 2
| 2

reach
USP9X thereby opposes activation of anaphase promoting complex and cyclosome (APC/C) and specifically inhibits the mitotic degradation of SAC controlled APC/C substrates.

reach
The deubiquitinase USP9X modulates the stability of MCC : APC/C complex thereby influencing the SAC dynamics.
TCR affects USP9X
| 2
TCR activates USP9X. 2 / 2
| 2

reach
This inhibition seems to be due to a decrease in NF-kappaB activation following TCR stimulation in Usp9x knockdown T cells.

reach
Given that TCR induced activation and phosphorylation of ZAP70 substrates was perturbed in Usp9x KO DP thymocytes (XREF_FIG), we hypothesized that both these processes would be affected.
FGF9 affects USP9X
| 2
FGF9 inhibits USP9X. 2 / 2
| 2

reach
Additional analysis revealed that Fibroblast growth factor 9 (FGF9) is a direct target of lncRNA FAF, as the overexpression of lncRNA FAF could increase the expression of FGF9 and knockdown of the FGF9 expression could attenuate the down-regulation of lncRNA FAF on TGFbeta1-P-Smad2/3 pathway.

reach
Furthermore, knockdown of the FGF9 expression also abolished the inhibitory effect of FAF on fibrosis.
| 2
| 2

reach
SCF (Slimb) as an E3 that antagonizes FAF in regulating PAR-1.

reach
Therefore, phosphorylation at Ser155, Ser159 and Thr163 not only drives the binding of E3 ubiquitin-ligases such as SCF beta-TrCP, SCF Fbw7 or Trim17, but also disrupts the binding of the deubiquitinase USP9X (XREF_FIG).
CTNNB1 affects USP9X
| 2
CTNNB1 activates USP9X. 2 / 2
| 2

reach
Similar to in-vivo and shRNA induced USP9X depletion, beta-catenin protein level was markedly increased in WP1130 treated ReNcell VM cells to the same level as proteasome inhibition (epoxomicin treatment).

reach
The increase beta-catenin levels raised the possibility that Wnt signalling might be activated in Usp9x -/Y neocortices.
CASP3 affects USP9X
| 2
CASP3 activates USP9X. 2 / 2
| 2

reach
Subsequent monitoring of the FAM fluorescence recovery (yellow-green) then provided information on the DOX induced apoptosis, since the increased expression of caspase-3 triggered release of FAM via cleavage of the DEVD linker.

reach
Caspase-3 involved in apoptosis was then activated to cleave the specific peptide substrate, releasing fluorophore FAM from AuNPs.
Alpp affects USP9X
| 2
Alpp activates USP9X. 2 / 2
| 2

sparser
Zeolite A was one of the major crystalline products in the control specimen cured at 85 °C, as was also observed by others in studies of the alkaline activation of FAF [ xref ], and after the hydration of CAC in the presence of sodium silicate [ xref ].

sparser
Crystallization of calcium-containing zeolites from a gel formed by the alkaline activation of FAF and the uptake of Al and Ca ions from CAC was shown for alkaline-activated blends of metakaolin and calcium-aluminate cement [ xref ].
Recombinase affects USP9X
| 1 1
Recombinase inhibits USP9X.
| 1
| 1

sparser
Studies have shown that the constitutive deletion of Fam20B in mice leads to embryonic lethality at E13.5 [ xref ], and that the conditional ablation of Fam20B in the dental epithelium of mice using K14 - Cre recombinase leads to supernumerary incisors, and inactivation of mouse Fam20B by Osr2-Cre recombinase causes chondrosarcoma and postnatal ossification defects in the joint cartilage via the alterations of the WNT, BMP, and PTHrP/IHH signaling pathways [ xref , xref ].
Recombinase activates USP9X.
| 1
| 1

reach
M, DL2000 DNA Marker; 1, PPV-RAA-1; 2, PPV-RAA-1-negative control; 3, PPV-RAA-2; 4, PPV-RAA-2-negative control; 5, PPV-RAA-3; 6, PPV-RAA-3-negative control.PPV = porcine parvovirus; RAA = recombinase-aided amplification; F = forward primer; R = reverse primer; FAM = 6-carboxy-fluorescein; THF = tetrahydrofuran abasic-site mimic.Screening of optimal primer pair using the RAA-AGE assay.
Nocodazole affects USP9X
| 2
Nocodazole inhibits USP9X.
| 1
| 1

reach
None of amiloride, chlorpromazine, cytochalasin D, Filipin III, nocodazole and methyl-beta-cyclodextrin blocked the entry of Fam labeled VPTLK and KLPVM into HeLa cells.
Nocodazole activates USP9X.
| 1
| 1

reach
To quantify Cdc20 ubiquitination, parental and USP9X KO cells were treated with nocodazole for 4hr.
| 1

reach
Under AGEs treatment conditions, USP9X overexpression markedly increased the total and nuclear levels, ARE binding ability, and transcriptional activity of Nrf2, upregulated the protein expressions of Nrf2 downstream genes HO-1 and NQO1, and eventually reduced the excessive production of ROS.

reach
We find that USP9X is itself stabilized by oxidative stress, and is required together with ZBTB38 to limit the basal generation of ROS, as well as the toxicity of an acute oxidative stress.
USP9X affects proteolysis
| 2
USP9X inhibits proteolysis.
| 1
| 1

reach
NANOG stimulates HIF-1 transcriptional activity by recruitment of the deubiquitinase USP9X, which inhibits HIF-1α protein degradation, and by stabilizing HIF-1α interaction with the coactivator p300, which mediates histone acetylation.
USP9X activates proteolysis.
| 1
Mutated USP9X activates proteolysis. 1 / 1
| 1

reach
16 Fersht and co-workers studied the thermodynamic stability of a Ca 2+ -free domain 2 construct of gelsolin and proposed that the FAF mutations allow proteolysis through destabilization of domain 2.
| 2
| 1

reach
USP9x shRNA delivery significantly inhibits TGF-beta-induced SMAD4 nuclear retention and eliminates PA promotion of TGF-beta-induced SMAD4 nuclear retention.
| 1

reach
Inhibition of ERK and USP9x in MCF-7 and MDA-MB-231 cells significantly decreases the promoting effect of PA on the TGF-beta1-induced invasive and migration ability of these cells (XREF_FIG).
| 2
USP9X inhibits localization.
| 1
| 1

reach
Depletion of USP9X, but not USP14 or the other DUBs, decreased the centrosomal localization and protein levels of STIL (XREF_FIG; and Fig.
USP9X activates localization.
| 1
| 1

reach
Depletion of USP9X induced down-regulation and mis localization of NPHP5 (XREF_FIG and XREF_SUPPLEMENTARY, XREF_SUPPLEMENTARY, XREF_SUPPLEMENTARY Figs).

reach
Taken together, these results indicate miR-132 prohibits the migration and invasion of NSCLC cells via targeting USP9X induced EMT.

reach
Our analysis of clinical HCC samples verifies that miR-26b also targets USP9X expression to inhibit the EMT of hepatocytes.
USP9X affects dopamine
| 2
USP9X increases the amount of dopamine.
| 1
USP9X increases the amount of dopamine. 1 / 1
| 1

reach
Given that reinforcement learning and FRN are modulated by dopamine levels, a possible explanation for our findings is that FAM practice causes persistent increases in tonic dopamine levels which scale with amount of practice, thus altering feedback processing.
USP9X activates dopamine.
| 1
| 1

reach
Capitalizing on previous findings that FAM practices seem to cause dopamine release, the present study shows that FAM experience predicts learning from negative feedback on a probabilistic selection task.
USP9X affects cell cycle
| 2
USP9X inhibits cell cycle.
| 1
| 1

reach
Knockdown of USP9X inhibited cell proliferation and cell cycle progression and increased apoptosis.
USP9X activates cell cycle.
| 1
| 1

reach
As transcriptional regulation of c-myc and cyclin D1 may be manifested indirectly by reduced cell cycle progression induced by USP9X knockdown, we need to clarify whether USP9X can regulate c-myc and cyclin D1 levels through the Wnt and beta- catenin pathway.
USP9X affects autophagy
| 1 1
USP9X inhibits autophagy.
| 1
| 1

sparser
Unexpectedly, FAM129A silencing increased autophagic flux, suggesting that FAM129A inhibits autophagy in these models.
USP9X activates autophagy.
| 1
| 1

reach
With respect to other forms of cell death, a recent study demonstrated that WP1130 inhibited autophagy through inhibition of ULK1, which may suggest that Usp9X inhibition blocks cytoprotective autophagy in order to enhance apoptosis [XREF_BIBR].
USP9X affects VIM
| 2
USP9X decreases the amount of VIM.
| 1
USP9X decreases the amount of VIM. 1 / 1
| 1

reach
As shown in Additional file XREF_SUPPLEMENTARY : Figure S5, ectopic expression of USP9X siRNA increased the expression levels of E-cadherin and decreased the expression levels of vimentin.
USP9X activates VIM.
| 1
USP9X activates VIM. 1 / 1
| 1

reach
XREF_FIG, 50 PC3 cells were mixed with ~ 10,000 Raji cells and analyzed with the PACS workflow using a HEX labeled TaqMan assay targeting VIM, and a FAM labeled TaqMan assay targeting PTPRC.
USP9X affects TGFB2
| 2
USP9X inhibits TGFB2.
| 1
USP9X inhibits TGFB2. 1 / 1
| 1

reach
More importantly, depletion of USP9X impairs TGF-beta2 and Smad signaling and radioresistance by destabilizing KDM4C in lung cancer cells.
USP9X increases the amount of TGFB2.
| 1
USP9X increases the amount of TGFB2. 1 / 1
| 1

reach
USP9X mediated KDM4C deubiquitination promotes lung cancer radioresistance by epigenetically inducing TGF-beta2 transcription.
USP9X affects STAT3
| 2
USP9X decreases the amount of STAT3.
| 1
USP9X decreases the amount of STAT3. 1 / 1
| 1

reach
The DUB inhibitor described here reduced Usp9x and Usp5 activity, induced p53, FAS and NOXA, reduced pStat3 levels and amplified vemurafenib apoptotic activity in vitro.
USP9X activates STAT3.
| 1
USP9X activates STAT3. 1 / 1
| 1

reach
USP9X positively regulated the JAK2 and STAT3 pathway to promote the malignant progression of liver cancer cells.
| 1

reach
USP9x knockdown increased sensitivity to IR in A172 and Ln229 cells.
| 1

reach
32 Although the three USP9x interaction partners have not been examined in our glioblastoma cells, it is possible that USP9x modulates the response to IR in Ln229 and A172 cells through these and other effector proteins.
USP9X affects RAS
| 2
USP9X inhibits RAS.
| 1
USP9X inhibits RAS. 1 / 1
| 1

reach
Ostensibly in the above pre-clinical contexts, loss of USP9X stabilizes YAP therefore indirectly enhancing RAS driven oncogenesis through YAP activation.
USP9X increases the amount of RAS.
| 1
USP9X increases the amount of RAS. 1 / 1
| 1

reach
Usp9x KD reduced the stability of Ets-1 in both BRAF (XREF_FIG) and NRAS (XREF_FIG) mutant melanoma and decreased NRAS, but not total RAS protein levels.
USP9X affects PRKAA2
| 2
USP9X inhibits PRKAA2.
| 1
USP9X inhibits PRKAA2. 1 / 1
| 1

reach
Results from the in vitro experiments suggested that USP9X mediates the ubiquitin dependent degradation of AMPK-alpha2.
USP9X activates PRKAA2.
| 1
USP9X activates PRKAA2. 1 / 1
| 1

reach
USP9X mediates the ubiquitylation dependent degeneration of AMPK-alpha2.
USP9X affects PMAIP1
| 2
USP9X inhibits PMAIP1.
| 1
USP9X inhibits PMAIP1. 1 / 1
| 1

reach
Along these lines, it is conceivable that Noxa up-regulation caused by Usp9X inhibition might contribute to the sensitization to BH3-mimetic cell death given the pro apoptotic effects of Noxa on Mcl-1 [XREF_BIBR - XREF_BIBR].
USP9X activates PMAIP1.
| 1
USP9X activates PMAIP1. 1 / 1
| 1

reach
Furthermore, Usp9x expression increased in Noxa knockdown cells, suggesting Noxa may regulate Mcl-1 expression by controlling the expression of Usp9x.
USP9X affects PBX1
| 2
USP9X inhibits PBX1.
| 1
USP9X inhibits PBX1. 1 / 1
| 1

reach
Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis.
USP9X decreases the amount of PBX1.
| 1
USP9X decreases the amount of PBX1. 1 / 1
| 1

reach
Moreover, the stability of PBX1 is controlled by a deubiquitinase USP9x, which decreases the polyubiquitination level of PBX1 (Liu et al., 2019).
USP9X affects NUMB
| 2
USP9X increases the amount of NUMB.
| 1
Modified USP9X increases the amount of NUMB. 1 / 1
| 1

reach
We also show for the first time that Usp9x interacts with the Notch inhibitor Numb in NPs and loss of Usp9x significantly decreased Numb and Itch protein levels.
USP9X activates NUMB.
| 1
USP9X activates NUMB. 1 / 1
| 1

reach
These results suggest that Usp9x positively regulates Numb in mouse NPs and that diminished Numb and Itch levels results in increased Notch signalling.
USP9X affects NOTCH1
| 2
USP9X inhibits NOTCH1.
| 1
USP9X inhibits NOTCH1. 1 / 1
| 1

reach
Hence, Usp9x controls tissue homeostasis in the murine gut by negatively regulating c-Myc and Notch1, most likely via stabilization of Fbw7.
USP9X increases the amount of NOTCH1.
| 1
USP9X increases the amount of NOTCH1. 1 / 1
| 1

reach
Inhibition of USP9X reduces expression of MIB1 and NOTCH1 to promote calcification.
USP9X affects MIB1
| 1 1
USP9X increases the amount of MIB1.
| 1
USP9X increases the amount of MIB1. 1 / 1
| 1

reach
Inhibition of USP9X reduces expression of MIB1 and NOTCH1 to promote calcification.
USP9X activates MIB1.
| 1
USP9X activates MIB1. 1 / 1
| 1

eidos
Inhibition of USP9X causes reduced expression of MIB1 and NICD and increased RUNX2 expression in pAVICs .
USP9X affects LATS2
| 2
USP9X inhibits LATS2.
| 1
USP9X inhibits LATS2. 1 / 1
| 1

reach
Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.
USP9X decreases the amount of LATS2.
| 1
USP9X decreases the amount of LATS2. 1 / 1
| 1

reach
In contrast, USP9X ablation drastically diminished LATS2 protein levels.
USP9X affects ERK
| 2
USP9X inhibits ERK.
| 1
USP9X inhibits ERK. 1 / 1
| 1

reach
Knockdown of USP9X suppressed basal activation of the Erk1/2 pathway, which was significantly restored by exogenous expression of IRS-2 but not by IGF-IR, suggesting that the stabilization of IRS-2 by USP9X is critical for basal Erk1/2 activation.
USP9X increases the amount of ERK.
| 1
USP9X increases the amount of phosphorylated ERK. 1 / 1
| 1

reach
Usp9x KD paradoxically increased pERK levels, suggesting a more complex regulation of the RAS/MEK/ERK pathway by Usp9x.
USP9X affects EIF4A1
| 2
USP9X increases the amount of EIF4A1.
| 1
Modified USP9X increases the amount of EIF4A1. 1 / 1
| 1

reach
Loss of USP9X in HEK293T cells decreased the expression of eIF4A1 by about 50%, while the protein levels of eIF4B, eIF4E and eIF4G were minimally affected by USP9X depletion.
USP9X decreases the amount of EIF4A1.
| 1
USP9X decreases the amount of EIF4A1. 1 / 1
| 1

reach
Depletion of USP9X in HEK293T cells accelerated eIF4A1 protein degradation, and eventually impaired endogenous eIF4A1 expression.
USP9X affects CDH1
| 2
USP9X inhibits CDH1.
| 1
USP9X inhibits CDH1. 1 / 1
| 1

reach
We found USP9X inhibition up-regulated expression of the epithelial-mesenchymal transition (EMT) marker E-cadherin, but down-regulated vimentin expression.
USP9X increases the amount of CDH1.
| 1
USP9X increases the amount of CDH1. 1 / 1
| 1

reach
As shown in Additional file XREF_SUPPLEMENTARY : Figure S5, ectopic expression of USP9X siRNA increased the expression levels of E-cadherin and decreased the expression levels of vimentin.
USP9X affects BAX
| 2
USP9X increases the amount of BAX.
| 1
USP9X increases the amount of BAX. 1 / 1
| 1

reach
Moreover, knockdown of USP9X expression can significantly reduce the expressions of MDR1, MRP2, Bcl-2, MMP2, and MMP9, but significantly increased the expression of Bax.
USP9X decreases the amount of BAX.
| 1
USP9X decreases the amount of BAX. 1 / 1
| 1

reach
Moreover, knockdown of USP9X expression can significantly reduce the expressions of MDR1, MRP2, Bcl-2, MMP2, and MMP9, but significantly increased the expression of Bax.
USP9X affects BAG3
| 2
USP9X inhibits BAG3.
| 1
USP9X inhibits BAG3. 1 / 1
| 1

reach
Thus, ABT263 mediated induction of both Usp9X and Bag3 is inhibited by interference with Usp9X levels, suggesting that Usp9X is upstream of Bag3 and that it is implicated in the regulation of its expression.
USP9X increases the amount of BAG3.
| 1
USP9X increases the amount of BAG3. 1 / 1
| 1

reach
Mechanistically, Usp9X knockdown caused concomitant suppression of Bag3, Mcl-1 and Bcl-2 expression, which remarkably recapitulates the effects of CP-d and n-ATF 5-S1 on these molecules.
USP9X affects AMPK
| 2
USP9X inhibits AMPK.
| 1
USP9X inhibits AMPK. 1 / 1
| 1

reach
Thus, Gal9 helps activate AMPK and recruits it to lysosomes following damage whereas the DUB USP9X antagonizes AMPK activation (XREF_FIG).
USP9X activates AMPK.
| 1
USP9X bound to adenosine 5'-monophosphate activates AMPK. 1 / 1
| 1

reach
USP9X binds to the AMP activated protein kinase (AMPK)-related kinases NUAK1 and MARK4 (Par-1 homologues) [XREF_BIBR, XREF_BIBR].
USP9X affects AKT
| 2
USP9X inhibits AKT.
| 1
USP9X inhibits AKT. 1 / 1
| 1

sparser
The results revealed that FAM122A silencing could significantly inhibit the phosphorylated AKT at Thr308 and Ser473 and S6K1 but not c-myc in all three cell lines, and the inhibited AKT and S6K1 phosphorylations could be restored by re-expression of FAM122A (Figure xref ).
USP9X activates AKT.
| 1
USP9X activates AKT. 1 / 1
| 1

sparser
Nevertheless, FAM3D did not activate AKT in neutrophils.
TP53 affects USP9X
| 2
TP53 inhibits USP9X.
| 1
TP53 inhibits USP9X. 1 / 1
| 1

reach
In conclusion, the present study confirms that WP1130 co-treatment increases cisplatin cytotoxicity by stabilizing p53 and reducing p53 ubiquitination mediated degradation in a USP9X dependent manner.
TP53 activates USP9X.
| 1
TP53 activates USP9X. 1 / 1
| 1

reach
In conclusion, the present study confirms that WP1130 co-treatment increases cisplatin cytotoxicity by stabilizing p53 and reducing p53 ubiquitination mediated degradation in a USP9X dependent manner.
SMAD4 affects USP9X
| 2
SMAD4 deubiquitinates USP9X.
| 1
SMAD4 leads to the deubiquitination of USP9X. 1 / 1
| 1

reach
A mechanistic explanation for this correlation is provided by the upstream network analysis of the USP9 knockdown transcriptome, exploiting existing molecular interaction data and identifying a regulatory relation between USP9 and MAPT via the USP9 deubiquitination target SMAD4 and the MAPT transcription repressor BACH1, whose transcription is in turn repressed by SMAD4.
SMAD4 activates USP9X.
| 1
SMAD4 activates USP9X. 1 / 1
| 1

reach
3.5 USP9X targets SMAD4 for deubiquitylation in the TGFbeta pathway.
SFI1 affects USP9X
| 2
SFI1 inhibits USP9X.
| 1
SFI1 inhibits USP9X. 1 / 1
| 1

reach
Depletion of SFI1 also blocked the centrosomal accumulation of USP9X (XREF_FIG and S3 I).
SFI1 activates USP9X.
| 1
SFI1 activates USP9X. 1 / 1
| 1

reach
SFI1 promotes centriole duplication by recruiting USP9X to stabilize the microcephaly protein STIL.
MYC affects USP9X
| 2
MYC inhibits USP9X.
| 1
MYC inhibits USP9X. 1 / 1
| 1

reach
Indeed, c-Myc heterozygosity was sufficient to reduce the tumor burden to WT levels in Usp9x DeltaG mice, with a clear reduction of c-Myc staining in c-Myc DeltaG/+ Usp9x DeltaG tumors (XREF_FIG).
MYC activates USP9X.
| 1
MYC activates USP9X. 1 / 1
| 1

reach
HEK293T cells were transfected to express HA tagged p130-AMOT and Myc tagged Ubiquitin with or without shRNAs targeting USP9x.
KCNMA1 affects USP9X
| 2
KCNMA1 activates USP9X. 1 / 1
| 1

reach
The novel cSLO allows FAF imaging with a resolution of up to 5 microm and pixel to delineate normal and pathological features in various retinal pathologies including early-stage and advanced atrophic or neovascular age related macular degeneration, macular edema, and retinal dystrophies.
KCNMA1 activates USP9X. 1 / 1
| 1

reach
Panretinal FAF was detected by a newly developed SLO, which allows FAF imaging of up to 200degrees of the retina in one scan without the need for pupil dilation.
JQ1 affects USP9X
| 2
JQ1 decreases the amount of USP9X.
| 1
JQ1 decreases the amount of USP9X. 1 / 1
| 1

reach
However, JQ1 suppressed Usp9X protein levels in NCH644 cells.
JQ1 activates USP9X.
| 1
JQ1 activates USP9X. 1 / 1
| 1

reach
The deubiquitinase Usp9X, which interacts with and stabilizes Mcl-1, was not significantly altered by JQ1 in T98G, LN229, U87 and GBM6 cells, suggesting that JQ1 mediated down-regulation of Mcl-1 is independent of Usp9X.
Vs affects USP9X
| 1
Vs increases the amount of USP9X. 1 / 1
| 1

reach
Brief stimulation of T cells increased the labeling of USP9X by HA-Ub-VS without an increase in USP9X levels, while the phospho-site [42, 43] Fluoromethyl ketone SUMO-FMK ii [44] a-Amino-b-lactone Ub-Lac [42] Chloromethyl ketone - [31] mutant, which still possess a potentially reactive active site Cys residue, was much less reactive toward the probe following stimulation.
1 |
Vanadium oxoanion increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Trim33 affects USP9X
| 1
Trim33 activates USP9X. 1 / 1
| 1

reach
Remarkably, in human cells, depletion of Ecto rescued TGFbeta responsiveness of FAM depleted cells, supporting the notion that FAM and Ecto work in the same biochemical pathway.
1 |
Trichostatin A decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Topotecan affects USP9X
1 |
Topotecan decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
1 |
Thapsigargin increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Tetrachloromethane increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Tert-butyl hydroperoxide increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
SufA affects USP9X
| 1
SufA activates USP9X. 1 / 1
| 1

reach
SufA promotes release of FAF from the bacterial surface, resulting in binding to and neutralization of the antibacterial activity of MIG and CXCL9 " on a distance. "
Succimer affects USP9X
1 |
Succimer decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
| 1
| 1

reach
Currently, there are two established distinct mechanisms which observe development of a FAM phenotype, namely phospholipidosis or apoptosis, which can be induced either by amiodarone or staurosporine respectively (9, 10).
| PMC

reach
First, the remnant sodium citrate in the colloid gold solution could increase the fluorescence intensity of FAM labeled on the aptamer that reduce the efficiency of AuNPs fluorescent quenching.
1 |
Sodium arsenate increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available

sparser
The results from CCK-8 and transwell assay showed that FAM107B inhibition by siRNA led to significantly increased proliferation and migrating abilities of MGC803 cells, respectively, indicating that FAM107B plays important roles in inhibiting the proliferation and migration of MGC803 cells.
Silver(1+) affects USP9X
| 1
| 1

reach
Also, the addition of Ag (I) cation decreased the intensity of Fam emission of F2C6W2D at 520 nm in a concentration dependent manner.
| 1

sparser
Human ovarian cancer xenograft model was used to determine the effects of inhibiting FAM210B by shRNA on tumor metastasis.
1 |
Selenium atom decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
| 1
| 1

reach
The FOXC2 probe was 5 ' GGTCCAGTAACTGCCCTTGCCGGGCTTCTTGTCGT3 ' modified by 3 ' FAM +5 ' FAM.As previously described, each RNA sample was treated with ribonuclease A+T (Sigma-Aldrich), which digests si[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
| 1

reach
Concomitant use of PZ significantly enhanced FAM induced reduction of overall gastric secretion, but did not enhance decreases in acid output, acidity, or pepsin secretion.
Prazosin affects USP9X
| 1
| 1

reach
A positive correlation was found between plasma epinephrine concentration and prazosin induced FAF in EHT but not in NT.
1 |
Pirimiphos-methyl decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Phlorizin affects USP9X
1 |
Phlorizin decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available

reach
Exogenously added SufA resulted in an increased FAF release that was blocked by the serine proteinase inhibitor PMSF (XREF_FIG B).

eidos
S-nitrosylation activates USP9X to deubiquitinate MIB1 .
Peptidase affects USP9X
| 1
| 1

reach
Conversely, overexpression of its peptidase domain resulted in spine head enlargement and rescued the effect of Usp9X knockdown on spine density (XREF_FIG - XREF_FIG).
Paracetamol affects USP9X
1 |
Paracetamol decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Oxaliplatin affects USP9X
1 |
Oxaliplatin decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
| 1
| 1

reach
Combined infusions (n = 9) of maximum forearm vasodilator doses of alpha-hANP and nitroprusside increased FAF to 22.7 +/- 3.4; this additive vasodilator effect of alpha-hANP and nitroprusside is consistent with their different actions on the guanylate cyclase system.
1 |
Nickel sulfate decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
1 |
Nickel subsulfide increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
1 |
Nickel monoxide decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
| 1

reach
To analyze gene expression changes after usp9 antisense morpholino MO knockdown in zebrafish for the target genes usp9, and the zebrafish MAPT paralogs mapta and maptb, titrated microinjections were performed with 4.8 and 8ng/injection of an e2i2 splice blocking usp9 MO in one to two cell-stage zebrafish embryos.
Miconazole affects USP9X
1 |
Miconazole decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
1 |
Methylparaben increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Methylmercury compound increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Methylmercury chloride decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
1 |
Methapyrilene decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Melatonin affects USP9X
| 1
Melatonin increases the amount of USP9X. 1 / 1
| 1

reach
These findings suggest that exogenous melatonin might enhance FAM levels and sperm motility.
Magnetite nanoparticle decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Macrocycle affects USP9X
| 1
| 1

reach
Ensemble Therapeutics has presented data describing the use of DECLs to develop macrocycle compounds (Mullard, 2016) that selectively and potently inhibit USP9x (Dodge, 2016), a DUB that is associated with many cancers (Murtaza, Jolly, Gecz, & Wood, 2015).
Lipopolysaccharide increases the amount of USP9X. 1 / 1
| 1

reach
Furthermore, LPS also induced the expression of USP9X in lungs, which was inhibited by PDTC.
| 1

sparser
We previously reported that phenethyl isothiocyanate (PEITC) inhibits two deubiquitinases (DUBs), USP9x and UCH37.
Hydroxyurea affects USP9X
| 1
| 1

reach
To this end, USP9X- or CEP131 depleted cells were treated with hydroxyurea (HU) to induce a prolonged S phase.
Hydroxide affects USP9X
| 1
| 1

reach
Tang et al. proposed a method to probe hydroxyl radicals using an AuNP-oligonucleotide-FAM system where the hydroxyl radical promotes strand breakage and consequent release of FAM, restoring the previously quenched fluorescence.
1 |
Hsa-miR-92a-3p decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-7162-3p decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-708-5p decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-6817-5p decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
Hsa-miR-640 affects USP9X
1 |
Hsa-miR-640 decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-544b decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-4769-3p decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-4768-3p decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-4459 decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-4433a-3p decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-330-3p decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-3160-3p decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-3151-3p decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-3139 decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-28-5p decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-26b-5p decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-222-3p decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-186-5p decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-16-5p decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-1283 decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
1 |
Hsa-miR-1180-3p decreases the amount of USP9X. 1 / 1
1 |

biopax:mirtarbase
No evidence text available
Hexabromocyclododecane decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Gold(1+) affects USP9X
| 1
| 1

reach
First, the remnant sodium citrate in the colloid gold solution could increase the fluorescence intensity of FAM labeled on the aptamer that reduce the efficiency of AuNPs fluorescent quenching.
Gallic acid affects USP9X
| 1
| 1

reach
Interestingly, FAF macular GA area appears to have higher diagnostic accuracy than logMAR, and combining logMAR and FAF macular GA area did not increase the diagnostic accuracy of FAF macular GA area alone.
Gag affects USP9X
| 1
Gag activates USP9X. 1 / 1
| 1

reach
Fluorescent TaqMan MGB probes (FAM-labeled R1322H mutant-5′-ATCATAGGTCATCATGC-3′ and VIC-labeled WT-5′-CATCATAGGTCGTCATGC-3′) were synthesized by Thermo Fisher Scientific (Waltham, MA, USA) [11].
| PMC
GB affects USP9X
| 1
GB inhibits USP9X. 1 / 1
| 1

reach
To determine whether knockdown of USP9X can perturb other brain tumor types, U87 and U118 GB tumors cells were also transduced with lentiviruses to knockdown USP9X.
Folic acid affects USP9X
| 1
| 1

reach
Nevertheless, the folic acid mediated preferential uptake of FA-M (PTX) than M (PTX) is not shown in the cell inhibition assay.
Flutamide affects USP9X
1 |
Flutamide increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Fipronil affects USP9X
1 |
Fipronil increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Filipin III affects USP9X
| 1
| 1

reach
None of amiloride, chlorpromazine, cytochalasin D, Filipin III, nocodazole and methyl-beta-cyclodextrin blocked the entry of Fam labeled VPTLK and KLPVM into HeLa cells.
Fenofibrate affects USP9X
1 |
Fenofibrate increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Exonuclease affects USP9X
| 1
| 1

reach
When the 5 '-terminus of the cDNA is phosphorylated by T4 PNK, the cDNA is degraded by lambda exonuclease to release the fluorescein amidite (FAM)-labeled SA aptamer, which subsequently binds to streptavidin beads.
1 |

ctd
No evidence text available
Doxycycline affects USP9X
| 1
| 1

reach
As for WP1130, doxycycline knockdown of USP9X produced similar results.
1 |
Dorsomorphin increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Dioxygen affects USP9X
1 |
Dioxygen increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available

reach
5 ' FAM fluorescein was activated by being mixed with NHS and EDC at a 1:1:1 ratio in DMSO and then incubated at room temperature for 20 min to activate 5 ' FAM.
1 |
Dibutyl phthalate decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
| 1

reach
Furthermore, dexamethasone at pharmacologic doses did not inhibit FAF production.
Copper(II) sulfate increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Citric acid affects USP9X
| 1
| 1

reach
Second, the reaction products of citric acid, HCl and ketoglutaric acid reduce the fluorescence recovery by quenching the fluorescence of FAM labeled on the aptamer dissociated from the surface of AuNPs upon addition of target.
1 |
Chromium(6+) decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Cholesterol affects USP9X
| 1
Cholesterol increases the amount of USP9X. 1 / 1
| 1

reach
The uptake experiment showed that the presence of cholesterol in PCLs enhanced the uptake amount of FAM labeled siAgo2 into HT1080 cells.
1 |
Chlorpyrifos decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
| 1

reach
None of amiloride, chlorpromazine, cytochalasin D, Filipin III, nocodazole and methyl-beta-cyclodextrin blocked the entry of Fam labeled VPTLK and KLPVM into HeLa cells.
Cadmium(2+) affects USP9X
| 1
| 1

reach
The CD melting curves of PNA and cDNA * and PNA and cDNA heteroduplexes revealed greater stability of the latter (Tm values of 40 degreesC and 45 degreesC, respectively), as also disclosed by a weak reduction in terms of the intensity of the CD signal of the FAM labeled DNA in PNA and cDNA * heteroduplex.
| PMC
Butanal affects USP9X
1 |
Butanal decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Bisphenol A affects USP9X
1 |
Bisphenol A decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
1 |
Benzo[a]pyrene decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
1 |

ctd
No evidence text available
AtsA affects USP9X
| 1
AtsA activates USP9X. 1 / 1
| 1

reach
The 48 h urine collected following oral administration of FAF to rats was treated with beta-glucuronidase and arylsulfatase and extracted with benzene.
Atrazine affects USP9X
1 |
Atrazine decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Amiloride affects USP9X
| 1
| 1

reach
None of amiloride, chlorpromazine, cytochalasin D, Filipin III, nocodazole and methyl-beta-cyclodextrin blocked the entry of Fam labeled VPTLK and KLPVM into HeLa cells.
1 |
Aflatoxin B1 increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Acrylamide affects USP9X
1 |
Acrylamide increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Abrine affects USP9X
1 |
Abrine decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
ZBTB38 affects USP9X
| 1
ZBTB38 activates USP9X. 1 / 1
| 1

reach
ZBTB38 : a new nuclear target of USP9X.
ZAP70 affects USP9X
| 1
ZAP70 activates USP9X. 1 / 1
| 1

reach
Whether Usp9X targets ZAP70 directly or indirectly remains to be determined.
YAP1 affects USP9X
| 1
YAP1 increases the amount of USP9X. 1 / 1
| 1

reach
These results suggested that USP9X regulates YAP1 dependent transcription.
Wnt affects USP9X
| 1
Wnt inhibits USP9X. 1 / 1
| 1

reach
Usp9x antagonises Wnt signalling in neural progenitors.
Vitamin E affects USP9X
1 |
Vitamin E decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Val-Ser affects USP9X
| 1
Val-Ser increases the amount of USP9X. 1 / 1
| 1

reach
Brief stimulation of T cells increased the labeling of USP9X by HA‐Ub‐VS without an increase in USP9X levels, while the phospho‐site mutant, which still possess a potentially reactive active site Cys residue, was much less reactive toward the probe following stimulation.
USP9Y affects USP9X
| 1
USP9Y activates USP9X. 1 / 1
| 1

reach
USP9Y expression therefore completely restores the USP9X dosage imbalance between males and females.
| 1

reach
In the present study, the FAM conjugation apparently attenuated the anti-resorptive activity of ZOL (XREF_FIG).

reach
In FAM, at day 0, 18% of the labelled fraction of these metabolites came from [U- 13 C] PA and [U- 13 C] OA and the remaining 82% from [U- 13 C] Gln, suggesting that in FAM glutaminolysis is an important pathway to support TCA cycle anaplerosis when compared with GLCM, where just a small portion of the TCA cycle pools incorporates carbon from [U- 13 C] Gln.
USP9X bound to CTNNB1 activates transcription, DNA-templated. 1 / 1
| 1

reach
In conclusion, USP9x interacted with and stabilized beta-catenin through deubiquitination to mediate transcription of the decoy receptors in breast cancer cells.
USP9X affects sub
| 1
USP9X activates sub. 1 / 1
| 1

reach
Interestingly, USP9X phosphorylation enhances the DUB activity towards ankyrin-G and correlates with spine development 48.
USP9X affects slide
| 1
USP9X activates slide. 1 / 1
| 1

reach
The vertical trace line corresponds to a cutoff calculated from the FAM signal of the G12V- slide, 3-sigma above the mean.
USP9X affects rplB
| 1
USP9X inhibits rplB. 1 / 1
| 1

reach
Close to the active site, USP9X contains two blocking loops, BL1 (1,801–1,810) connecting β13 and β14 and BL2 (1,872–1,879) connecting β16 and β17 (Fig. 1B and SI Appendix, Fig. S2), similar to those in USP7 (5–7, 26) that form the binding cleft for the C-terminal tail of Ub.
USP9X affects prednisone
| 1
| 1

reach
First, the rapidity with which the FAM patients were able to reduce their prednisone doses or avoid prednisone suggests that BOS patients may not require prolonged corticosteroid tapers that can lead to significant morbidities.
USP9X affects pepsin
| 1
USP9X inhibits pepsin. 1 / 1
| 1

reach
Compared with physiologic saline, both FAM and the FAM + PZ combination significantly reduced gastric secretion, acidity, acid output, and pepsin secretion.
USP9X affects pdeR
| 1
USP9X inhibits pdeR. 1 / 1
| 1

reach
Conversely, introduction of a FAF RNA interference (RNAi) transgene, which was effective in knocking down FAF mRNA and protein expression (XREF_SUPPLEMENTARY), partially suppressed GMR-Gal4> PAR-1 effect (XREF_SUPPLEMENTARY).
USP9X affects parathion
| 1
| 1

reach
The cumulative survival at 5 years was 61.1% in all patients, 62.5% in patients treated with PAC and 54.7% in patients treated with FAM.
USP9X affects paclitaxel
| 1
USP9X bound to XIAP activates paclitaxel. 1 / 1
| 1

reach
Moreover, the interaction of USP9X and XIAP increased upon prolonged exposure to taxol, which leads to a gradual mitotic enrichment of cells (XREF_SUPPLEMENTARY).
USP9X affects p38
| 1
USP9X activates p38. 1 / 1
| 1

sparser
Moreover, both the p38MAPK inhibitor SB203580 and the Src inhibitor AZD0530 significantly blocked FAM3D-activated Mac-1, implying that FAM3D also activated p38MAPK- and Src-related β-arrestin-dependent signaling to induce Mac-1 activation (Figure xref F).

reach
In contrast, neither the expression of such genes nor hepatocellular necrosis occurred in rats treated with LPS and FAM.
USP9X affects mecA
| 1
USP9X activates mecA. 1 / 1
| 1

reach
The FAM probes were used to target mecA and aminoglycoside acetyltransferase genes, the Cy5 probe was used for reference phage gene coding for the head-tail connector protein.

reach
USP9X promotes LPS induced pulmonary epithelial barrier breakdown and hyperpermeability by activating NF-kBp65 feedback loop.
USP9X affects lactose
| 1
| 1

reach
FAM produced a lower fat yield and a lower fat content compared with FDM, and a lower lactose content than either FBM and FDM.
| 1

reach
HSA, HSA (FAF), HSA (GF) and human alpha-globulins all reduced CL int to 50-65 and 30% of control value at concentrations of 0.3 and 1%, respectively.

reach
Therefore, if USP9x increases MCL-1 expression [XREF_BIBR], then it could be suggested the USP9x indirectly promotes HR repair via MCL-1.

reach
Hence mutations in USP9X could impair the homeostasis of multiple important proteins in convergence among several neurodevelopmental risk factors, whereby one risk factor regulates the stability of many other risk factors.
USP9X affects homeobox
| 1
| 1

reach
Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis.
USP9X affects helicase
| 1
| 1

reach
Initially, we employed a real-time FAM based quantitative assay as a first-pass screen of the ITBA library to determine the extent of compound mediated inhibition of helicase catalyzed DNA unwinding (See XREF_SUPPLEMENTARY).
USP9X affects gyrB
| 1
USP9X activates gyrB. 1 / 1
| 1

reach
The primers and probes sets were synthesized by Sangon Biotech (Shanghai, China), and probes labeled with the fluorescent reporter dye carboxy-4 ',5 '-dichloro-2 ',7 '-dimethoxyfluorescein (JOE) targeting invA and 6-carboxyfluorescein (FAM) targeting gyrB were covalently coupled to the 5 '-end, with Black Hole Quencher 1 (BHQ-1) at the 3 '-end.
USP9X affects gdf6a
| 1
USP9X activates gdf6a. 1 / 1
| 1

reach
Although deletion of ubp15 or knock down of USP9X activated the RADAR pathway (as demonstrated by the low level of Pex5), cargo import was not significantly affected, indicating the existence of redundant DUBs acting on Pex5.
USP9X affects gacH
| 1
USP9X activates gacH. 1 / 1
| 1

reach
All samples were tested in duplicates with the previously published primers SpoT-F, SpoT-R and the FAM labelled TaqMan probe SpoT-FAM-LNA [XREF_BIBR] targeting the spoT gene of Phlomobacter.
USP9X affects fibrillin
| 1
| 1

reach
These results confirm that protein FAF mediates binding of fibrillin to F. magna, both at the bacterial surface and in solution.
USP9X affects ethanol
| 1
USP9X activates ethanol. 1 / 1
| 1

reach
Stressed rats received the second footshock in a familiar (FAM, same IA box as the first footshock) or novel context (NOV, single-chambered apparatus); the FAM paradigm more effectively increased alcohol drinking in males and the NOV paradigm in females.
USP9X affects epnA
| 1
USP9X activates epnA. 1 / 1
| 1

reach
Usp9x promotes Notch signalling by antagonising the degradation of Mind bomb1, as well as activating Epsin in the signal sending cell XREF_BIBR, XREF_BIBR.

reach
BSA (FAF) was able to support blastocyst and subsequent embryo development at rates equivalent to that of fetal calf serum (FCS)-supplemented medium when fresh embryos were transferred.
USP9X affects doxorubicin
| 1
| 1

reach
WP1130 also increases sensitivity to doxorubicin via degrading p53 by a USP9X dependent mechanism in HCC cells XREF_BIBR.
USP9X affects cocaine
| 1
USP9X activates cocaine. 1 / 1
| 1

reach
Our study here raises the intriguing possibility that USP9x might contribute to cocaine induced neuroplasticity via modulating the level of AGS3 in the brain.
| 1

reach
Bioluminescence measurement reveals that USP9X knockdown decreases the amplitude of the cellular circadian rhythm but the period and phase are not affected.
| 1

eidos
Knockdown of USP9X inhibits ciliogenesis [ 126 ] .
| PMC
| 1

reach
Pain alleviation was seen in 25% of patients treated with CTX and in 64% of those treated with FAM ' (P less than.01).

reach
We demonstrate that depletion or loss of USP9X reduces the effectiveness of the SAC, elevates chromosome segregation defects, and enhances chromosomal instability (CIN).

reach
Although the overall brain architecture was intact, loss of Usp9x disrupted the cellular organization of the ventricular and sub-ventricular zones, and cortical plate.
USP9X affects cell
| 1
USP9X activates cell. 1 / 1
| 1

eidos
USP9X enhances proliferation of HCC cells and is correlated with undesirable prognosis .
| PMC
| 1

reach
Importantly, depletion of USP9X in MDAMB231 metastatic breast cancer cells, which have elevated SMURF1 expression, inhibits SMURF1 dependent breast cancer cell motility [XREF_BIBR].
USP9X affects bortezomib
| 1
| 1

reach
Reduction in USP9X levels increases bortezomib induced downregulation of ErbB2, suggesting that USP9X is associated with the internalisation and ubiquitylation status of ErbB2 [XREF_BIBR].
USP9X affects XVI
| 1
USP9X activates XVI. 1 / 1
| 1

reach
Proteins FAF and L also induced the secretion of several pro inflammatory neutrophil proteins; HBP, IL-8 and INFgamma.
USP9X affects Val-Met
| 1
USP9X activates Val-Met. 1 / 1
| 1

reach
Nor did USP9X depletion promote the differentiation of ReNcells VM to post-mitotic neuronal or glial lineages.
USP9X affects VMP1
| 1
USP9X activates VMP1. 1 / 1
| 1

reach
USP9x is likely to modulate zymogen granule selective engulfment during acute pancreatitis by modulating VMP1 or providing a preferential recognition signal for altered zymogen granules.
USP9X affects USP11
| 1
USP9X inhibits USP11. 1 / 1
| 1

reach
Structures of two compounds which inhibit USP9x (and other DUBs) and a structurally related BTK inhibitor.Structures inhibitors of USP10/13 and USP11.
USP9X affects TWIST1
| 1
USP9X increases the amount of TWIST1. 1 / 1
| 1

reach
Accordingly, USP9x knockdown could block TGF-beta-induced Twist expression and inhibited the promoting effect of PA on TGF-beta-induced Twist expression.
USP9X affects TSC22D3
| 1
| 1

reach
Analysis of cultured undifferentiated spermatogonia lacking GILZ confirmed aberrant activation of ERK MAPK upstream mTORC1 plus USP9X downregulation and interaction of GILZ with TSC22D proteins.
USP9X affects THEMIS
| 1
USP9X bound to LAT activates THEMIS. 1 / 1
| 1

reach
Grb2 Mediated Recruitment of USP9X to LAT Enhances Themis Stability following Thymic Selection.
USP9X affects TGOLN2
| 1
USP9X activates TGOLN2. 1 / 1
| 1

reach
Results in XREF_FIG indicate that depleting USP9x with either of the two shRNAs caused the dispersal of beta-GalT1 and TGN46.
USP9X affects TCR
| 1
USP9X inhibits TCR. 1 / 1
| 1

reach
Inherited mutations causing primary human immunodeficiency are rare, so analyses of genetic alterations such as T cell specific deletion of Usp9x that subtly reduce TCR signal strength may inform our understanding of a greater proportion of human immunopathology.
USP9X affects TAZ
| 1
USP9X inhibits TAZ. 1 / 1
| 1

reach
These three lines of evidence suggest that USP9x normally functions to limit YAP and TAZ activity.

eidos
The loss of USP9X leads to the decrease in T cell proliferation and T cell differentiation into helper T cells , hence affecting cytokine production .
| PMC

eidos
The loss of USP9X leads to the decrease in T cell proliferation and T cell differentiation into helper T cells , hence affecting cytokine production .
| PMC
USP9X affects SYNM
| 1
USP9X inhibits SYNM. 1 / 1
| 1

reach
Given that both FAM and OMM reduce mind wandering and activity in DMN regions 2, our findings are consistent with those of previous studies.
USP9X affects SYDE1
| 1
USP9X activates SYDE1. 1 / 1
| 1

sparser
Fam13A directly binds to AnxA2 and activates Rho GTPase to facilitate autophagosome formation during PAO1 infection.
USP9X affects STMN1
| 1
USP9X activates STMN1. 1 / 1
| 1

reach
Confirming a previous description of the direct interaction of USP9X (Ubiquitin Specific Peptidase 9, X Linked) with SMN [XREF_BIBR], it was shown that USP9X knock-down promotes the degradation of Flag tagged SMN constructs, but does not affect the degradation of Flag-SMNincrement7 [XREF_BIBR].
USP9X affects STK11
| 1
USP9X activates STK11. 1 / 1
| 1

reach
Thus, LKB1 and FAF both positively regulate PAR-1, and the overexpression of FAF may enhance LKB1 overexpression effects through the stabilization of p-PAR-1 generated by LKB1.
USP9X affects STAM2
| 1
USP9X activates STAM2. 1 / 1
| 1

reach
Proteins FAF and L also induced the secretion of several pro inflammatory neutrophil proteins; HBP, IL-8 and INFgamma.
USP9X affects SNRPN
| 1
USP9X decreases the amount of SNRPN. 1 / 1
| 1

reach
Knockdown of Usp9x promotes SMN degradation and reduces the protein levels of SMN and the SMN complex in cultured mammalian cells.
USP9X affects SNCA
| 1
USP9X activates SNCA. 1 / 1
| 1

reach
Knockdown of USP9X expression promotes accumulation of monoubiquitinated alpha-synuclein species and enhances the formation of toxic alpha-synuclein inclusions upon proteolytic inhibition.
USP9X affects SMN1
1 |
USP9X increases the amount of SMN1. 1 / 1
1 |

signor
Ubiquitin-specific Protease 9x Deubiquitinates and Stabilizes the Spinal Muscular Atrophy Protein-Survival Motor Neuron
USP9X affects SLC25A10
| 1
| 1

reach
A patient with cancer of unknown primary site suffering from diffuse bone marrow metastasis and DIC, was treated with FAM (5-fluorouracil, adriamycin and mitomycin C) combination chemotherapy.
USP9X affects SDHA
| 1
USP9X inhibits SDHA. 1 / 1
| 1

reach
By the same mechanism, in the absence of the DNA MTase, DpnII will then cleave at the unmethylated site, leaving a small fragment bound to the FAM which drastically decreases the FP value.
USP9X affects SARS-CoV-2
| 1
| 1

reach
Please note that the study was performed on existing samples collected during standard diagnostic tests, posing no extra burden to patients.The dPCR assay was performed via the digital PCR chips (Thermofisher, cat#A26317) following the manufacturer's protocols, and QuantStudio 3D Digital The result was considered positive when the FAM signals of the SARS-CoV-2 target ≥ 3 with the VIC signals of the RNase P reference target ≥ 0, and negative when the FAM signals ≤ 2 with the VIC signals ≥ 60.

reach
FAF allows noninvasive and in vivo topographical imaging of retinal metabolic changes and general health of the photoreceptor and RPE layers.
| PMC

reach
Conclusions: Increase in FAF and loss of definition of the layers of the ellipsoid zone, interdigitation zone and external limiting membrane were early features of canine and feline retinal dystrophies.
| PMC
USP9X affects RPTOR
| 1
Modified mutated USP9X increases the amount of RPTOR. 1 / 1
| 1

reach
Over-expression of three USP9X mutations, which are associated with human intellectual disability but do not affect their deubiquitylating activity 13, also increased RAPTOR levels.
USP9X affects RPS6
| 1
USP9X activates RPS6. 1 / 1
| 1

reach
The depletion of USP9X levels, loss of mTORC1 signalling, as indicated by failure to induce p-S6, and ReNcell VM cell-cycle arrest, all occurred with very similar kinetics strongly suggesting these NPs rely on USP9X dependent mTORC1 activity for proliferation.
USP9X affects RNF115
| 1
USP9X activates RNF115. 1 / 1
| 1

reach
In contrast, knockdown of USP9X in breast cancer cells by siRNAs reduced RNF115 protein abundance, which was partially restored following treatment with proteasome inhibitor MG-132.
USP9X affects RIOX2
| 1
USP9X activates RIOX2. 1 / 1
| 1

reach
The multicolour beacon produced the characteristic fluorescence when it bound to the designed targets: p16 produced the blue colour of FAM emission, p21 produced the red of Cy5 and p53 produced the orange of Rox.
USP9X affects REN
| 1
USP9X activates REN. 1 / 1
| 1

reach
Asselbergs FAM, Rahuel J, Cumin F, Leist C : Scaled-Up Production of Recombinant Human Renin in CHO Cells for Enzymatic and X-Ray Structure Analysis.
USP9X affects Protease
| 1
| 1

reach
Faldaprevir analogue molecule (FAM) has been reported to effectively inhibit the catalytic activity of HCV NS3/4A protease, making it a potential lead compound against HCV.
| 1

reach
Interestingly, USP9x protein expression was altered in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-(MPTP-) induced PD mouse model study that measured protein abundance changes, suggesting that it might be associated with neurodegeneration [XREF_BIBR].
USP9X affects Pain
| 1
USP9X inhibits Pain. 1 / 1
| 1

reach
Interestingly, FAM was able to suppress late-phase pain response in female mice (30 mg/kg) although it did not show any such effect in male mice.
USP9X affects PTPRC
| 1
USP9X activates PTPRC. 1 / 1
| 1

reach
XREF_FIG, 50 PC3 cells were mixed with ~ 10,000 Raji cells and analyzed with the PACS workflow using a HEX labeled TaqMan assay targeting VIM, and a FAM labeled TaqMan assay targeting PTPRC.
USP9X affects PTGS2
| 1
USP9X inhibits PTGS2. 1 / 1
| 1

reach
Contribution = COX-2 inhibition FAM/COX-2 inhibition extract × 100 (6) 3.7.
| PMC
USP9X affects PTGER4
| 1
USP9X activates PTGER4. 1 / 1
| 1

reach
We estimated the capacity of FAM (2.5 X 10 (5] to synthesize DNA (3H-thymidine uptake) and RNA (3H-uridine uptake), and the activities of silica stimulated FAM to cause proliferation of mouse thymocytes (IL-1 activity) and rat lung fibroblasts (FP activity), and to produce PGE2.
USP9X affects PSD
| 1
USP9X increases the amount of PSD. 1 / 1
| 1

reach
Furthermore, knockdown of either EFA6 or USP9x impairs TJ biogenesis and EFA6 overexpression rescues TJ biogenesis in USP9x-knockdown cells.
USP9X affects PRSS50
| 1
USP9X activates PRSS50. 1 / 1
| 1

reach
When the mutation overlaps the HEX probe, the FAM signal is increased (CT20), whereas the opposite occurs when the mutation overlaps the FAM probe (as in sample FC39-4).
USP9X affects PRKCQ
| 1
USP9X activates PRKCQ. 1 / 1
| 1

reach
Consequently, our genetic and biochemical data do not support the reported model wherein the role of Usp9X during T cell activation is to modulate the CARMA1-Bcl10-MALT1 (CBM) complex downstream of PKCtheta.
USP9X affects PARP1
| 1
USP9X activates PARP1. 1 / 1
| 1

reach
Furthermore, Usp9x KD increased PARP and BID cleavage, a hallmark of apoptosis induction in all three cell lines (XREF_FIG - XREF_FIG).
USP9X affects PARN
| 1
USP9X activates PARN. 1 / 1
| 1

reach
Figure XREF_FIG shows the confocal images of neuronal cells (DAN) treated with (a) FAM labeled siRNA (siRNA FAM), (b) Lipofectamine-siRNA FAM (Lipo-siRNA FAM) nanoplex, (c) QR + nanomicelle, (d) siRNA FAM conjugated QR + nanomicelle (QR-siRNA FAM) and (e) thiolated siRNA FAM conjugated with QR mal (QR mal -thiosiRNA FAM) for 20 hours.
USP9X affects Neck Pain
| 1
| 1

reach
(J Am Board Fam Med 2015;28:000-000.) In recent years, health care visits for back and neck pain have increased substantially, with annual expenditures on the diagnosis and management exceeding $85 billion.
USP9X affects NUAK1
| 1
USP9X bound to adenosine 5'-monophosphate activates NUAK1. 1 / 1
| 1

reach
USP9X binds to the AMP activated protein kinase (AMPK)-related kinases NUAK1 and MARK4 (Par-1 homologues) [XREF_BIBR, XREF_BIBR].
USP9X affects NQO1
| 1
Modified USP9X activates NQO1. 1 / 1
| 1

reach
Under AGEs treatment conditions, USP9X overexpression markedly increased the total and nuclear levels, ARE binding ability, and transcriptional activity of Nrf2, upregulated the protein expressions of Nrf2 downstream genes HO-1 and NQO1, and eventually reduced the excessive production of ROS.

reach
To begin with, TRP has to be converted into N-formylkynurenine, which is mediated by indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO), and then into kynurenine (KYN) by Nformylkynurenine formamidase (FAM) [35] .

reach
The negative charge of the FAM moiety most likely decreases the reactivity of BCN toward the azides that are located close to the anionic phosphodiesters in the DNA major groove.
USP9X affects MTTP
| 1
USP9X activates MTTP. 1 / 1
| 1

reach
The median time to progression (MTP) of all patients treated with CTX was six weeks and the MTP of patients treated with FAM ' was 16 weeks (P less than.007).
USP9X affects MT-CYB
| 1
USP9X activates MT-CYB. 1 / 1
| 1

reach
The VIC and FAM labelled probes specifically target the mitochondrial cytochrome b genes of B. bovis and B. bigemina, respectively.
USP9X affects MCC
| 1
USP9X activates MCC. 1 / 1
| 1

reach
The deubiquitinase USP9X modulates the stability of MCC : APC/C complex thereby influencing the SAC dynamics.
USP9X affects MB
| 1
USP9X activates MB. 1 / 1
| 1

reach
Thus, the increase of FAM emission in the presence of H45 allows monitoring the opening kinetics of the molecular beacon in the presence of H45.
USP9X affects MARK4
| 1
USP9X bound to adenosine 5'-monophosphate activates MARK4. 1 / 1
| 1

reach
USP9X binds to the AMP activated protein kinase (AMPK)-related kinases NUAK1 and MARK4 (Par-1 homologues) [XREF_BIBR, XREF_BIBR].
USP9X affects MAPT
| 1
USP9X increases the amount of MAPT. 1 / 1
| 1

reach
After observing a high positive correlation between the expression of USP9 and MAPT in the public transcriptomics data, we show that USP9 knockdown results in significantly decreased MAPT expression in a DU145 cell culture model and a concentration dependent decrease for the MAPT orthologs mapta and maptb in a zebrafish model.
USP9X affects MAP3K5
| 1
USP9X activates MAP3K5. 1 / 1
| 1

reach
Thus, USP9X positively regulates ASK1 activity and ASK1 dependent cell death through the deubiquitination and stabilization of ASK1 [XREF_BIBR].
USP9X affects Leu-Cys
| 1
USP9X activates Leu-Cys. 1 / 1
| 1

reach
For ddPCR quantitation of cetuximab LC transgenes, 25ng of genomic DNA were amplified with LC specific primers GL1459 and GL1460 and goat beta-lactoglobulin gene (LGB) primers GL1470 and GL1471 as reference, in the presence of the LC target FAM probe GL1468 and reference HEX probe GL1472 in a 22microL reaction.
USP9X affects LPO
| 1
USP9X inhibits LPO. 1 / 1
| 1

reach
LPO was almost completely inhibited by FAM beads plus QRT; the difference between the normal control and QRT group was not significant (P> 0.05) as the value of the LPO may be normalized.
USP9X affects LAMP assay
| 1
| 1

reach
Measuring changes in fluorescence of FAM enabled the LAMP method to detect two different genes simultaneously.

reach
FAM therapy did not suppress the cytotoxicities of PBL and LAK cells.
USP9X affects KLF5
| 1
USP9X inhibits KLF5. 1 / 1
| 1

reach
Knockdown of Circular Ubiquitin-specific Peptidase 9 X-Linked Alleviates Oxidized Low-density Lipoprotein-induced Injuries of Human Umbilical Vein Endothelial Cells by Mediating the miR-148b-3p/KLF5 Signaling Pathway.
USP9X affects KLC3
| 1
USP9X activates KLC3. 1 / 1
| 1

reach
Regular RT-PCR and RT-ddPCR were performed on different cDNA samples using FAM labeled probes targeting luciferase gene or endogenous KLC2 gene and Hex labeled probe targeting an internal control housekeeping gene AAEL002401.
USP9X affects JNK
| 1
USP9X inhibits JNK. 1 / 1
| 1

reach
In this scenario, low USP9x levels would lead to reduced JNK activation and to reduced stress induced apoptosis.
USP9X affects Imd
| 1
USP9X inhibits Imd. 1 / 1
| 1

reach
In the silkworm, the Fas related factor, FAF, negatively regulates the Imd pathway and regulates antibacterial immunity by binding and degrading Relish [XREF_BIBR].
USP9X affects Ile-Ala
| 1
USP9X activates Ile-Ala. 1 / 1
| 1

reach
All 9 patients at stage Ia treated with CAP are free of disease, however, 3 patients out of 13 at stage Ia treated with FAM experienced a recurrence of the disease and died.
USP9X affects IL6
| 1
USP9X activates IL6. 1 / 1
| 1

reach
FAF induced higher levels of IL-6 production in human gingival fibroblasts compared to cells stimulated with P. gingivalis LPS and did not show action against human periodontal ligament cells [XREF_BIBR, XREF_BIBR].
USP9X affects IGF1R
| 1
USP9X activates IGF1R. 1 / 1
| 1

reach
Since USP9X knockdown reduced two important mediators of IGF-I signaling, IRS-2 and IGF-IR in PC3 cells, we assessed the effect of knockdown of USP9X on IGF-I signaling.
USP9X affects ID2
| 1
USP9X increases the amount of ID2. 1 / 1
| 1

reach
For example USP9X may upregulate ID2 gene expression by deubiquitinating and stabilizing the transcription factor SMAD4 (Dupont et al., 2009).

reach
The pH dependent ligand dissociation may prevail for other RGD receptors, since extracellular acidification can remove the majority of prebound FN from the PM, expressing various integrins.The deubiqu[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
USP9X affects HMOX1
| 1
Modified USP9X activates HMOX1. 1 / 1
| 1

reach
Under AGEs treatment conditions, USP9X overexpression markedly increased the total and nuclear levels, ARE binding ability, and transcriptional activity of Nrf2, upregulated the protein expressions of Nrf2 downstream genes HO-1 and NQO1, and eventually reduced the excessive production of ROS.
USP9X affects HIF1
| 1
USP9X activates HIF1. 1 / 1
| 1

reach
NANOG stimulates HIF-1 transcriptional activity by recruitment of the deubiquitinase USP9X, which inhibits HIF-1α protein degradation, and by stabilizing HIF-1α interaction with the coactivator p300, which mediates histone acetylation.
USP9X affects HIF
| 1
USP9X activates HIF. 1 / 1
| 1

reach
This strongly suggests that USP9X positively regulates HIF activity through alteration of pVHL.
USP9X affects HGF
| 1
USP9X activates HGF. 1 / 1
| 1

reach
USP9x knockdown further reduced SF in A172 and Ln229 cells.
USP9X affects GSN
| 1
USP9X activates GSN-D187N. 1 / 1
| 1

reach
We report a mouse model of FAF featuring a muscle specific promoter to drive D187N gelsolin synthesis.
USP9X affects GDP
| 1
USP9X activates GDP. 1 / 1
| 1

reach
Neri et al. (2013) used the Circular Flow of Income to measure the direct and indirect short-term impacts of social transfers on GDP through a Social Accounting Matrix, verifying the multiplier effects of various social benefits on Gross Domestic Product (GDP), such as Bolsa Família (BF) and General Social Security Benefits.
| PMC
USP9X affects GALNS
| 1
USP9X activates GALNS. 1 / 1
| 1

reach
Green fluorescent FAM labeled versions of nine of these (listed in XREF_TABLE) and two negative control aptamers (RAND-39 and RAND-80) were synthesized and tested for binding to live GAS SF370 cells by flow cytometry.
USP9X affects FUS
| 1
USP9X activates FUS. 1 / 1
| 1

reach
The conformational results of the FAF induced TLS system are summarized in Table 1.
USP9X affects FOXM1
| 1
USP9X activates FOXM1. 1 / 1
| 1

reach
PLGA (50:50), PVA (30,000-70,000 kDa), Chitosan (low molecular weight), MTT reagent, Human duplex siRNA targeting FOXM1 (sequence : GCACUAUCAACAAUAGCCU), and FAM labeled negative siRNA were obtained from Sigma-Aldrich (St. Louis, MO).
| PMC
USP9X affects FAM126A
| 1
USP9X activates FAM126A. 1 / 1
| 1

reach
USP9X enhances proliferation of HCC cells and is correlated with undesirable prognosis.
| PMC
USP9X affects ERG
| 1
USP9X activates ERG. 1 / 1
| 1

eidos
Inhibition of USP9X by WP1130 leads to ERG degradation and inhibits tumor growth ( 183 ) .
USP9X affects ERBB3
| 1
USP9X decreases the amount of ERBB3. 1 / 1
| 1

reach
USP8 or USP9X silencing increased HER3 protein level in basal conditions (medium alone) in BxPC3 cells, suggesting that each deubiquitinase promotes basal HER3 degradation by stabilizing ITCH, as proposed for USP8 [XREF_BIBR].
USP9X affects ERBB2
| 1
USP9X inhibits ERBB2. 1 / 1
| 1

reach
Reduction in USP9X levels increases bortezomib induced downregulation of ErbB2, suggesting that USP9X is associated with the internalisation and ubiquitylation status of ErbB2 [XREF_BIBR].
USP9X affects EPS15
1 |
USP9X inhibits EPS15. 1 / 1
1 |

signor
We identify the endocytic protein Eps15 as one of the critical substrates of USP9X
USP9X affects EPN
| 1
USP9X activates EPN. 1 / 1
| 1

reach
It was proposed that the ubiquitylation of epsin may prevent its interaction with several binding partners, including lipids, AP-2, and clathrin; therefore, FAM mediated deubiquitylation activates epsin.
USP9X affects EPCAM
| 1
USP9X activates EPCAM. 1 / 1
| 1

reach
We used a FAM conjugated Taqman probe targeting the EpCAM transcript and a hexachlorofluorescein (HEX) conjugated Taqman probe recognizing the B-lymphocyte-specific transcript PTPRC.
USP9X affects EIF4A
| 1
USP9X inhibits EIF4A. 1 / 1
| 1

reach
Engel et al. noted that depletion of USP9X significantly reduced the rate of lymphoma development in Emu-Myc mice in a XIAP (eIF4A regulated gene) dependent manner.
USP9X affects EGLN3
| 1
USP9X inhibits EGLN3. 1 / 1
| 1

reach
USP9X elicited tumor suppressor role by preventing degradation of EGLN3.

reach
In this study, we examined intradermal siRNA permeability in the tape stripped (20 times) back skin of mice or AD like skin of auricles treated with 6-carboxyfluorescein-aminohexyl phosphoramidite (FAM)-labeled siRNA, the tight junction modulator AT1002, and the functional cytoplasm responsive stearylated peptide STR-CH2R4H2C by using confocal laser microscopy.
| 1

reach
USP9X depletion profoundly impairs the progression of DNA replication forks, causing unscheduled termination events with a frequency similar to CLASPIN depletion, resulting in excessive endogenous DNA damage.
USP9X affects DLK1
| 1
Modified USP9X increases the amount of DLK1. 1 / 1
| 1

reach
The Dscam1 stabilizing function of Faf appears to be conserved in mammals, as FAM and Usp9x overexpression also leads to increased levels of Dscam1 protein DLK1 and Wnd levels and activity are known to be regulated by the ubiquitin ligase Highwire in Drosophila.
USP9X affects DCX
| 1
USP9X inhibits DCX. 1 / 1
| 1

reach
13 Thus the mutations in USP9X may perturb DCX function.
USP9X affects DBI
| 1
USP9X activates DBI. 1 / 1
| 1

reach
A FAF overexpressing EP line (EP381), which alone caused a mild rough eye phenotype, likely due to its moderate upregulation of endogenous PAR-1 protein level (XREF_SUPPLEMENTARY), caused a dramatic reduction of eye size when introduced into GMR-Gal4> PAR-1 background (XREF_FIG).
USP9X affects Collagen
| 1
| 1

reach
FAF and aFGF promoted fibroblast induced collagen gel contraction with similar potency.
USP9X affects Colitis
| 1
| 1

reach
Besides, USP9X negatively regulated c-Myc by directly stabilizing FBW7 to restore damaged intestinal epithelium and inhibit the development of colitis-associated colon cancer in animal models (140).
| PMC

reach
However, although USP9X depletion might contribute to tumorigenesis by elevating CIN, there are many other routes to CIN that do not require USP9X loss.
USP9X affects Caspase
| 1
| 1

reach
Usp9X knockdown induces apoptosis, caspase activation and recapitulates effects of CP-d and n-ATF 5-S1.
| 1

reach
More than 50 % of tumors exhibit inactive USP9X protein, and the deletion of Usp9x increases pancreatic tumorigenesis in mice [32].
| PMC
USP9X affects CYP2D6
| 1
USP9X activates CYP2D6. 1 / 1
| 1

reach
FAM signals of CYP2D6 amplification are detected by the 530 nm photohybrid and HEX of albumin by the 560 nm one.
USP9X affects CXCL8
| 1
USP9X activates CXCL8. 1 / 1
| 1

reach
Proteins FAF and L also induced the secretion of several pro inflammatory neutrophil proteins; HBP, IL-8 and INFgamma.
USP9X affects CRC
| 1
USP9X inhibits CRC. 1 / 1
| 1

reach
Usp9x suppresses CRC.
USP9X affects CLSPN
| 1
USP9X activates CLSPN. 1 / 1
| 1

reach
The deubiquitinases USP9X and USP29 promote Claspin stabilization during the S phase, and thus, adequate replication fork progression, by opposing its proteasomal degradation [23,24].
USP9X affects CASP3
| 1
USP9X activates CASP3. 1 / 1
| 1

reach
As expected, the FI FAM / FI PpIX increased to 0.59 after treatment with STS in the absence of caspase-3 inhibitor at the same time interval, exhibiting a caspase-3 specific ratiometric fluorescence r[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
USP9X affects BRAF
| 1
USP9X inhibits mutated BRAF. 1 / 1
| 1

reach
Usp9x KD reduced NRAS protein levels in both NRAS and BRAF mutant cells with little to no effect on HRAS or KRAS expression (XREF_FIG).
USP9X affects BIRC5
| 1
USP9X activates BIRC5. 1 / 1
| 1

reach
Conversely, USP9X is known to promote the activities of anti-apoptotic factors, MCL1 and Survivin.
USP9X affects BIRC3
| 1
USP9X activates BIRC3. 1 / 1
| 1

reach
Furthermore, DUBs are known to regulate stability of only 4 of these proteins, including the ubiquitin ligases MARCH7 and BIRC3, which are targeted by USP7 or USP9 and USP19, respectively.
USP9X affects BID
| 1
USP9X activates BID. 1 / 1
| 1

reach
Furthermore, Usp9x KD increased PARP and BID cleavage, a hallmark of apoptosis induction in all three cell lines (XREF_FIG - XREF_FIG).
USP9X affects Arg-Ser
| 1
USP9X activates Arg-Ser. 1 / 1
| 1

reach
A number of studies have examined the FAF signal in RRD, RS, and RS detachment (RSD) given previous work noting FAF changes related to retinal layer separations and metabolic changes.
| PMC
| 1

reach
From a network analysis of this dataset, we derive a model for the involvement of USP9 in the regulation of MAPT expression and phosphorylation and discuss possible applications for developing USP9 based intervention strategies targeting tau hyperphosphorylation and aggregation in AD and other tauopathies.
USP9X affects Alpha
| 1
USP9X inhibits Alpha. 1 / 1
| 1

reach
However, as reported earlier XREF_BIBR, FAM is an effective inhibitor of the alpha- and beta-CAs from H. pylori, with K I s of 20.7-49.8 Nm XREF_BIBR.
USP9X affects Actin
| 1
USP9X activates Actin. 1 / 1
| 1

reach
Detection of FAM and TAMRA emissions by confocal microscopy allowed visualisation of actin staining by Lifeact and the distribution of the carriers in cells, respectively.
USP9X affects ARRB1
| 1
USP9X inhibits ARRB1. 1 / 1
| 1

reach
Of note, the meta-analysis of the published transcriptomics datasets highlighted potential dysregulation of upstream regulators able to activate (MECOM and USP9X) [50,51] or inhibit Notch (e.g., ARRB1) [52].
| PMC
USP9X affects ARL6IP4
| 1
USP9X activates ARL6IP4. 1 / 1
| 1

reach
ITCH and AIP4 activity was activated by the deubiquitinases USP8 and USP9X, as demonstrated by RNA interference.
USP9X affects APP
| 1
USP9X activates APP. 1 / 1
| 1

reach
In a drosophila Alzheimer 's model, overexpression of the USP9 ortholog faf was reported to enhance phospho-MAPT-mediated postsynaptic toxicity of amyloid precursor protein (APP)/Abeta-42 [XREF_BIBR].
USP9X affects ANS
| 1
USP9X activates ANS. 1 / 1
| 1

reach
In conclusion, the HFAM model allows, for the first time, assessment of a specific state of the autonomic control of HR, characterized by co-existence or co-activation of both components of the ANS.
USP9X affects ANK3
| 1
USP9X-S3D increases the amount of ANK3. 1 / 1
| 1

reach
Interestingly, Usp9X S3D increased the ratio of ankyrin-G expressing spines co-incident with an increase in PLA positive spines (XREF_FIG) and it prompted increase of spine density (XREF_FIG).
USP9X affects AMD1
| 1
USP9X inhibits AMD1. 1 / 1
| 1

reach
Quantitative FAF measurement showed that the intensity of lipofuscin related FAF decreased in early, intermediate, and late AMD [XREF_BIBR].
USP9X affects ALDH1A3
| 1
| 1

reach
Depletion of USP9X markedly downregulated ALDH1A3, resulting in a loss of self-renewal and tumorigenic capacity of MES GSCs, which could be largely rescued by ectopic expression of ALDH1A3.
USP9X affects AFM
| 1
USP9X inhibits AFM. 1 / 1
| 1

reach
Moreover, these findings confirm that the covalently labeled fluorophore (FAM) did not disrupt the original recognition properties of the AFM 1 aptamer.
USP9X affects ACTA1
| 1
USP9X activates ACTA1. 1 / 1
| 1

reach
XREF_BIBR To measure gene expression level, we used a previously published primer pair and Fam labeled probe for human ACTA1 mRNA XREF_BIBR and used Primer3 software XREF_BIBR, XREF_BIBR to design a primer pair and Fam labeled probe targeting ACTA1 pre-mRNA at the intron 1-exon 2 splice site.
USP9X affects ACC
| 1
USP9X activates ACC. 1 / 1
| 1

reach
The absence of AMPK and ACC activation in Gal9KO Huh7 was reversed by USP9X knockdown (XREF_FIG).
USP9X affects ABCB1
| 1
USP9X increases the amount of ABCB1. 1 / 1
| 1

reach
Moreover, knockdown of USP9X expression can significantly reduce the expressions of MDR1, MRP2, Bcl-2, MMP2, and MMP9, but significantly increased the expression of Bax.
| 1

reach
5-FU, doxorubicin plus mitomycin (FAM) and 5-FU plus doxorubicin (Adriamycin) (FA) did not significantly increased OS vs 5-FU alone [XREF_BIBR].

reach
Since USP9X was previously reported to positively regulate SMAD4 transcriptional activity 17 and SMAD4 is commonly mutated in PDA 4, we hypothesized that Usp9x loss would attenuate Smad4 function or TGFbeta responsiveness in PDA cell lines.
USP24 affects USP9X
| 1
USP24 increases the amount of USP9X. 1 / 1
| 1

reach
Interestingly, knockdown of USP24 in Jurkat cells significantly induced cell death and reduced Mcl-1 but not USP9X protein level.
USP15 affects USP9X
| 1
USP15 deubiquitinates USP9X. 1 / 1
| 1

reach
UCHL37, USP11, and USP15 de-ubiquitinate TbetaRI, XREF_BIBR, XREF_BIBR, XREF_BIBR while USP15, CYLD, and USP9X target SMAD4 or SMAD7.
USP11 affects USP9X
| 1
USP11 deubiquitinates USP9X. 1 / 1
| 1

reach
UCHL37, USP11, and USP15 de-ubiquitinate TbetaRI, XREF_BIBR, XREF_BIBR, XREF_BIBR while USP15, CYLD, and USP9X target SMAD4 or SMAD7.
Tobacco Smoke Pollution decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
TNFSF10 affects USP9X
| 1
TNFSF10 activates USP9X. 1 / 1
| 1

reach
Moreover, there was no additional down-regulation of Usp9X levels when comparing SF188 cells treated with TRAIL alone or the combination.
THPO affects USP9X
| 1
THPO inhibits USP9X. 1 / 1
| 1

reach
RNA (2 ml) was added to 23 l of PCR mix in each well of a MicroAmp optical reaction plate containing 12.5 l of Taqman One-Step PCR Mastermix, 0.625 l of 40× Multiscribe/RNase inhibitor, 5.75 l of distilled water, 1.25 l each of 18 M NiV or HeV forward and reverse primers, 1.25 l of 5 M HeV or NiV FAM-labeled probe, 0.125 l each of 10 M 18S rRNAF and 18S rRNAR, and 0.125 l of 40 M 18S rRNA-VIClabeled probe.
TGFB affects USP9X
| 1
TGFB inhibits USP9X. 1 / 1
| 1

reach
Where indicated, control cells were supplemented with 5 muM SB431542 (Tocris) in the medium to quench autocrine TGFbeta signaling.For FAM knockdown, the sequences of the siRNA were as follows : # 1 : [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
TBA affects USP9X
| 1
TBA activates USP9X. 1 / 1
| 1

reach
The addition of increasing amounts of TBA or TBA-N8 restored FAM fluorescence with notably differing efficiencies as shown in XREF_FIG.
| PMC
SRRT affects USP9X
| 1
SRRT activates USP9X. 1 / 1
| 1

reach
Further addition of unlabelled NELF-E 244-380 to m 7 GTP-CBC-ARS2 845-871 (FAM) or unlabelled ARS2 827-871 to m 7 GTP-CBC-NELF-E 354-380 (FAM) led to a decrease in polarisation indicating the competitive dissociation of the FAM labelled peptide from m 7 GTP-CBC.
SMAD affects USP9X
| 1
SMAD activates USP9X. 1 / 1
| 1

reach
If FAM targets Smad activity, then it should be required for both types of responses.
SH3GL2 affects USP9X
| 1
SH3GL2 decreases the amount of USP9X. 1 / 1
| 1

reach
It is evident from our results that SH3GL2 downregulated the expression of both USP9X and activated CTNNB1 along with the concomitant low expression of activated EGFR and its downstream signaling molecules PI3K, activated AKT and STAT3.
Radiation, Ionizing increases the amount of USP9X. 1 / 1
| 1

reach
Levels of the Mcl-1-regulating deubiquitylating enzyme USP9x were only slightly increased by IR in Ln229 cells and not affected in the other five cell lines.
RTN3 affects USP9X
| 1
RTN3 inhibits USP9X. 1 / 1
| 1

reach
XREF_BIBR; XREF_BIBR Consistently, we found that the HAP and ClpP mediated degradation of heat aggregated FAM labeled MDH requires the M-domain, and is strictly dependent on the cooperation with the cognate Hsp70 system (XREF_FIG).
RPL22 affects USP9X
| 1
RPL22 inhibits USP9X. 1 / 1
| 1

reach
Here, no relevant increase in fluorescence at 520 nm was observed with any of the Eap preparations, when compared to the negative control (PCR grade water), indicating that Eap did not degrade the FAM and BHQ -1 labeled oligonucleotide probe.

reach
Briefly, for the singleplex assay, the 20 μl heat-inactivated RT reaction was combined with a 30-μl PCR mix such that the final reaction volume contained 1× QuantiTect Multiplex PCR Master Mix, 400 nM each of CDV N forward and reverse primers and 200 nM of the VIC-labeled probe or 400 nM each of SIV gag genome-forward and reverse primers and 200 nM of the FAM-labeled probe.
RAC1 affects USP9X
| 1
RAC1 increases the amount of USP9X. 1 / 1
| 1

reach
At the molecular level, we found that RAC1 inhibition led to a decreased expression of the deubiquitinase Usp9X, followed by a decreased stability of Mcl-1.
Progestins affects USP9X
1 |
Progestins increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
1 |
Plant Extracts increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
| 1

reach
Nevertheless, the folic acid mediated preferential uptake of FA-M (PTX) than M (PTX) is not shown in the cell inhibition assay.
Pentosan Sulfuric Polyester increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Pemetrexed affects USP9X
| 1
| 1

reach
While Usp9X was suppressed by Pemetrexed, the pro apoptotic protein Noxa was inversely regulated.
PSMD4 affects USP9X
| 1
PSMD4 activates USP9X. 1 / 1
| 1

reach
[XREF_BIBR XREF_BIBR XREF_BIBR] Schmitz-Valckenberg et al. observed a diminished retinal sensitivity where the AF is increased on the borders of GA. [XREF_BIBR] Different FAF classifications of GA have been proposed.
PSEN1 affects USP9X
| 1
PSEN1 inhibits USP9X. 1 / 1
| 1

reach
XREF_BIBR, XREF_BIBR In support of this notion, transient overexpression of PS1 reduced phagocytic uptake of FAM labeled Abeta42 within a 2-h incubation period in BV2 cells (XREF_FIG).
PRNP affects USP9X
| 1
PRNP activates USP9X. 1 / 1
| 1

reach
Although Muqit et al. already evaluated laser photocoagulation scars using FAF, they compared the FAF changes between the conventional laser and short-pulse laser only for 4 weeks [XREF_BIBR], or they only followed FAF changes of 2 cases treated with short-pulse laser PRP [XREF_BIBR].
PRMT1 affects USP9X
| 1
PRMT1 increases the amount of USP9X. 1 / 1
| 1

reach
Transient knockdown of PRMT1 reduced the USP9X ADMA methylation level and the TDRD3-USP9X interaction (XREF_FIG).
PPP1R12A affects USP9X
| 1
| 1

reach
Recent MBs have been synthesized using a FAM reporter and two or three Dabcyl molecules as quenchers (XREF_FIG) at the 5 ' end [XREF_BIBR].
POU1F1 affects USP9X
1 |
POU1F1 decreases the amount of USP9X. 1 / 1
1 |

biopax:msigdb
No evidence text available
PLXNA2 affects USP9X
| 1
PLXNA2 activates USP9X. 1 / 1
| 1

reach
The combined cSLO and OCT system allowed for simultaneous recordings of topographic and tomographic images with accurate correlation between the confocal angiograms, FAF images as well as other imaging modes with the OCT scans.
PI3 affects USP9X
| 1
PI3 activates USP9X. 1 / 1
| 1

reach
S11 in the ESI,+ cells incubated with the MnO 2 nanosheet mediated FAM labelled probes presented stronger fluorescence signals in the cytoplasm than those incubated with free probes, indicating that the MnO 2 nanosheets could enhance the cellular uptake of the DNA probes.
PDC affects USP9X
| 1
PDC increases the amount of USP9X. 1 / 1
| 1

reach
These results clearly demonstrate that the Saint PhD lipid formulation is enhancing vesicular escape of the stapled peptide and enabling higher intracellular levels of ATSP-7041 FAM to be reached at much lower treatment concentrations when compared to stapled peptide alone.
PCM1 affects USP9X
| 1
PCM1 activates USP9X. 1 / 1
| 1

reach
We believe that investigating whether and how PCM1 contributes to USP9X regulated centrosome biogenesis will be helpful in understanding the functionality of USP9X in centrosome biology.
PAX6 affects USP9X
1 |
PAX6 decreases the amount of USP9X. 1 / 1
1 |

biopax:msigdb
No evidence text available
PAX4 affects USP9X
1 |
PAX4 decreases the amount of USP9X. 1 / 1
1 |

biopax:msigdb
No evidence text available
USP9X is modified
| 1
USP9X is produced. 1 / 1
| 1

reach
USP9X overexpression promoted NF-kB activation, while NF-kB inactivation inhibited USP9X transcription and HPAEpiC injury induced by USP9X overexpression.
NTHL1 affects USP9X
| 1
NTHL1 inhibits USP9X. 1 / 1
| 1

reach
Of note, the interaction of NTH1 with these substrates caused a decrease in FAM fluorescence followed by an increase even in the case of the type I duplex substrate (XREF_FIG).
NPRL3 affects USP9X
| 1
NPRL3 activates USP9X. 1 / 1
| 1

reach
In this study, we examined the expression pattern of Af-6 and Usp9x and their intracellular localization in testes and ovaries of mice treated with or without pregnant mare serum gonadotropin (PMSG), an FSH like hormone.
NFkappaB affects USP9X
| 1
NFkappaB decreases the amount of USP9X. 1 / 1
| 1

reach
USP9X overexpression promoted NF-kB activation, while NF-kB inactivation inhibited USP9X transcription and HPAEpiC injury induced by USP9X overexpression.
NFE2L2 affects USP9X
| 1
NFE2L2 activates USP9X. 1 / 1
| 1

reach
Silencing Nrf2 abolished the renoprotective effects of USP9X.
NFE2L1 affects USP9X
| 1
NFE2L1 increases the amount of USP9X. 1 / 1
| 1

reach
Furthermore, we show that Nrf1 can activate Usp9x gene expression related to neurodegeneration.
NELFE affects USP9X
| 1
NELFE activates USP9X. 1 / 1
| 1

reach
Further addition of unlabelled NELF-E 244-380 to m 7 GTP-CBC-ARS2 845-871 (FAM) or unlabelled ARS2 827-871 to m 7 GTP-CBC-NELF-E 354-380 (FAM) led to a decrease in polarisation indicating the competitive dissociation of the FAM labelled peptide from m 7 GTP-CBC.
NAC affects USP9X
| 1
NAC inhibits USP9X. 1 / 1
| 1

reach
Both TAMRA and FAM signals appeared earlier in reduced cells (treated with NAC) than in oxidized cells (treated with CDNB), suggesting some dependence of cellular peptide uptake on cellular redox state.
1 |
N-methylformamide increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available

reach
When USP9X -/- and WT cells were treated with proteasome inhibitor MG132, eIF4A1 protein levels were increased in a time dependent manner.
Microglia affects USP9X
| 1
| 1

eidos
Taken together , we newly showed that microglia along with RPE cells contributed to the formation of FAF that reflect the type and the extent of photoreceptor apoptosis in RP .
Met-Trp affects USP9X
| 1
| 1

reach
The results revealed that MW treatment did not promote the degradations of FAM and AAP or delay their release from the ODTs, while dissolution of the ODTs containing IBU delayed by MW treatment.
| 1

eidos
The special properties of the fovea offer challenges to such a study : blocking of FAF by macular pigment ( MP ) and a particularly thick ONL .
MOS affects USP9X
| 1
MOS activates USP9X. 1 / 1
| 1

reach
However, when the concentration of MoS 2 exceeded 4.0 mug/mL or higher, the DeltaF decreased, indicating that the MoS 2 of high concentration would cause an excessive quenching effect on the cleavage produced FAM labeled double stranded DNA.
Leu-Cys affects USP9X
| 1
Leu-Cys activates USP9X. 1 / 1
| 1

reach
For ddPCR quantitation of cetuximab LC transgenes, 25ng of genomic DNA were amplified with LC specific primers GL1459 and GL1460 and goat beta-lactoglobulin gene (LGB) primers GL1470 and GL1471 as reference, in the presence of the LC target FAM probe GL1468 and reference HEX probe GL1472 in a 22microL reaction.
LGALS4 affects USP9X
| 1
LGALS4 increases the amount of USP9X. 1 / 1
| 1

reach
Although this might be caused by different levels of FAF expression driven by different Gal4 drivers, or different sensitivities of eye and muscle to FAF activity, it is also possible that the activity of FAF or its interacting proteins are differentially regulated in a tissue specific manner in flies.
L2 affects USP9X
| 1
L2 activates USP9X. 1 / 1
| 1

reach
The CPP and the cargo are differentially labeled with the fluorophores FAM (carboxyfluorescein), and TAMRA (carboxytetramethylrhodamine) respectively, and coupled via a disulfide bond to promote quenching of FAM fluorescence by the proximal TAMRA.
KCNQ1 affects USP9X
| 1
KCNQ1 activates mutated USP9X. 1 / 1
| 1

reach
This is the first study to link a known LQT1 mutation (R231C) to FAF and to show that an LQT1 mutation can generate a functional phenotype similar to the other KCNQ1 mediated FAF mutations.
JAK2 affects USP9X
| 1
JAK2 inhibits USP9X. 1 / 1
| 1

eidos
The best-described USP9X inhibitor is WP1130 ( TABLE 2 ) , identified in a screen for Janus kinase 2 ( JAK2 ) inhibitors , which was shown to inhibit USP9X as well as other DUBs ( USP5 , USP14 and UCHL5 ) 86 , 87 .
ITCH affects USP9X
| 1
ITCH activates USP9X. 1 / 1
| 1

reach
Although the E3 ligase Itch was shown to mediate the antitumor effects of USP9X in the pancreas, our data demonstrate that USP9X can prevent intestinal cancer by directly regulating the stability of FBW7 protein.
IRF7 affects USP9X
1 |
Transcriptionally active IRF7 increases the amount of USP9X. 1 / 1
1 |

bel
TABLE IV Selected genes up-regulated by IRF-7
IQCB1 affects USP9X
| 1
IQCB1 inhibits USP9X. 1 / 1
| 1

reach
Depletion of NPHP5 specifically disrupted the centrosomal localization of USP9X (XREF_FIG), suggesting that a pool of cytoplasmic USP9X is recruited to the centrosome where it might serve to deubiquitinate NPHP5.
IK affects USP9X
| 1
IK activates USP9X. 1 / 1
| 1

reach
PHYLOGENETIC ANALYSES OF THE RED ALGAL ORDER RHODYMENIALES SUPPORTS RECOGNITION OF THE HYMENOCLADIACEAE FAM.
ICG 001 affects USP9X
1 |
ICG 001 increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
His-Gly affects USP9X
| 1
| 1

reach
The addition of Hg (II) cation decreased the intensity of Fam emission of F2T6W2D at 520 nm in a concentration dependent manner.
| 1
Hemagglutinins increases the amount of USP9X. 1 / 1
| 1

reach
Brief stimulation of T cells increased the labeling of USP9X by HA‐Ub‐VS without an increase in USP9X levels, while the phospho‐site mutant, which still possess a potentially reactive active site Cys residue, was much less reactive toward the probe following stimulation.
HMBS affects USP9X
| 1
HMBS activates USP9X. 1 / 1
| 1

reach
ddPCR was run in a final volume of 22muL with tumor DNA, 10mul ddPCR Supermix for probes (no dUTP), primers for the EGFR- and HMBS targeted amplicons (0.9 muM), 6-carboxyfluorescein (FAM)-labeled LNA based hydrolysis probe for the EGFR targeted sequence (0.18 muM), and VIC labeled probe for the HMBS amplicon (0.18 muM).
HLF affects USP9X
1 |
HLF decreases the amount of USP9X. 1 / 1
1 |

biopax:msigdb
No evidence text available
HEL affects USP9X
| 1
HEL activates USP9X. 1 / 1
| 1

reach
FAM fluorescence was quenched by TAMRA and increased 180-fold after cleavage of the ribouridine (rU) site by RNase.
HBEGF affects USP9X
| 1
HBEGF decreases the amount of USP9X. 1 / 1
| 1

reach
HB-EGF is implicated in DSBs repair as silencing of HB-EGF increased gammaH2AX foci half-life as well as USP9X expression, two features that could be linked to the observed effect on Mcl-1.
Gel affects USP9X
| 1
Gel inhibits USP9X. 1 / 1
| 1

reach
Gel profiles showed decreasing FAM intensity of the nanostructure band with increasing UV exposure time and appearance of an additional band near the bottom of the gel corresponding to the released FAM (XREF_FIG - XREF_FIG and XREF_SUPPLEMENTARY).
GNRHR2 affects USP9X
| 1
GNRHR2 inhibits USP9X. 1 / 1
| 1

reach
The PCR amplification of GNRHR2 was performed using forward (F-CCCCGGACAAGGAAGGG) and reverse (R-AAGGAGCGACGGAGGGTCAA) primers (Integrated DNA Technologies, Coralville, Iowa) as well as a FAM labeled TaqMan MGB probe (ATGATGCCCCTGCCGG; Applied Biosystems, Foster City, CA).
GCM1 affects USP9X
1 |
GCM1 decreases the amount of USP9X. 1 / 1
1 |

biopax:msigdb
No evidence text available
FAS affects USP9X
| 1
FAS activates USP9X. 1 / 1
| 1

reach
These results suggest that this regulation of ICE caspases in the Werner 's Syndrome cell line may inhibit normal apoptosis despite higher level of Fas and Fas associated signaling molecules FAP, FADD[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
ETS affects USP9X
| 1
ETS activates USP9X. 1 / 1
| 1

reach
For example, ETS proteins can bind to mutated upstream promoters of critical genes (that is, hTERT) and may also underlie the biological importance of Usp9x in melanoma and other tumours XREF_BIBR XREF_BIBR.
EPS15 affects USP9X
| 1
EPS15 inhibits USP9X. 1 / 1
| 1

reach
Increased levels of modified Eps15 (indicated by arrowheads in Figure 5 B) were evident upon depletion of USP9X.
1 |
Dietary Fats increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
1 |

ctd
No evidence text available
DXO affects USP9X
| 1
DXO inhibits USP9X. 1 / 1
| 1

reach
A 30 nucleotide RNA substrate with a 5 '-end monophosphate and a 3 '-end FAM (6-carboxyfluorescein) fluorophore was degraded by wild-type Dom3Z from the 5 '-end with clear intermediates detected (XREF_FIG, lanes 2-4)), but not by a catalytically inactive Dom3Z (lane 5), suggesting that Dom3Z has distributive, 5 '-3' exoribonuclease activity.
DIABLO affects USP9X
| 1
DIABLO inhibits USP9X. 1 / 1
| 1

reach
Moreover, SMAC mimetics, which are known to interfere with protein binding of XIAP via its BIR2 domain (Krieg etal, 2009; Damgaard etal, 2013), disrupted the interaction of USP9X to XIAP (Fig XREF_FIG D).
DDIT3 affects USP9X
1 |
DDIT3 decreases the amount of USP9X. 1 / 1
1 |

biopax:msigdb
No evidence text available
1 |
D-glucopyranose increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Collagen affects USP9X
| 1
| 1

sparser
Also, FAM120A may be involved in GPR56 signal transduction, as this receptor for type III collagen activates RhoA, and FAM120A is associated to RhoGEFs.
CYLD affects USP9X
| 1
CYLD activates USP9X. 1 / 1
| 1

reach
The co-expression of CYLD failed to modify the effect of PAR-1 at the NMJ (XREF_SUPPLEMENTARY), supporting FAF as a positive regulator of PAR-1.
CTXN1 affects USP9X
| 1
CTXN1 activates USP9X. 1 / 1
| 1

reach
Likewise, the addition of 80 nM CTX1, CTX2, CTX4, CTX5, and CTXn restored the FAM fluorescence of hairpin shaped MB (Inset of XREF_FIG A).
CTX5 affects USP9X
| 1
CTX5 activates USP9X. 1 / 1
| 1

reach
Likewise, the addition of 80 nM CTX1, CTX2, CTX4, CTX5, and CTXn restored the FAM fluorescence of hairpin shaped MB (Inset of XREF_FIG A).
CTX4 affects USP9X
| 1
CTX4 activates USP9X. 1 / 1
| 1

reach
Likewise, the addition of 80 nM CTX1, CTX2, CTX4, CTX5, and CTXn restored the FAM fluorescence of hairpin shaped MB (Inset of XREF_FIG A).
CTX2 affects USP9X
| 1
CTX2 activates USP9X. 1 / 1
| 1

reach
Likewise, the addition of 80 nM CTX1, CTX2, CTX4, CTX5, and CTXn restored the FAM fluorescence of hairpin shaped MB (Inset of XREF_FIG A).
CTX1 affects USP9X
| 1
CTX1 activates USP9X. 1 / 1
| 1

reach
Likewise, the addition of 80 nM CTX1, CTX2, CTX4, CTX5, and CTXn restored the FAM fluorescence of hairpin shaped MB (Inset of XREF_FIG A).
CLPP affects USP9X
| 1
CLPP inhibits USP9X. 1 / 1
| 1

reach
XREF_BIBR; XREF_BIBR Consistently, we found that the HAP and ClpP mediated degradation of heat aggregated FAM labeled MDH requires the M-domain, and is strictly dependent on the cooperation with the cognate Hsp70 system (XREF_FIG).
CISH affects USP9X
| 1
CISH activates USP9X. 1 / 1
| 1

reach
As shown in XREF_FIG, the GAO strand was extended as demonstrated by the appearance of peaks that were located close to the peaks for the CIS reaction product of the FAM labelled upper strand.
CEP131 affects USP9X
| 1
CEP131 activates USP9X. 1 / 1
| 1

reach
These results suggest that CEP131 functions cooperatively with but independently of other USP9X substrates in USP9X promoted breast cancer cell survival, and also provide an explanation for why overexpression of CEP131 could not fully restore the growth of USP9X knocked down tumour cells.
CEBPD affects USP9X
1 |
CEBPD decreases the amount of USP9X. 1 / 1
1 |

biopax:msigdb
No evidence text available
CEBPB affects USP9X
1 |
CEBPB decreases the amount of USP9X. 1 / 1
1 |

biopax:msigdb
No evidence text available
CDKN2A affects USP9X
| 1
CDKN2A activates USP9X. 1 / 1
| 1

reach
The multicolour beacon produced the characteristic fluorescence when it bound to the designed targets : p16 produced the blue colour of FAM emission, p21 produced the red of Cy5 and p53 produced the orange of Rox.
CAVIN2 affects USP9X
| 1
CAVIN2 activates USP9X. 1 / 1
| 1

reach
In the presence of HMF, the obtained S0-CHO induced the formation of T-shaped DNA by strand displacement reaction (SDR), lighting the fluorescence of FAM.
BCL2L1 affects USP9X
| 1
BCL2L1 activates USP9X. 1 / 1
| 1

reach
Treatment with TIC10 and ONC201 and concomitant inhibition of Bcl-2 and Bcl-xL depletes the Mcl-1 chaperone Bag3 and the deubiquitinase Usp9X.
BCL2 affects USP9X
| 1
BCL2 activates USP9X. 1 / 1
| 1

reach
Treatment with TIC10 and ONC201 and concomitant inhibition of Bcl-2 and Bcl-xL depletes the Mcl-1 chaperone Bag3 and the deubiquitinase Usp9X.
BAX affects USP9X
| 1
BAX decreases the amount of USP9X. 1 / 1
| 1

reach
Bax -/- mice also had reduced expression of Fas, caspase 8, FADD, FAF, TRAIL and TRADD mRNA, suggesting a link between Bax and death domain receptor mediated apoptotic pathways belonging to the TNFR-FAS extrinsic signaling pathways.
Asp-Trp affects USP9X
| 1
Asp-Trp activates USP9X. 1 / 1
| 1

reach
Individual fAM concentrations (XREF_SUPPLEMENTARY) increased by 73% during the breeding period (0.59 +/- 0.04 mug/g DW; mean +/- SD) compared to the entire non breeding period and by 85% when compared to only the lactation and gestation period only (0.31 +/- 0.04 mug/g DW) but increased by 5.28% when compared exclusively to the birth period (0.54 +/- 0.11 mug/g DW).
Antirheumatic Agents decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
Actin affects USP9X
| 1
Actin activates mutated USP9X. 1 / 1
| 1

reach
Since the actin fibre staining of GSN-EF cells expressing either the wild-type or FAF mutant gelsolin were similar, these results would suggest that the actin modulating func- tions of the wild-type a[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]
ATP affects USP9X
| 1
ATP activates USP9X. 1 / 1
| 1

reach
On intact hindlimbs ADO (4 mmol/l) and ATP (0.5 mmol/l) elicited 3.5-fold increase of FAF, in average.
ASPG affects USP9X
| 1
ASPG decreases the amount of USP9X. 1 / 1
| 1

reach
The finding that L-asparaginase decreases levels of the deubiquitinase Usp9X has not been observed thus far.
ALPI affects USP9X
| 1
ALPI inhibits USP9X. 1 / 1
| 1

reach
To investigate this possibility, we analyzed the stability of different IAP proteins under the condition of RNAi mediated USP9X knockdown.
AICDA affects USP9X
| 1
AICDA increases the amount of USP9X. 1 / 1
| 1

reach
The AID tagging system enhances the underlying heterogeneity of Usp9x expression in ES cells cultured in serum and LIF, enabling us to use GFP expression to isolate subpopulations that resist degradation (Usp9x-high) or lose Usp9x (Usp9x-low) in response to auxin, each fraction corresponding to ~ 20% of the total population.
ADO affects USP9X
| 1
ADO activates USP9X. 1 / 1
| 1

reach
On intact hindlimbs ADO (4 mmol/l) and ATP (0.5 mmol/l) elicited 3.5-fold increase of FAF, in average.
ADIPOQ affects USP9X
| 1
ADIPOQ inhibits USP9X. 1 / 1
| 1

reach
Adiponectin treatment attenuates inflammatory response in FAF macrophages.
7,12-dimethyltetraphene decreases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
| 1

reach
The patients assigned to 1/2 FAM group were treated with 5-FU 200 mg/m2/day IV, ADM 15 mg/m2/day IV and MMC 5 mg/m2/day IV.
3-methylcholanthrene increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available
1 |

ctd
No evidence text available
1 |

ctd
No evidence text available
17alpha-ethynylestradiol increases the amount of USP9X. 1 / 1
1 |

ctd
No evidence text available

ctd
No evidence text available

reach
Triplicates of the FAM modified oligonucleotide conjugates were treated with DTT (10mM) and left to completely aggregate.
1 |

ctd
No evidence text available

reach
Quenching of FAM signal by Dab occurs when the molecules are brought in proximity to one another (i.e. when the G4 DNA folds).
1 |

ctd
No evidence text available